Cover
Cover - USD ($) | 12 Months Ended | ||
Mar. 29, 2024 | May 10, 2024 | Sep. 29, 2023 | |
Cover [Abstract] | |||
Document Type | 10-K | ||
Document Annual Report | true | ||
Document Period End Date | Mar. 29, 2024 | ||
Current Fiscal Year End Date | --03-29 | ||
Document Transition Report | false | ||
Entity File Number | 000-17781 | ||
Entity Registrant Name | Gen Digital Inc. | ||
Entity Incorporation, State or Country Code | DE | ||
Entity Tax Identification Number | 77-0181864 | ||
Entity Address, Address Line One | 60 E. Rio Salado Parkway, | ||
Entity Address, Address Line Two | Suite 1000, | ||
Entity Address, City or Town | Tempe, | ||
Entity Address, State or Province | AZ | ||
Entity Address, Postal Zip Code | 85281 | ||
City Area Code | 650 | ||
Local Phone Number | 527-8000 | ||
Title of 12(b) Security | Common Stock, | ||
Trading Symbol | GEN | ||
Security Exchange Name | NASDAQ | ||
Entity Well-known Seasoned Issuer | No | ||
Entity Voluntary Filers | No | ||
Entity Current Reporting Status | Yes | ||
Entity Interactive Data Current | Yes | ||
Entity Filer Category | Large Accelerated Filer | ||
Entity Small Business | false | ||
Entity Emerging Growth Company | false | ||
ICFR Auditor Attestation Flag | true | ||
Document Financial Statement Error Correction | false | ||
Entity Shell Company | false | ||
Entity Public Float | $ 7,116,883,792 | ||
Entity Common Stock, Shares Outstanding | 626,145,897 | ||
Documents Incorporated by Reference | Portions of the registrant’s definitive proxy statement for the 2024 annual meeting of stockholders are incorporated herein by reference into Part III of this Annual Report on Form 10-K where indicated. Such Proxy Statement will be filed with the Securities and Exchange Commission within 120 days of the registrant’s fiscal year ended March 29, 2024. | ||
Amendment Flag | false | ||
Document Fiscal Year Focus | 2024 | ||
Document Fiscal Period Focus | FY | ||
Entity Central Index Key | 0000849399 |
Audit Information
Audit Information | 12 Months Ended |
Mar. 29, 2024 | |
Audit Information [Abstract] | |
Auditor Name | KPMG, LLP |
Auditor Location | Santa Clara, CA |
Auditor Firm ID | 185 |
CONSOLIDATED BALANCE SHEETS
CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions | Mar. 29, 2024 | Mar. 31, 2023 |
Current assets: | ||
Cash and cash equivalents | $ 846 | $ 750 |
Accounts receivable, net | 163 | 168 |
Other current assets | 334 | 284 |
Assets held for sale | 15 | 31 |
Total current assets | 1,358 | 1,233 |
Property and equipment, net | 72 | 76 |
Intangible assets, net | 2,638 | 3,097 |
Goodwill | 10,210 | 10,217 |
Other long-term assets | 1,494 | 1,324 |
Total assets | 15,772 | 15,947 |
Current liabilities: | ||
Accounts payable | 66 | 77 |
Accrued compensation and benefits | 78 | 102 |
Current portion of long-term debt | 175 | 233 |
Contract liabilities | 1,730 | 1,708 |
Other current liabilities | 599 | 729 |
Total current liabilities | 2,648 | 2,849 |
Long-term debt | 8,429 | 9,529 |
Long-term contract liabilities | 76 | 80 |
Deferred income tax liabilities | 261 | 395 |
Long-term income taxes payable | 1,490 | 820 |
Other long-term liabilities | 671 | 74 |
Total liabilities | 13,575 | 13,747 |
Commitments and contingencies (Note 18) | ||
Stockholders’ equity (deficit): | ||
Common stock and additional paid-in capital, $0.01 par value: 3,000 shares authorized; 623 and 640 shares issued and outstanding as of March 29, 2024 and March 31, 2023, respectively | 2,227 | 2,800 |
Accumulated other comprehensive income (loss) | 11 | (15) |
Retained earnings (accumulated deficit) | (41) | (585) |
Total stockholders’ equity (deficit) | 2,197 | 2,200 |
Total liabilities and stockholders’ equity (deficit) | $ 15,772 | $ 15,947 |
CONSOLIDATED BALANCE SHEETS (Pa
CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares | Mar. 29, 2024 | Mar. 31, 2023 |
Statement of Financial Position [Abstract] | ||
Common stock, par value (in dollars per share) | $ 0.01 | $ 0.01 |
Common stock, shares authorized (in shares) | 3,000,000,000 | 3,000,000,000 |
Common stock, shares issued (in shares) | 623,000,000 | 640,000,000 |
Common stock, shares outstanding (in shares) | 623,000,000 | 640,000,000 |
CONSOLIDATED STATEMENTS OF OPER
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Millions, $ in Millions | 12 Months Ended | ||
Mar. 29, 2024 | Mar. 31, 2023 | Apr. 01, 2022 | |
Income Statement [Abstract] | |||
Net revenues | $ 3,812 | $ 3,338 | $ 2,796 |
Cost of revenues | 731 | 589 | 408 |
Gross profit | 3,081 | 2,749 | 2,388 |
Operating expenses: | |||
Sales and marketing | 733 | 682 | 622 |
Research and development | 332 | 313 | 253 |
General and administrative | 604 | 286 | 392 |
Amortization of intangible assets | 233 | 172 | 85 |
Restructuring and other costs | 57 | 69 | 31 |
Total operating expenses | 1,959 | 1,522 | 1,383 |
Operating income (loss) | 1,122 | 1,227 | 1,005 |
Interest expense | (669) | (401) | (126) |
Other income (expense), net | 6 | (22) | 163 |
Income (loss) before income taxes | 459 | 804 | 1,042 |
Income tax expense (benefit) | (157) | (545) | 206 |
Net income (loss) | $ 616 | $ 1,349 | $ 836 |
Net income (loss) per share - basic (in dollars per share) | $ 0.97 | $ 2.20 | $ 1.44 |
Net income (loss) per share - diluted (in dollars per share) | $ 0.96 | $ 2.16 | $ 1.41 |
Weighted-average shares outstanding: | |||
Basic (in shares) | 637 | 614 | 581 |
Diluted (in shares) | 642 | 624 | 591 |
CONSOLIDATED STATEMENTS OF COMP
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) - USD ($) $ in Millions | 12 Months Ended | ||
Mar. 29, 2024 | Mar. 31, 2023 | Apr. 01, 2022 | |
Statement of Comprehensive Income [Abstract] | |||
Net income (loss) | $ 616 | $ 1,349 | $ 836 |
Other comprehensive income (loss), net of taxes: | |||
Foreign currency translation adjustments | 10 | (11) | (51) |
Net unrealized gain (loss) on interest rate derivative instruments | 16 | 0 | 0 |
Other comprehensive income (loss), net of taxes | 26 | (11) | (51) |
Comprehensive income (loss) | $ 642 | $ 1,338 | $ 785 |
CONSOLIDATED STATEMENTS OF STOC
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (DEFICIT) - USD ($) $ in Millions | Total | Cumulative Effect, Period of Adoption, Adjustment | [1] | Common Stock and Additional Paid-In Capital | Common Stock and Additional Paid-In Capital Cumulative Effect, Period of Adoption, Adjustment | [1] | Accumulated Other Comprehensive Income (Loss) | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) Cumulative Effect, Period of Adoption, Adjustment | [1] | ||
Beginning balance (in shares) at Apr. 02, 2021 | 580,000,000 | |||||||||||
Beginning balance at Apr. 02, 2021 | $ (500) | $ 2,229 | $ 47 | $ (2,776) | ||||||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||||||||
Net income (loss) | 836 | 836 | ||||||||||
Other comprehensive income (loss), net of taxes | (51) | (51) | ||||||||||
Common stock issued under employee stock incentive plans (in shares) | 3,000,000 | |||||||||||
Common stock issued under employee stock incentive plans | 14 | $ 14 | ||||||||||
Shares withheld for taxes related to vesting of restricted stock units (in shares) | (1,000,000) | |||||||||||
Shares withheld for taxes related to vesting of stock units | (16) | $ (16) | ||||||||||
Cash dividends declared and dividend equivalents accrued | (294) | (294) | ||||||||||
Stock-based compensation | 70 | 70 | ||||||||||
Extinguishment of convertible debt | (152) | $ (152) | ||||||||||
Ending balance (in shares) at Apr. 01, 2022 | 582,000,000 | |||||||||||
Ending balance at Apr. 01, 2022 | (93) | $ (1) | $ 1,851 | $ (7) | (4) | (1,940) | $ 6 | |||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||||||||
Net income (loss) | 1,349 | 1,349 | ||||||||||
Other comprehensive income (loss), net of taxes | (11) | (11) | ||||||||||
Common stock issued under employee stock incentive plans (in shares) | 5,000,000 | |||||||||||
Common stock issued under employee stock incentive plans | 12 | $ 12 | ||||||||||
Shares withheld for taxes related to vesting of restricted stock units (in shares) | (1,000,000) | |||||||||||
Shares withheld for taxes related to vesting of stock units | $ (19) | $ (19) | ||||||||||
Repurchases of common stock (in shares) | (40,000,000) | (40,000,000) | ||||||||||
Repurchases of common stock | $ (904) | $ (904) | ||||||||||
Cash dividends declared and dividend equivalents accrued | (308) | (308) | ||||||||||
Stock-based compensation | 134 | 134 | ||||||||||
Extinguishment of convertible debt | (100) | $ (100) | ||||||||||
Acquisition consideration (in shares) | 94,000,000 | |||||||||||
Acquisition consideration | $ 2,141 | $ 2,141 | ||||||||||
Ending balance (in shares) at Mar. 31, 2023 | 640,000,000 | 640,000,000 | ||||||||||
Ending balance at Mar. 31, 2023 | $ 2,200 | $ 2,800 | (15) | (585) | ||||||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||||||||
Accounting Standards Update [Extensible Enumeration] | Accounting Standards Update 2020-06 [Member] | |||||||||||
Net income (loss) | $ 616 | 616 | ||||||||||
Other comprehensive income (loss), net of taxes | 26 | 26 | ||||||||||
Common stock issued under employee stock incentive plans (in shares) | 6,000,000 | |||||||||||
Common stock issued under employee stock incentive plans | 12 | $ 12 | ||||||||||
Shares withheld for taxes related to vesting of restricted stock units (in shares) | (2,000,000) | |||||||||||
Shares withheld for taxes related to vesting of stock units | $ (26) | $ (26) | ||||||||||
Repurchases of common stock (in shares) | (21,000,000) | (21,000,000) | [2] | |||||||||
Repurchases of common stock | [2] | $ (444) | $ (444) | |||||||||
Cash dividends declared and dividend equivalents accrued | (325) | (253) | (72) | |||||||||
Stock-based compensation | $ 138 | $ 138 | ||||||||||
Ending balance (in shares) at Mar. 29, 2024 | 623,000,000 | 623,000,000 | ||||||||||
Ending balance at Mar. 29, 2024 | $ 2,197 | $ 2,227 | $ 11 | $ (41) | ||||||||
[1]Effective on April 2, 2022, we adopted ASU 2020-06 (Debt with Conversion and Other Options, ASC 470-20) using a modified retrospective method.[2]Amount includes excise tax on share repurchases. |
CONSOLIDATED STATEMENTS OF ST_2
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (DEFICIT) (Parenthetical) - $ / shares | 12 Months Ended | ||
Mar. 29, 2024 | Mar. 31, 2023 | Apr. 01, 2022 | |
Statement of Stockholders' Equity [Abstract] | |||
Cash dividends declared per common share (in dollars per share) | $ 0.50 | $ 0.50 | $ 0.50 |
CONSOLIDATED STATEMENTS OF CASH
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions | 12 Months Ended | ||
Mar. 29, 2024 | Mar. 31, 2023 | Apr. 01, 2022 | |
OPERATING ACTIVITIES: | |||
Net income | $ 616 | $ 1,349 | $ 836 |
Adjustments: | |||
Amortization and depreciation | 485 | 329 | 140 |
Impairments and write-offs of current and long-lived assets | 25 | 13 | |
Impairments and write-offs of current and long-lived assets | (3) | ||
Stock-based compensation expense | 138 | 134 | 70 |
Deferred income taxes | (991) | (145) | (81) |
Loss (gain) on extinguishment of debt | 0 | 9 | 3 |
Gain on sale of properties | (9) | 0 | (175) |
Non-cash operating lease expense | 18 | 23 | 20 |
Impairment on non-marketable equity investments | 40 | 0 | 0 |
Other | 22 | 2 | 1 |
Changes in operating assets and liabilities, net of acquisitions: | |||
Accounts receivable, net | 7 | 11 | (9) |
Accounts payable | (12) | (8) | 10 |
Accrued compensation and benefits | (24) | (6) | (26) |
Contract liabilities | 35 | (5) | 67 |
Income taxes payable | 446 | (128) | (78) |
Other assets | 864 | (696) | (7) |
Other liabilities | 432 | (137) | 190 |
Net cash provided by (used in) operating activities | 2,064 | 757 | 974 |
INVESTING ACTIVITIES: | |||
Purchases of property and equipment | (20) | (6) | (6) |
Payments for acquisitions, net of cash acquired | 0 | (6,547) | (39) |
Proceeds from the maturities and sales of short-term investments | 0 | 4 | 15 |
Proceeds from the sale of properties | 25 | 0 | 355 |
Other | (3) | 2 | 1 |
Net cash provided by (used in) investing activities | 2 | (6,547) | 326 |
FINANCING ACTIVITIES: | |||
Repayments of debt and related equity component | (1,183) | (3,047) | (541) |
Proceeds from issuance of debt, net of issuance costs | 0 | 8,954 | 512 |
Net proceeds from sales of common stock under employee stock incentive plans | 12 | 12 | 14 |
Tax payments related to vesting of stock units | (26) | (20) | (15) |
Dividends and dividend equivalents paid | (323) | (314) | (303) |
Repurchases of common stock | (441) | (904) | 0 |
Net cash provided by (used in) financing activities | (1,961) | 4,681 | (333) |
Effect of exchange rate fluctuations on cash and cash equivalents | (9) | (28) | (13) |
Change in cash and cash equivalents | 96 | (1,137) | 954 |
Beginning cash and cash equivalents | 750 | 1,887 | 933 |
Ending cash and cash equivalents | $ 846 | $ 750 | $ 1,887 |
Description of Business and Sum
Description of Business and Summary of Significant Accounting Policies | 12 Months Ended |
Mar. 29, 2024 | |
Accounting Policies [Abstract] | |
Description of Business and Summary of Significant Accounting Policies | Description of Business and Significant Accounting Policies Business Gen Digital Inc. is a global company powering Digital Freedom with a family of trusted consumer brands including Norton, Avast, LifeLock, Avira, AVG, ReputationDefender and CCleaner. Our cyber safety portfolio provides protection across multiple channels and geographies, including security and performance, identity protection, and online privacy. Our technology platforms bring together software and service capabilities into comprehensive and easy-to-use products and solutions across our brands. We have also evolved beyond traditional cyber safety to offer adjacent trust-based solutions, including digital identity and access management, digital reputation, and restoration support services. On September 12, 2022, we completed our acquisition of Avast, plc (Avast). Avast has been included in our Consolidated Statements of Operations since the acquisition date. See Note 4 for further information about this business combination. Basis of presentation The accompanying Consolidated Financial Statements of Gen Digital Inc. and our wholly-owned subsidiaries are prepared in conformity with generally accepted accounting principles in the United States (U.S. GAAP). All significant intercompany accounts and transactions have been eliminated in consolidation. Fiscal calendar We have a 52/53-week fiscal year ending on the Friday closest to March 31. Fiscal 2024, 2023 and 2022 in this report refers to fiscal years ended March 29, 2024, March 31, 2023 and April 1, 2022, respectively, each of which was a 52-week year. Use of estimates The preparation of Consolidated Financial Statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions that affect the amounts reported in the Consolidated Financial Statements and accompanying Notes. Such estimates include, but are not limited to, valuation of business combinations including acquired intangible assets and goodwill, loss contingencies, the recognition and measurement of current and deferred income taxes, including assessing of unrecognized tax benefits, and valuation of assets and liabilities. On an ongoing basis, management determines these estimates and assumptions based on historical experience and on various other assumptions that are believed to be reasonable. Third-party valuation specialists are also utilized for certain estimates. Actual results could differ from such estimates and assumptions due to risks and uncertainties, including uncertainty in the current economic environment as a result of macroeconomic factors such as inflation, fluctuations in foreign currency exchange rates relative to the U.S. dollars, our reporting currency, changes in interest rates, Russia’s invasion of Ukraine, and the Israel-Hamas conflict, and such differences may be material to the Consolidated Financial Statements. Significant Accounting Policies With the exception of those discussed in Note 2, there were no material changes in accounting pronouncements issued by the Financial Accounting Standards Board (FASB) that were applicable or adopted by us during fiscal 2024. Revenue recognition We sell products and services directly to end-users and through multiple partner distribution channels. Revenue recognition begins when we transfer control of the promised products or services to our customers in an amount that reflects the consideration we expect to be entitled to in exchange for such products or services. Our customer definition aligns with the control principles as outlined under Accounting Standards Codification (ASC) 606. Performance periods are generally one year or less, and payments are generally collected up front. Revenue is recognized net of any taxes collected from customers and subsequently remitted to governmental authorities. Our customers are primarily users of our products and solutions who sign up on our e-commerce platform and have a direct billing relationship with us. However, our customers, also include users who do not have a direct billing relationship with us but register on our e-commerce site through our e-commerce partners. When referring to e-commerce partners, we are referring to those that are our fulfillment and payment processors who perform primarily administrative functions, such as collecting payment and remitting any required sales tax to governmental authorities. Revenue from these e-commerce partners is recognized on a gross basis, excluding fees paid to e-commerce partners. We offer various channel rebates for our products. Our estimated reserves for channel volume incentive rebates are based on distributors’ and resellers’ performance compared to the terms and conditions of volume incentive rebate programs, which are typically entered into quarterly. Our reserves for rebates are estimated based on the terms and conditions of the promotional program, actual sales during the promotion, the amount of redemptions received, historical redemption trends by product and by type of promotional program and the value of the rebate. We record estimated reserves for rebates as an offset to revenue or contract liabilities. Reserves for rebates, recorded in Other current liabilities, were $4 million as of March 29, 2024 and March 31, 2023. For products that include content updates and services, rebates are recognized as a ratable offset to revenue or contract liabilities over the term of the subscription. Performance obligations At contract inception, we assess the products and services promised in the contract to identify each performance obligation and evaluate whether the performance obligations are capable of being distinct and are distinct within the context of the contract. Performance obligations that are not both capable of being distinct and are distinct within the context of the contract are combined and treated as a single performance obligation in determining the allocation and recognition of revenue. Our software solutions typically consist of a term-based subscription as well as when-and-if available software updates and upgrades. We have determined that our promises to transfer the software license subscription and the related support and maintenance are not separately identifiable because: • the licensed software and the software updates and upgrades are highly interdependent and highly interrelated, working together to deliver continuously updated protection to customers; • by identifying and addressing new threats, the software updates and upgrades significantly modify the licensed software and are integral to maintaining its utility; and • given the rapid pace with which new threats are identified, the value of the licensed software diminishes rapidly without the software updates and upgrades. We therefore consider the software license and related support obligations a single, combined performance obligation with revenue recognized over time as our solutions are delivered. Revenue from services is recognized as services are completed or ratably over the contractual period. Fair value measurements For assets and liabilities measured at fair value, fair value is the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining fair value, we consider the principal or most advantageous market in which we would transact, and we consider assumptions that market participants would use when pricing the asset or liability. The three levels of inputs that may be used to measure fair value are: • Level 1: Quoted prices in active markets for identical assets or liabilities. • Level 2: Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities, quoted prices in less active markets or model-derived valuations. All significant inputs used in our valuations, such as discounted cash flows, are observable or can be derived principally from or corroborated with observable market data for substantially the full term of the assets or liabilities. • Level 3: Unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of assets or liabilities. We monitor and review the inputs and results of these valuation models to help ensure the fair value measurements are reasonable and consistent with market experience in similar asset classes. Assets measured and recorded at fair value: Cash equivalents . We consider all highly liquid investments with an original maturity of three months or less at the time of purchase to be cash equivalents. Cash equivalents are carried at amounts that approximate fair value due to the short period of time to maturity. Non-marketable investments. Our non-marketable investments consist of equity investments in privately-held companies without a readily determinable fair value. We primarily measure these investments at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for identical or similar investments of the same issuer. We may elect to measure certain investments at fair value, for which we utilize third-party valuation specialists at least annually in the fourth quarter of each fiscal year, or more frequently if events or changes in circumstances indicate a change in the fair value of the investment. Gains and losses on these investments, whether realized or unrealized, are recognized in Other income (expense), net in our Consolidated Statements of Operations. We assess the recoverability of our non-marketable investments by reviewing various indicators of impairment. If indicators are present, a fair value measurement is made by performing a discounted cash flow analysis of the investment. We immediately recognize the impairment to our non-marketable equity investments if the carrying value exceeds the fair value. Accounts receivable Accounts receivable are recorded at the invoiced amount and are not interest bearing. We maintain an allowance for doubtful accounts or expected credit losses to reserve for expected uncollectible receivables. We review our accounts receivable by aging category to identify specific customers with known disputes or collectability issues. In addition, we maintain an allowance for all other receivables not included in the specific reserve by applying specific percentages of projected uncollectible receivables to the various aging categories. In determining these percentages, we use judgment based on our historical collection experience and current economic trends as well as reasonable and supportable forecasts of future economic conditions. Assets held for sale Long-lived assets held for sale are recorded at the lower of carrying value or fair value less costs to sell. Fair value is determined based on discounted cash flows, appraised values or management’s estimates, depending upon the nature of the assets and external data available. Property and equipment Property, equipment, and leasehold improvements are stated at cost, net of accumulated depreciation. Depreciation is provided on a straight-line basis over the estimated useful lives. Estimated useful lives for financial reporting purposes are as follows: buildings, 20 to 30 years; building improvements, 7 to 20 years; leasehold improvements, the lesser of the life of the improvement or the initial lease term, and computer hardware and software and office furniture and equipment, 3 to 5 years. Software development costs The costs for the development of new software products and substantial enhancements to existing software products are expensed as incurred until technological feasibility has been established, at which time any additional costs would be capitalized in accordance with the accounting guidance for software. Because our current process for developing software is essentially completed concurrently with the establishment of technological feasibility, which occurs upon the completion of a working model, no costs have been capitalized for any of the periods presented. Internal-use software development costs We capitalize qualifying costs incurred during the application development stage related to software developed for internal-use and amortize them over the estimated useful life of 3 years. We expense costs incurred related to the planning and post-implementation phases of development as incurred. As of March 29, 2024 and March 31, 2023, capitalized costs, net of amortization, were $5 million and $6 million, respectively. Leases We determine if an arrangement is a lease at inception. We have elected to not recognize a lease liability or right-of-use (ROU) asset for short-term leases (leases with a term of twelve months or less that do not include an option to purchase the underlying asset). Operating lease ROU assets and operating lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term at commencement date. The interest rate we use to determine the present value of future payments is our incremental borrowing rate because the rate implicit in our leases is not readily determinable. Our incremental borrowing rate is a hypothetical rate for collateralized borrowings in economic environments where the leased asset is located based on credit rating factors. Our operating lease assets also include adjustments for prepaid lease payments , lease incentives and initial direct costs . Certain lease contracts include obligations to pay for other services, such as operations and maintenance. We elected the practical expedient whereby we record all lease components and the related minimum non-lease components as a single lease component. Cash payments made for variable lease costs are not included in the measurement of our operating lease assets and liabilities. Many of our lease terms include one or more options to renew. We do not assume renewals in our determination of the lease term unless it is reasonably certain that we will exercise that option. Lease costs for minimum lease payments for operating leases are recognized on a straight-line basis over the lease term. Our lease agreements do not contain any residual value guarantees. Business combinations We use the acquisition method of accounting under the authoritative guidance on business combinations. We allocate the purchase price of our acquisitions to the assets acquired and liabilities assumed based on their estimated fair values. The excess of the purchase price over the fair values of these identifiable assets and liabilities is recorded as goodwill. Acquisition-related expenses are recognized separately from the business combination and are expensed as incurred. Each acquired company’s operating results are included in our Consolidated Financial Statements starting on the date of acquisition. Goodwill Goodwill is recorded when consideration paid for an acquisition exceeds the fair value of net tangible and intangible assets acquired. We perform an impairment assessment of goodwill at the reporting unit level at least annually in the fourth quarter of each fiscal year, or more frequently if events or changes in circumstances indicate that the asset may be impaired. The accounting guidance gives us the option to perform a qualitative assessment to determine whether further impairment testing is necessary. The qualitative assessment considers events and circumstances that might indicate that a reporting unit’s fair value is less than its carrying amount. If it is determined, as a result of the qualitative assessment, that it is more likely than not that the fair value of a reporting unit is less than its carrying amount, a quantitative test is performed. In fiscal 2024, based on our qualitative assessments, we concluded that it is more likely than not that the fair values are more than their carrying values. Accordingly, there was no indication of impairment of goodwill, and further quantitative testing was not required. Long-lived assets In connection with our acquisitions, we generally recognize assets for customer relationships, developed technology, finite-lived trade names and indefinite-lived trade names. Finite-lived intangible assets are carried at cost less accumulated amortization. Such amortization is provided on a straight-line basis over the estimated useful lives of the respective assets, generally from 1 to 10 years. Amortization for developed technology is recognized in cost of revenue. Amortization for customer relationships and certain trade names is recognized in operating expenses. Indefinite-lived intangible assets are not subject to amortization but instead tested for impairment annually or more frequently if events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Long-lived assets, including finite-lived intangible assets and property and equipment, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset or group may not be recoverable. The evaluation is performed at the lowest level of identifiable cash flows independent of other assets. An impairment loss is recognized when estimated undiscounted future cash flows generated from the assets are less than their carrying amount. Measurement of an impairment loss is based on the excess of the carrying amount of the asset group over its fair value. In fiscal 2024, based on our qualitative and quantitative assessments, we concluded that it is more likely than not that the fair values are more than their carrying values. Accordingly, there was no indication of impairment of long-lived assets, and further quantitative testing was not required. Contract liabilities Contract liabilities consist of deferred revenue and customer deposit liabilities and represent cash payments received or due in advance of fulfilling our performance obligations. Deferred revenue represents billings under non-cancelable contracts before the related product or service is transferred to the customer. Certain arrangements include terms that allow the customer to terminate the contract and receive a refund for a period of time. In these arrangements, we have concluded there are no enforceable rights and obligations during the period in which the option to cancel is exercisable by the customer, and therefore the consideration received or due from the customer is recorded as a customer deposit liability. Debt Our debt includes senior unsecured notes, senior term loans and a senior secured revolving credit facility. Our senior unsecured notes are recorded at par value at issuance less a discount representing the amount by which the face value exceeds the fair value at the date of issuance and an amount which represents issuance costs. Our senior term loans are recorded at par value less debt issuance costs, which are recorded as a reduction in the carrying value of the debt. The discount and issuance costs associated with the various notes are amortized using the effective interest rate method over the term of the debt as a non-cash charge to interest expense. Borrowings under our revolving credit facility, if any, are recognized at principal balance plus accrued interest based upon stated interest rates. Debt maturities are classified as current liabilities on our Consolidated Balance Sheets if we are contractually obligated to repay them in the next twelve months or, prior to the balance sheet date, we have the authorization and intent to repay them prior to their contractual maturities and within the next twelve months. Treasury stock We account for treasury stock under the cost method. Shares repurchased under our share repurchase program are retired. Upon retirement, we allocate the value of treasury stock between Additional paid-in capital and Retained earnings. Restructuring Restructuring actions generally include significant actions involving employee-related severance charges, contract termination costs and asset write-offs and impairments. Employee-related severance charges are largely based upon substantive severance plans, while some charges result from mandated requirements in certain foreign jurisdictions. These charges are reflected in the period when both the actions are probable and the amounts are estimable. Contract termination costs reflect costs that will continue to be incurred under a contract for its remaining term without future economic benefit. These charges are reflected in the period when a contract is terminated. Asset write-offs and impairments, including those related to ROU lease assets, are recognized in the period that an asset is decommissioned or a facility ceases to be used. Income taxes We compute the provision for income taxes using the asset and liability method, under which deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax basis of assets and liabilities and for operating losses and tax credit carryforwards in each jurisdiction in which we operate. We measure deferred tax assets and liabilities using the currently enacted tax rates that apply to taxable income in effect for the years in which those tax assets are expected to be realized or settled. We also assess the likelihood that deferred tax assets will be realized from future taxable income and based on weighting positive and negative evidence, we will assess and determine the need for a valuation allowance, if required. The determination of our valuation allowance involves assumptions, judgments and estimates, including forecasted earnings, future taxable income and the relative proportions of revenue and income before taxes in the various domestic and international jurisdictions in which we operate. To the extent we establish a valuation allowance or change the valuation allowance in a period, we reflect the change with a corresponding increase or decrease to Income tax expense (benefit) in our Consolidated Statements of Operations. We record accruals for unrecognized tax benefits when we believe that it is not more likely than not that the tax position will be sustained on examination by the taxing authorities based on the technical merits of the position. We also record accruals for unrecognized tax benefits at the largest amount that is greater than 50% likely of being realized based on the technical merits of the position. We adjust these accruals when facts and circumstances change, such as the closing of a tax audit or the refinement of an estimate. The provision for income taxes includes the effects of adjustments for unrecognized tax benefits as well as any related interest and penalties. Stock-based compensation We measure and recognize stock-based compensation for all stock-based awards, including restricted stock units (RSU), performance-based restricted stock units (PRU), stock options and rights to purchase shares under our employee stock purchase plan (ESPP), based on their estimated fair value on the grant date. We recognize the costs in our Consolidated Financial Statements on a straight-line basis over the award’s requisite service period except for PRUs with graded vesting, for which we recognize the costs on a graded basis. For awards with performance conditions, the amount of compensation cost we recognize over the requisite service period is based on the actual or estimated achievement of the performance condition. We estimate the number of stock-based awards that will be forfeited due to employee turnover. The fair value of each RSU and PRU that does not contain a market condition is equal to the market value of our common stock on the date of grant. The fair value of each PRU that contains a market condition is estimated using the Monte Carlo simulation model. The fair values of RSUs and PRUs are not discounted by the dividend yield because our RSUs and PRUs include dividend-equivalent rights, except for the 4 million unvested RSUs assumed as part of our acquisition of Avast. We use the Black-Scholes model to determine the fair value of stock options and the fair value of rights to acquire shares of common stock under our ESPP . The Black-Scholes valuation model incorporates a number of variables, including our expected stock price volatility over the expected life of the awards, actual and projected employee exercise and forfeiture behaviors, risk-free interest rates and expected dividends. If we do not have sufficient historical exercise data to provide a reasonable basis upon which to estimate expected life, we estimate the expected life of the stock option awards granted based on its expected term using the simplified method available under U.S. GAAP. Foreign currency For foreign subsidiaries whose functional currency is the local currency, assets and liabilities are translated to U.S. dollars at exchange rates in effect at the balance sheet date. Gains and losses resulting from translation of these foreign currency financial statements into U.S. dollars are recorded in AOCI. Remeasurement adjustments are recorded in Other income (expense), net in our Consolidated Statements of Operations. Concentrations of risk A significant portion of our revenue is derived from international sales. Fluctuations of the U.S. dollar against foreign currencies, changes in local regulatory or economic conditions, or piracy could adversely affect our operating results. Financial instruments that potentially subject us to concentrations of risk consist principally of cash and cash equivalents and trade accounts receivable. Our investment policy limits the amount of credit risk exposure to any one issuer and to any one country. A majority of our trade receivables are derived from sales to E-commerce partners and retailers. The credit risk in our trade accounts receivable is substantially mitigated by our credit evaluation process, reasonably short collection terms and the geographical dispersion of sales transactions. E-commerce partners that accounted for over 10% of our total billed and unbilled accounts receivable, are as follows: March 29, 2024 March 31, 2023 E-commerce partner A 13 % 13 % E-commerce partner B 11 % 14 % Advertising and other promotional costs Advertising and other promotional costs are expensed as incurred, and are recorded in sales and marketing expenses. These costs totaled $438 million, $405 million, and $423 million for fiscal 2024, 2023 and 2022, respectively. Contingencies |
Recent Accounting Standards
Recent Accounting Standards | 12 Months Ended |
Mar. 29, 2024 | |
Accounting Policies [Abstract] | |
Recent Accounting Standards | Recent Accounting Standards Recently issued authoritative guidance not yet adopted ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. In November 2023, the Financial Accounting Standards Board (FASB) issued new guidance to update reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses and information used to assess segment performance. This is effective for fiscal years beginning after December 15, 2023 and interim periods within fiscal years beginning after December 15, 2024. We do not expect the adoption of this guidance will have a material impact on our Consolidated Financial Statements and disclosures. ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. In December 2023, the FASB issued new guidance to update income tax disclosure requirements, requiring disaggregated information about an entity’s effective tax rate reconciliation as well as income taxes paid. This is effective for fiscal years beginning after December 15, 2024. We are currently evaluating the impact of the adoption of this guidance on our Consolidated Financial Statements and disclosures. Although there are several other new accounting pronouncements issued or proposed by the FASB that we have adopted or will adopt, as applicable, we do not believe any of these accounting pronouncements has had, or will have, a material impact on our Consolidated Financial Statements or disclosures. |
Assets Held for Sale
Assets Held for Sale | 12 Months Ended |
Mar. 29, 2024 | |
Discontinued Operations and Disposal Groups [Abstract] | |
Assets Held for Sale | Assets Held for Sale During fiscal 2020, we reclassified certain land and buildings previously reported as property and equipment to assets held for sale when the properties were approved for immediate sale in their present condition and the sale was expected to be completed within one year. However, the commercial real estate market was adversely affected by the COVID-19 pandemic, which delayed the expected timing of such sales. During the first quarter of fiscal 2022, we completed the sale of certain land and buildings in Mountain View, California for cash consideration of $355 million, net of selling costs, and recognized a gain of $175 million on the sale. During fiscal 2023, we determined land and buildings in Dublin, Ireland, which were previously reported as property and equipment, now qualifies as held for sale. During the first quarter of fiscal 2024, we completed the sale of certain land and buildings in Dublin, Ireland, which were previously classified as held for sale as of March 31, 2023, for cash consideration of $13 million, net of selling costs, and recognized a gain on sale of $4 million. The remaining land and building in Dublin, Ireland, remains as held for sale. During the third quarter of fiscal 2024, we completed the sale of certain land and buildings in Tucson, Arizona, which were previously classified as held for sale as of March 31, 2023, for cash consideration of $12 million, net of selling costs. We recognized a gain on sale of $5 million. We have taken into consideration the current real estate values and demand and continue to execute pla ns to sell the remaining property. As of March 29, 2024, this property remains classified as assets held for sale. During fiscal 2024, there were no impairments because the fair value of the property less costs to sell either equals or exceeds its carrying value. |
Business Combinations
Business Combinations | 12 Months Ended |
Mar. 29, 2024 | |
Business Combination and Asset Acquisition [Abstract] | |
Business Combinations | Business Combinations Fiscal 2023 Avast acquisition During the second quarter of fiscal 2023, we acquired all of the outstanding common stock of Avast. Prior to the acquisition, Avast was a global leader in consumer cybersecurity, offering a comprehensive range of digital security and privacy products and services that protected and enhanced users’ online experiences. With this acquisition, we are positioned to provide a broad and complementary consumer product portfolio with greater geographic diversification and access to a larger user base. The total consideration for the acquisition of Avast was approximately $8,688 million, net of cash acquired. Our final allocation of the aggregate purchase price for the acquisition as of September 12, 2022, was as follows: (In millions) September 12, 2022 Assets: Accounts receivable $ 63 Other current assets 17 Property and equipment 33 Operating lease assets 18 Intangible assets 2,383 Goodwill 7,335 Other long-term assets 11 Total assets acquired 9,860 Liabilities: Current liabilities 180 Contract liabilities 509 Operating lease liabilities 18 Long-term deferred tax liabilities 419 Other long-term obligations 46 Total liabilities assumed 1,172 Total purchase price $ 8,688 Our estimates and assumptions were subject to refinement within the measurement period, which ended during the second quarter of fiscal 2024. Adjustments to the purchase price during the measurement period required adjustments to be made to goodwill. During fiscal 2024, we recorded measurement period adjustments resulting in a net decrease to goodwill of $14 million, resulting from updated information regarding deferred tax liabilities, which resulted in a decrease of $14 million of long-term deferred tax liabilities. Unaudited pro forma information The following unaudited pro forma financial information represents the combined historical results for the year ended March 31, 2023 and April 1, 2022, as if the acquisition had been completed on April 3, 2021, the first day of fiscal 2022. The results presented below include adjustments to conform Avast financial information, prepared in accordance with International Financial Reporting Standards (IFRS), to U.S. GAAP as well as the impacts of material, nonrecurring pro forma adjustments, including amortization of acquired intangible assets, interest on debt issued to finance the acquisition, and acquisition-related transaction costs, and the income tax effect of the other pro forma adjustments. The unaudited pro forma results do not include any anticipated synergies or other expected benefits of the acquisition. The following table summarizes the unaudited pro forma financial information: Year Ended (In millions) March 31, 2023 April 1, 2022 Net revenues $ 3,804 $ 3,737 Net income (loss) $ 1,133 $ 242 The unaudited pro forma financial information is provided for informational purposes only and is not indicative of future operations or results that would have been achieved had the acquisition been completed as of the beginning of fiscal 2022. |
Revenues
Revenues | 12 Months Ended |
Mar. 29, 2024 | |
Revenue from Contract with Customer [Abstract] | |
Revenues | Revenues Contract liabilities During fiscal 2024 and 2023, we recognized $1,671 million and $1,213 million of revenue, respectively, from the contract liabilities balance at the beginning of the respective fiscal years. Remaining performance obligations Remaining performance obligations represent contracted revenue that has not been recognized, which include contract liabilities and amounts that will be billed and recognized as revenue in future periods. As of March 29, 2024, we had $1,209 million of remaining performance obligations, excluding customer deposit liabilities of $597 million, of which we expect to recognize approximately 94% as revenue over the next 12 months. |
Goodwill and Intangible Assets
Goodwill and Intangible Assets | 12 Months Ended |
Mar. 29, 2024 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Goodwill and Intangible Assets | Goodwill and Intangible Assets Goodwill The changes in the carrying amount of goodwill are as follows: (In millions) Balance as of April 1, 2022 $ 2,873 Acquisition of Avast 7,265 Purchase accounting adjustments 84 Translation adjustments (5) Balance as of March 31, 2023 10,217 Purchase accounting adjustments (14) Translation adjustments 7 Balance as of March 29, 2024 $ 10,210 Intangible assets, net The following table summarizes the components of our intangible assets, net: March 29, 2024 March 31, 2023 (In millions) Gross Accumulated Net Gross Accumulated Net Customer relationships $ 1,642 $ (773) $ 869 $ 1,641 $ (549) $ 1,092 Developed technology 1,343 (388) 955 1,462 (279) 1,183 Other 90 (15) 75 91 (8) 83 Total finite-lived intangible assets 3,075 (1,176) 1,899 3,194 (836) 2,358 Indefinite-lived trade names 739 — 739 739 — 739 Total intangible assets $ 3,814 $ (1,176) $ 2,638 $ 3,933 $ (836) $ 3,097 Amortization expense for purchased intangible assets is summarized below: Year Ended Consolidated Statements of Operations Classification (In millions) March 29, 2024 March 31, 2023 April 1, 2022 Customer relationships and other $ 233 $ 172 $ 85 Operating expenses Developed technology 229 136 39 Cost of revenues Total $ 462 $ 308 $ 124 As of March 29, 2024, future amortization expense related to intangible assets that have finite lives is as follows by fiscal year: (In millions) March 29, 2024 2025 $ 401 2026 395 2027 382 2028 379 2029 249 Thereafter 93 Total $ 1,899 |
Supplementary Information
Supplementary Information | 12 Months Ended |
Mar. 29, 2024 | |
Supplementary Information [Abstract] | |
Supplementary Information | Supplementary Information Cash and cash equivalents: (In millions) March 29, 2024 March 31, 2023 Cash $ 408 $ 576 Cash equivalents 438 174 Total cash and cash equivalents $ 846 $ 750 Accounts receivable, net: (In millions) March 29, 2024 March 31, 2023 Accounts receivable $ 165 $ 169 Allowance for doubtful accounts (2) (1) Accounts receivable, net $ 163 $ 168 Other current assets: (In millions) March 29, 2024 March 31, 2023 Prepaid expenses $ 142 $ 122 Income tax receivable and prepaid income taxes 174 123 Other tax receivable 1 16 Other 17 23 Total other current assets $ 334 $ 284 Property and equipment, net: (In millions) March 29, 2024 March 31, 2023 Land $ 13 $ 13 Computer hardware and software 491 498 Office furniture and equipment 16 17 Buildings 28 28 Building and leasehold improvements 35 28 Construction in progress 1 1 Total property and equipment, gross 584 585 Accumulated depreciation and amortization (512) (509) Total property and equipment, net $ 72 $ 76 Depreciation and amortization expense of property and equipment was $23 million, $21 million, and $16 million in fiscal 2024, 2023 and 2022, respectively. Other long-term assets: (In millions) March 29, 2024 March 31, 2023 Non-marketable equity investments $ 136 $ 176 Long-term income tax receivable and prepaid income taxes 11 669 Deferred income tax assets 1,215 353 Operating lease assets 45 43 Long-term prepaid royalty 21 36 Other 66 47 Total other long-term assets $ 1,494 $ 1,324 Short-term contract liabilities: (In millions) March 29, 2024 March 31, 2023 Deferred revenue $ 1,133 $ 1,153 Customer deposit liabilities 597 555 Total short-term contract liabilities $ 1,730 $ 1,708 Other current liabilities: (In millions) March 29, 2024 March 31, 2023 Income taxes payable $ 198 $ 172 Other taxes payable 72 76 Accrued legal fees 103 284 Accrued royalties 52 48 Accrued interest 78 27 Current operating lease liabilities 13 26 Other accrued liabilities 83 96 Total other current liabilities $ 599 $ 729 Other long-term liabilities: (In millions) March 29, 2024 March 31, 2023 Long-term accrued legal fees $ 586 $ — Long-term operating lease liabilities 38 31 Other 47 43 Total other long-term liabilities $ 671 $ 74 Long-term income taxes payable: (In millions) March 29, 2024 March 31, 2023 Unrecognized tax benefits (including interest and penalties) $ 1,346 $ 509 Deemed repatriation tax payable 139 310 Other long-term income taxes 5 1 Total long-term income taxes payable $ 1,490 $ 820 Other income (expense), net: Year Ended (In millions) March 29, 2024 March 31, 2023 April 1, 2022 Interest income $ 25 $ 15 $ — Foreign exchange gain (loss) (1) 3 (8) (2) Gain (loss) on early extinguishment of debt — (9) (3) Gain (loss) on equity investments (40) (7) (7) Gain (loss) on sale of properties 9 — 175 Other 9 (13) — Total other income (expense), net $ 6 $ (22) $ 163 (1) We recognize foreign currency remeasurement adjustments on unrecognized tax benefits and deferred taxes as a component of Income tax expense (benefit) in our Consolidated Statements of Operations. Foreign currency remeasurement adjustments recognized in Income tax expense (benefit) were ($27) million, ($18) million, and ($19) million for fiscal 2024, 2023 and 2022, respectively. Supplemental cash flow information: Year Ended (In millions) March 29, 2024 March 31, 2023 April 1, 2022 Income taxes paid (received), net $ (476) $ 456 $ 356 Interest expense paid $ 607 $ 390 $ 120 Cash paid for amounts included in the measurement of operating lease liabilities $ 24 $ 26 $ 27 Non-cash operating activities: Operating lease assets obtained in exchange for operating lease liabilities $ — $ 23 $ 35 Reduction (increase) of operating lease assets as a result of lease terminations and modifications $ (20) $ 31 $ 17 Non-cash investing and financing activities: Purchases of property and equipment in current liabilities $ — $ 1 $ 1 Extinguishment of debt with borrowings from same creditors $ — $ — $ 494 Non-cash consideration for the acquisition of Avast $ — $ 2,141 $ — |
Financial Instruments and Fair
Financial Instruments and Fair Value Measurements | 12 Months Ended |
Mar. 29, 2024 | |
Fair Value Disclosures [Abstract] | |
Financial Instruments and Fair Value Measurements | Financial Instruments and Fair Value Measurements The following table summarizes our financial instruments measured at fair value on a recurring basis: March 29, 2024 March 31, 2023 (In millions) Fair Value Level 1 Level 2 Fair Value Level 1 Level 2 Assets: Money market funds $ 438 $ 438 $ — $ 174 $ 174 $ — Interest rate swaps (1) 16 — 16 — — — Total $ 454 $ 438 $ 16 $ 174 $ 174 $ — (1) The fair value of our interest rate swaps is less than $1 million as of March 31, 2023. Financial instruments not recorded at fair value on a recurring basis include our non-marketable equity investments and long-term debt. Non-marketable equity investments As of March 29, 2024 and March 31, 2023, the carrying value of our non-marketable equity investments was $136 million and $176 million, respectively. During fiscal 2024, we recognized $40 million in impairment on our non-marketable equity investments. Current and long-term debt As of March 29, 2024 and March 31, 2023, the total fair value of our current and long-term fixed rate debt was $2,624 million and $2,593 million, respectively. The fair value of our variable rate debt approximated their carrying value. The fair values of all our debt obligations were based on Level 2 inputs. |
Leases
Leases | 12 Months Ended |
Mar. 29, 2024 | |
Leases [Abstract] | |
Leases | Leases We lease certain of our facilities, equipment, and data center co-locations under operating leases that expire on various dates through fiscal 2030. Our leases generally have terms that range from 1 year to 8 years for our facilities, 1 year to 4 years for equipment and 1 year to 5 years for data center co-locations. Some of our leases contain renewal options, escalation clauses, rent concessions and leasehold improvement incentives. The following summarizes our lease costs for fiscal 2024, 2023 and 2022: Year Ended (In millions) March 29, 2024 March 31, 2023 April 1, 2022 Operating lease costs $ 12 $ 16 $ 16 Short-term lease costs 3 2 2 Variable lease costs 6 8 6 Total lease costs $ 21 $ 26 $ 24 Other information related to our operating leases for fiscal 2024, 2023 and 2022 was as follows: Year Ended March 29, 2024 March 31, 2023 April 1, 2022 Weighted-average remaining lease term 4.6 years 2.8 years 4.7 years Weighted-average discount rate 5.35 % 4.38 % 4.04 % See Note 7 for cash flow information related to our operating leases. As of March 29, 2024, the maturities of our lease liabilities by fiscal year are as follows: (In millions) 2025 $ 15 2026 12 2027 12 2028 7 2029 6 Thereafter 5 Total lease payments 57 Less: Imputed interest (6) Present value of lease liabilities $ 51 |
Debt
Debt | 12 Months Ended |
Mar. 29, 2024 | |
Debt Disclosure [Abstract] | |
Debt | Debt The following table summarizes components of our debt: (In millions, except percentages) March 29, 2024 March 31, 2023 Effective 5.0% Senior Notes due April 15, 2025 $ 1,100 $ 1,100 5.00 % Term A Facility due September 12, 2027 3,666 3,861 SOFR + % (2) 6.75% Senior Notes due September 30, 2027 900 900 6.75 % Term B Facility due September 12, 2029 2,444 3,431 SOFR + % (3) 1.29% Avira Mortgage due December 30, 2029 (1) 3 4 1.29 % 7.125% Senior Notes due September 30, 2030 600 600 7.13 % 0.95% Avira Mortgage due December 30, 2030 (1) 3 3 0.95 % Total principal amount 8,716 9,899 Less: unamortized discount and issuance costs (112) (137) Total debt 8,604 9,762 Less: current portion (175) (233) Total long-term debt $ 8,429 $ 9,529 (1) The Avira Mortgages are denominated in a foreign currency so the balances of these mortgages may fluctuate based on changes in foreign currency exchange rates. (2) Term A Facility due 2027 bears interest at a rate equal to Term SOFR plus a credit spread adjustment (CSA) plus a margin based either on the current debt rating of our non-credit-enhanced, senior unsecured long-term debt or consolidated adjusted leverage as defined in the underlying loan agreement. (3) Term B Facility due 2029 bears interest at a rate equal to Term SOFR plus CSA plus 2.00%. The interest rates for the outstanding term loans are as follows: March 29, 2024 March 31, 2023 Term A Facility due September 12, 2027 7.18 % 6.66 % Term B Facility due September 12, 2029 7.43 % 6.91 % As of March 29, 2024, the future contractual maturities of debt by fiscal year are as follows: (In millions) 2025 $ 175 2026 1,392 2027 233 2028 4,017 2029 38 Thereafter 2,861 Total future maturities of debt $ 8,716 Senior credit facilities On September 12, 2022, we entered into the Amended and Restated Credit Agreement (Credit Agreement) with certain financial institutions, in which they agreed to provide us with (i) a $1,500 million revolving credit facility (Revolving Facility), (ii) a $3,910 million term loan A facility (Term A Facility), (iii) a $3,690 million term loan B facility (Term B Facility) and (iv) a $750 million tranche A bridge loan (Bridge Loan) (collectively, the senior credit facilities). The Bridge Loan was undrawn and immediately terminated upon the close of the acquisition of Avast. The Credit Agreement provides that we have the right at any time, subject to customary conditions, to request incremental revolving commitments and incremental term loans up to an unlimited amount, subject to certain customary conditions precedent and other provisions. The lenders under these facilities will not be under any obligation to provide any such incremental loans or commitments. We drew down the aggregate principal amounts of the Term A Facility and Term B Facility to finance the cash consideration payable for the transaction and to fully repay the outstanding principal and accrued interest of the existing credit facilities. The Credit Agreement replaced the existing credit facilities upon the close of the transaction. The Revolving Facility and Term A Facility will mature in September 2027, and the Term Facility B will mature in September 2029; the senior credit facilities remain senior secured. The principal amounts of Term A Facility must be repaid in quarterly installments on the last business day of each calendar quarter equal to 1.25% of the aggregate principal amount as of the date of the Credit Agreement. The principal amounts of Term Facility B must be repaid in quarterly installments on the last business day of each calendar quarter equal to 0.25% of the aggregate principal amount as of the date of the Credit Agreement. Quarterly installment payments commenced on March 31, 2023. We may voluntarily repay outstanding principal balances under the Revolving Facility and both Term Loan facilities without penalty. As of March 29, 2024, there were no borrowings outstanding under our Revolving Facility; however, from time to time we utilize letters of credits as part of our ordinary course of business. Letters of credit reduce our Revolving Facility commitment amounts. Interest on borrowings under the Credit Agreement can be based on a base rate or the SOFR at our election. Based on our debt ratings and our consolidated leverage ratios as determined in accordance with the Credit Agreement, loans borrowed bear interest, in the case of base rate loans, at a per annum rate equal to the applicable base rate plus CSA plus a margin ranging from 0.125% to 0.75%, and in the case of the SOFR loans, SOFR, as adjusted for statutory reserves, plus a margin ranging from 1.125% to 1.75%. Debt covenant compliance The Credit Agreement contains customary representations and warranties, affirmative and negative covenants. Each of the Revolving Facility and Term A Facility are subject to a covenant that we maintain a consolidated leverage ratio less than or equal to (i) 6.0 to 1.0 from the second quarter of fiscal 2023 through the last day of the second quarter of fiscal 2024, (ii) 5.75 to 1.0 following the last day of the second quarter of fiscal 2024 through the last day of the second quarter of fiscal 2025 and (iii) 5.25 to 1.0 for each fiscal quarter thereafter; provided that such maximum consolidated leverage ratio will increase to 5.75 to 1.0 for the four fiscal quarters ending immediately should we acquire property, business or assets in an aggregate amount greater than $250 million. In addition, the Credit Agreement contains customary events of default under which our payment obligations may be accelerated, including, among others, non-payment of principal, interest or other amounts when due, inaccuracy of representations and warranties, violation of certain covenants, payment and acceleration cross defaults with certain other indebtedness, certain undischarged judgments, bankruptcy, insolvency or inability to pay debts, change of control, the occurrence of certain events related to the Employee Retirement Income Security Act of 1974 (ERISA), and the Company experiencing a change of control. As of March 29, 2024 we were in compliance with all debt covenants. Senior Notes On February 9, 2017, we issued $1,100 million aggregate principal amount of our 5.0% Senior Notes due April 15, 2025 (the 5.0% Senior Notes). The 5.0% Senior Notes bear interest at a rate of 5.00% per year, payable semiannually in arrears on April 15 and October 15 of each year, beginning on October 15, 2017. On or after April 15, 2020, we may redeem some or all of the 5.0% Senior Notes at the applicable redemption prices set forth in the supplemental indenture, plus accrued and unpaid interest. O n September 19, 2022, we issued two series of senior notes, consisting of 6.75% Senior Notes due 2027 and 7.125% Senior Notes due 2030, for an aggregate principal of $1,500 million. They are senior unsecured obligations that rank equally in right of payment with all of our existing and future senior, unsecured, unsubordinated obligations and may be redeemed at any time, subject to the make-whole provisions contained in the applicable indenture relating to such series of notes. Interest on these series of notes is payable semi-annually in arrears on March 31 and September 30 for both the 6.75% Senior Notes and 7.125% Senior Notes, commencing on March 31, 2023. We may redeem some or all of the 6.75% Senior Notes due 2027 and 7.125% Senior Notes due 2030 at any time, subject to a prepayment penalty that expires one year prior to the maturity of each respective note. The First Call Dates of the 6.75% Senior Notes due 2027 and 7.125% Senior Notes due 2030 are September 30, 2024 and September 30, 2025, respectively. Convertible Senior Notes On August 15, 2022, we settled the $525 million principal and conversion rights of our New 2.0% Convertible Notes in cash. The aggregate settlement amount of $630 million was based on $20.41 per underlying share into which the New 2.0% Convertible Notes were convertible. In addition, we paid $5 million of accrued and unpaid interest through the date of settlement. The repayments resulted in an adjustment to stockholders’ equity of $100 million. As of March 29, 2024, we have extinguished all remaining convertible debt instruments. The following table sets forth total interest expense recognized related to our convertible notes: Year Ended (In millions) March 31, 2023 April 1, 2022 Contractual interest expense $ 4 $ 12 Amortization of debt discount and issuance costs $ — $ 4 Payments in lieu of conversion price adjustments (1) $ 1 $ 8 (1) Payments in lieu of conversion price adjustments consist of amounts paid to holders of the Convertible Senior Notes when our quarterly dividend to our common stockholders exceeds the amounts defined in the Convertible Senior Notes agreements. During fiscal 2024, we did not recognize any interest expense related to our Convertible Senior Notes as they were settled during the second quarter of fiscal year 2023. |
Derivatives
Derivatives | 12 Months Ended |
Mar. 29, 2024 | |
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |
Derivatives | Derivatives Our primary objective in holding derivatives is to reduce the volatility of earnings and cash flow associated with changes in foreign currency exchange rates and interest rates. These hedging contracts reduce, but do not entirely eliminate the impact of adverse foreign exchange rate and interest rate movements. We do not use our derivative instruments for speculative trading purposes. By using derivative financial instruments to hedge exposures to changes in foreign exchange and interest rates, we are exposed to credit risk; however, we mitigate this risk by entering into hedging instruments with highly rated institutions that can be expected to fully perform under the terms of the applicable contracts. Foreign currency exchange forward contracts We conduct business in numerous currencies throughout our worldwide operations, and our entities hold monetary assets or liabilities, earn revenues, or incur costs in currencies other than the entity’s functional currency. As a result, we are exposed to foreign exchange gains or losses which impacts our operating results. As part of our foreign currency risk mitigation strategy, we have entered into monthly foreign exchange forward contracts to hedge foreign currency balance sheet exposure. These forward contracts are not designated as hedging instruments. We do not hedge our foreign currency exposure in a manner that entirely offsets the effects of the changes in foreign exchange rates. Interest rate swap In March 2023, we entered into interest rate swap agreements to mitigate risks associated with the variable interest rate of our Term A Facility. These pay-fixed, receive-floating rate interest rate swaps have the economic effect of hedging the variability of forecasted interest payments until their maturity on March 31, 2026. Pursuant to the agreements, we have effectively converted $1 billion of our variable rate borrowings under Term A Facility to fixed rates, with $500 million at a fixed rate of 3.762% and $500 million at a fixed rate of 3.55%. These arrangements are designated as cash flow hedges for accounting purposes and as such, we will recognize the changes in the fair value of these interest rate swaps in Accumulated other comprehensive income (loss) (AOCI), and the periodic settlements or accrued settlements of the swap will be recognized within or against interest expense in our Consolidated Statements of Operations. Cash flows related to these hedges are classified under operating activities in our Consolidated Statement of Cash Flows. Summary of derivative instruments The following table summarizes our outstanding derivative instruments as of March 29, 2024 and March 31, 2023: Notional Amount Fair Value of Derivative Assets Fair Value of Derivative Liabilities (In millions) March 29, 2024 March 31, 2023 March 29, 2024 March 31, 2023 March 29, 2024 March 31, 2023 Foreign exchange contracts not designated as hedging instrument (1) $ 345 $ 291 $ — $ — $ — $ — Interest rate swap contract designed as cash flow hedge 1,000 1,000 16 1 — 2 Total $ 1,345 $ 1,291 $ 16 $ 1 $ — $ 2 (1) The fair values of the foreign exchange contracts are less than $1 million as of March 29, 2024 and March 31, 2023. The following table summarizes the effect of our cash flow hedges on AOCI during the periods indicated: Year Ended (In millions) March 29, 2024 March 31, 2023 Interest rate swap contracts designated as cash flow hedge $ (32) $ — The effect of our interest rate on AOCI was immaterial during fiscal 2023. We did not have any interest rate swaps during fiscal 2022. The related gain (loss) recognized in our Consolidated Statements of Operations was as follows: Year Ended Consolidated Statements of Operations Classification (In millions) March 29, 2024 March 31, 2023 April 1, 2022 Foreign exchange contracts not designated as hedging instrument $ (7) $ (7) $ (7) Other income (expense), net Interest rate swap contracts designated as cash flow hedge 16 — — Interest expense Total $ 9 $ (7) $ (7) As of March 29, 2024, we estimate that $12 million of net deferred gains related to our interest rate hedges will be recognized in earnings over the next 12 months. |
Restructuring and Other Costs
Restructuring and Other Costs | 12 Months Ended |
Mar. 29, 2024 | |
Restructuring and Related Activities [Abstract] | |
Restructuring and Other Costs | Restructuring and Other Costs Our restructuring and other costs consist primarily of severance and termination benefits, contract cancellation charges, asset write-offs and impairments and other exit and disposal costs. Severance costs generally include severance payments, outplacement services, health insurance coverage and legal costs. Contract cancellation charges primarily include penalties for early termination of contracts and write-offs of related prepaid assets. Other exit and disposal costs include costs to exit and consolidate facilities in connection with restructuring events. Separation costs primarily consist of consulting costs incurred in connection with our divestitures. September 2022 Plan In connection with our acquisition of Avast, our Board of Directors approved a restructuring plan (the September 2022 Plan) to realize cost savings and operational synergies, which became effective upon the close of acquisition on September 12, 2022. Actions under this plan include the reduction of our workforce, contract terminations, facilities closures, and the sale of underutilized facilities as well as stock-based compensation charges for accelerated equity awards to certain terminated employees. We expect that we will incur total costs up to $150 million following the completion of the acquisition. These actions are expected to be completed by fiscal 2025. As of March 29, 2024, we have incurred costs of $125 million related to the September 2022 Plan. December 2020 Plan In December 2020, our Board of Directors approved a restructuring plan (the December 2020 Plan) to consolidate facilities and reduce operating costs in connection with our acquisition of Avira. These actions were completed in fiscal 2022. Any remaining costs or adjustments are immaterial. We incurred total costs of $24 million under the December 2020 Plan. Restructuring summary Our activities and liability balances related to our September 2022 Plan are presented in the tables below: (In millions) Liability Balance as of March 31, 2023 Net Charges Cash Payments Non-Cash Items Liability Balance as of March 29, 2024 Severance and termination benefit costs $ 7 $ 42 $ (29) $ — $ 20 Contract cancellation charges — 5 (5) — — Stock-based compensation charges — 1 — (1) — Asset write-offs — 1 — (1) — Other exit and disposal costs — 7 (7) — — Total $ 7 $ 56 $ (41) $ (2) $ 20 The restructuring liabilities are included in Other current liabilities in our Consolidated Balance Sheets. Restructuring and other costs summary Our restructuring and other costs are presented in the table below: Year Ended (In millions) March 29, 2024 March 31, 2023 April 1, 2022 Severance and termination benefit costs $ 42 $ 40 $ 5 Contract cancellation charges 5 2 3 Stock-based compensation charges 1 11 — Asset write-offs and impairments 1 4 5 Other exit and disposal costs 8 12 18 Total restructuring and other $ 57 $ 69 $ 31 Occasionally, we incur costs related to past restructuring plans. These charges were immaterial during fiscal 2024. |
Income Taxes
Income Taxes | 12 Months Ended |
Mar. 29, 2024 | |
Income Tax Disclosure [Abstract] | |
Income Taxes | Income Taxes The components of our income (loss) before income taxes are as follows: Year Ended (In millions) March 29, 2024 March 31, 2023 April 1, 2022 Domestic $ 78 $ 350 $ 791 International 381 454 251 Income (loss) before income taxes $ 459 $ 804 $ 1,042 The components of income tax expense (benefit) are as follows: Year Ended (In millions) March 29, 2024 March 31, 2023 April 1, 2022 Current: Federal $ 201 $ (479) $ 217 State 43 (28) 50 International 579 99 20 Total 823 (408) 287 Deferred: Federal (727) (111) (42) State (133) (10) (6) International (120) (16) (33) Total (980) (137) (81) Income tax expense (benefit) $ (157) $ (545) $ 206 The U.S. federal statutory income tax rates we have applied for fiscal 2024, 2023 and 2022 are as follows: Year Ended March 29, 2024 March 31, 2023 April 1, 2022 U.S. federal statutory income tax rate 21.0 % 21.0 % 21.0 % The difference between our effective income tax and the federal statutory income tax is as follows: Year Ended (In millions) March 29, 2024 March 31, 2023 April 1, 2022 Federal statutory tax expense (benefit) $ 96 $ 169 $ 219 State taxes, net of federal benefit — 1 33 Foreign earnings taxed at other than the federal rate (22) (11) (47) Nondeductible expenses 48 20 — Federal research and development credit (6) (5) (4) Valuation allowance increase (decrease) (4) (33) 2 Change in unrecognized tax benefits 338 163 (2) Tax interest and penalties 129 13 13 Stock-based compensation 17 9 7 US tax on foreign earnings 20 12 12 Return to provision adjustment — 1 (8) Foreign exchange loss (gain) (28) (17) (19) Capital loss (44) (910) — Legal entity restructuring (719) 42 — Other, net 18 1 — Income tax expense (benefit) $ (157) $ (545) $ 206 The principal components of deferred tax assets and liabilities are as follows: (In millions) March 29, 2024 March 31, 2023 Deferred tax assets: Tax credit carryforwards $ 27 $ 24 Net operating loss carryforwards of acquired companies 60 60 Interest 63 37 Other accruals and reserves not currently tax deductible 332 95 Goodwill 517 — Capitalized research and experimental expenditures 82 46 Loss on investments not currently tax deductible 60 68 Other 56 97 Gross deferred tax assets 1,197 427 Valuation allowance (93) (97) Deferred tax assets, net of valuation allowance 1,104 330 Deferred tax liabilities: Intangible assets (127) (328) Unremitted earnings of foreign subsidiaries (14) (15) Other (9) (20) Deferred tax liabilities (150) (363) Net deferred tax assets (liabilities) $ 954 $ (33) Deferred income taxes reflect the net effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and their basis for income tax purposes and the tax effects of net operating losses and tax credit carryforwards. The valuation allowance provided against our deferred tax assets as of March 29, 2024 of $93 million is provided primarily against state and foreign capital loss carryforwards and certain tax credits. As of March 29, 2024, we have U.S. federal net operating losses attributable to various acquired companies of approximately $192 million, of which $28 million begins to expire in fiscal 2025 and $164 million has an indefinite life. The net operating loss carryforwards are subject to an annual limitation under U.S. federal tax regulations but are expected to be fully realized. Furthermore, we have U.S. state net operating loss carryforwards attributable to various acquired companies of approximately $133 million. If not used, our U.S. state net operating losses will expire between fiscal 2033 and 2038. In addition, we have foreign net operating loss carryforwards of approximately $14 million. In assessing the realizability of our gross deferred tax assets, we consider both the positive and negative evidence of future taxable income to support utilization. We considered the following: historical cumulative book income, as measured by the current and prior two years; historical taxable income; and future reversals of taxable temporary differences. We have concluded that this positive evidence outweighs the negative evidence and, thus, that the gross deferred tax assets as of March 29, 2024, are realizable on a “more likely than not” basis. In fiscal 2023 as part of Avast integration plan we undertook a legal entity and operational restructuring that resulted in tax capital losses. The capital losses were carried back to the fiscal 2020 tax return to offset a capital gain, which resulted in a tax refund on our federal and state tax returns for the 2020 tax year. We have filed claims for all federal and state refunds for a total amount of $954 million. As of March 29, 2024, we have received $899 million in federal refunds and $2 million in state refunds related to the carryback claim. As part of this process, we had recorded a net tax receivable in an amount less than the $954 million, due to the complexity of applying evolving tax laws and uncertainties with respect to sustaining our refunds claims, the success of which we believe is more likely than not. This net amount takes into account our best estimate of the likely outcome of the refund claim given the information available to us at this time. Our ability to recognize the financial statement benefit of the refund claim is subject to change based on a number of factors, including but not limited to, changes in facts and circumstances, changes in tax laws, correspondence with both IRS and State tax authorities, and the results of tax audits and related proceedings, which may take several years or more to resolve. We intend to vigorously defend our position if challenged by the tax authorities and will contest any proposed adjustments. If we are not able to resolve any proposed adjustments at the examination level, we plan to pursue all available administrative and, if necessary, judicial remedies. If we do not ultimately prevail on some or all of the components of our position, we would be required to pay the IRS and the states some or all of any cash tax refund, along with interest on such amount, and penalties, if assessed. As with all actual and potential tax audits and related proceedings, there can be no assurances on the final outcome. To the extent the final outcome is different than the amounts recorded, such differences will affect the provision for income taxes in the period in which such determination is made and could have a material impact on our Consolidated Balance Sheets and Statements of Operations. In the second quarter of fiscal 2024, as part of the Avast integration plan, which geographically realigned and simplified our business, we undertook a legal entity and operational restructuring. As part of that process, we distributed certain assets within the legal entity operating structure and as a result, we recorded a net tax benefit of $285 million in fiscal 2024. Differences between the final outcome and recorded amounts will impact the provision for income taxes in the period in which such a determination is made and could have a material impact on our Consolidated Balance Sheets and Statements of Operations in future years. The aggregate changes in the balance of gross unrecognized tax benefits were as follows: Year Ended (In millions) March 29, 2024 March 31, 2023 April 1, 2022 Balance at beginning of year $ 710 $ 527 $ 548 Settlements with tax authorities (8) (2) — Lapse of statute of limitations (14) (96) (34) Increase related to prior period tax positions 47 9 16 Decrease related to prior period tax positions (9) (15) (11) Increase related to current year tax positions 467 259 8 Increase due to acquisition — 28 — Increase (decrease) related to foreign currency exchange rates (30) — — Balance at end of year $ 1,163 $ 710 $ 527 There was a change of $453 million in gross unrecognized tax benefits during the year ended March 29, 2024, as disclosed above, mainly on account of a legal entity and operational restructuring. This gross liability does not include offsetting tax benefits associated with the correlative effects of potential transfer pricing adjustments, interest deductions and state income taxes. Of the total unrecognized tax benefits at March 29, 2024, $1,007 million, if recognized, would affect our effective tax rate. We recognize interest and/or penalties related to unrecognized tax benefits in income tax expense. At March 29, 2024, before any tax benefits, we had $225 million of accrued interest and penalties on unrecognized tax benefits. Interest included in our provision for income taxes was an expense of approximately $43 million for fiscal 2024. If the accrued interest and penalties do not ultimately become payable, amounts accrued will be reduced in the period that such determination is made and reflected as a reduction of the overall income tax provision. We file income tax returns in the U.S. and in many U.S. state and foreign jurisdictions. Our most significant tax jurisdictions are U.S. federal, Ireland, and the Czech Republic. Our tax filings remain subject to examination by applicable tax authorities for a certain length of time following the tax year to which those filings relate. Our fiscal years 2018 through 2022 remain subject to examination by the IRS for U.S. federal tax purposes. Our fiscal years 2018 through 2020 are currently under examination by the IRS. Our 2020 through 2022 fiscal years remain subject to examination by the appropriate governmental agencies for Irish tax purposes. Our 2016 through 2022 fiscal years remain subject to examination by the appropriate governmental agencies for Czech tax purposes. The timing of the resolution of income tax examinations is highly uncertain, and the amounts ultimately paid, if any, upon resolution of the issues raised by the taxing authorities may differ materially from the amounts accrued for each year. Although potential resolution of these matters involves multiple tax periods and jurisdictions, it is reasonably possible that the gross unrecognized tax benefits related to these audits could significantly change (whether by payment, release, or a combination of both) in the next 12 months; however, an estimate of this range cannot be made. Depending on the nature of the settlement or expiration of statutes of limitations, it could affect our income tax provision and therefore benefit the resulting effective tax rate. We continue to monitor the progress of ongoing income tax controversies and the impact, if any, of the expected tolling of the statute of limitations in various taxing jurisdictions. We provide U.S. income taxes on the earnings of foreign subsidiaries unless the subsidiaries’ earnings are considered permanently reinvested outside the U.S. or are exempted from further taxation. As of March 29, 2024, the tax liability recorded on the undistributed earnings is approximately $14 million. |
Stockholders' Equity
Stockholders' Equity | 12 Months Ended |
Mar. 29, 2024 | |
Stockholders' Equity Note [Abstract] | |
Stockholders' Equity | Stockholders' Equity Dividends On May 9, 2024, we announced that our Board of Directors declared a cash dividend of $0.125 per share of common stock to be paid in June 2024. All shares of common stock issued and outstanding and all RSUs and PRUs as of the record date will be entitled to the dividend and dividend equivalent rights (DERs), respectively, which will be paid out if and when the underlying shares are released. However, the 4 million unvested RSUs assumed in connection with the acquisition of Avast will not be entitled to DERs. See Note 15 for further information about these equity awards. Any future dividends and DERs will be subject to the approval of our Board of Directors. Stock repurchase program Under our stock repurchase program, we may purchase shares of our outstanding common stock on the open market and through accelerated stock repurchase transactions. As of March 29, 2024, we had $429 million remaining under the authorization to be completed in future periods with no expiration date. In May 2024, our Board of Directors authorized a new stock repurchase program through which we may repurchase shares of our common stock in an aggregate amount of up to $3 billion with no fixed expiration. This new stock repurchase program will supersede any amounts under the prior stock repurchase programs. The following table summarizes activity related to our stock repurchase program during the years ended March 29, 2024 and March 31, 2023: Year Ended (In millions, except per share amounts) March 29, 2024 March 31, 2023 Number of shares repurchased 21 40 Average price per share $ 20.87 $ 22.63 Aggregate purchase price $ 441 $ 904 Accumulated other comprehensive income (loss) Accumulated other comprehensive income (loss), net of taxes, consisted of foreign currency translation adjustments: (In millions) Foreign Currency Translation Adjustments Net Unrealized Gain (Loss) On Interest Rate Derivative Total Balance as of April 1, 2022 $ (4) $ — $ (4) Other comprehensive income (loss), net of taxes (11) — (11) Balance as of March 31, 2023 (15) — (15) Other comprehensive income (loss), net of taxes 10 16 26 Balance as of March 29, 2024 $ (5) $ 16 $ 11 |
Stock-Based Compensation and Be
Stock-Based Compensation and Benefit Plans | 12 Months Ended |
Mar. 29, 2024 | |
Share-Based Payment Arrangement [Abstract] | |
Stock-Based Compensation and Benefit Plans | Stock-Based Compensation and Benefit Plans Stock incentive plans The purpose of our stock incentive plans is to attract, retain and motivate eligible persons whose present and potential contributions are important to our success by offering them an opportunity to participate in our future performance through equity awards. We maintain the 2013 Equity Incentive Plan (the 2013 Plan), under which awards may be granted to employees, officers, directors, consultants, independent contractors, and advisors. As amended, our stockholders have approved and reserved 82 million shares of common stock for issuance under the 2013 Plan. Stock options granted under the 2013 Plan expire no more than 10 years from the date of grant. In connection with our acquisition of Avast, we assumed the outstanding equity awards under two of Avast’s equity incentive plans (the Avast Holding B.V. 2014 Share Option Plan and the Rules of the Avast plc Long Term Incentive Plan (collectively, the Avast Plans)), which consisted of 4 million unvested RSUs. The assumed RSUs generally retain the terms and conditions under which they were originally granted. We intend to grant all additional shares that remain available for issuance under the Avast Plans. Upon vesting, these assumed RSUs and any additional shares granted will settle into shares of our common stock. See Note 4 for further information about this business combination. As of March 29, 2024, 3 million shares remained available for future grant, calculated using the maximum potential shares that could be earned and issued at vesting. RSUs (In millions, except per share and year data) Number of Weighted- Outstanding as of March 31, 2023 9 $ 22.45 Granted 5 $ 17.42 Vested (5) $ 22.30 Forfeited (1) $ 20.84 Outstanding as of March 29, 2024 8 $ 19.39 RSUs generally vest over a three-year period. The weighted-average grant date fair value per share of RSUs granted during fiscal 2024, 2023 and 2022 was $17.42, $22.38, and $22.53, respectively. The total fair value of RSUs released in fiscal 2024, 2023 and 2022 was $85 million, $74 million, and $57 million, respectively, which represents the market value of our common stock on the date the RSUs were released. PRUs (In millions, except per share and year data) Number of Weighted- Outstanding and unvested as of March 31, 2023 5 $ 27.93 Granted 2 $ 22.83 Vested (2) $ 28.24 Forfeited (1) — $ 28.49 Outstanding and unvested as of March 29, 2024 5 $ 26.02 (1) The number of shares is less than 1 million. The total fair value of PRUs released in fiscal 2024, 2023 and 2022 was $20 million, $5 million, and $0 million, respectively, which represents the market value of our common stock on the date the PRUs were released. We have granted PRUs to certain of our executives. Typically, these PRUs have a three-year vest period. PRUs granted in fiscal 2024, 2023 and 2022 contain a combination of our company’s performance and market conditions. The performance conditions are based on the achievement of specified two-year non-GAAP financial metrics. The market conditions are based on the achievement of our relative total shareholder return over a three Valuation of PRUs The fair value of each PRU that does not contain a market condition is equal to the market value of our common stock on the date of grant. The fair value of each PRU that contains a market condition is estimated using the Monte Carlo simulation model. The valuation and the underlying weighted-average assumptions for PRUs are summarized below: Year Ended March 29, 2024 March 31, 2023 April 1, 2022 Expected term 2.9 years 3.3 years 3.9 years Expected volatility 31.5 % 34.8 % 37.6 % Risk-free interest rate 3.5 % 3.4 % 1.0 % Expected dividend yield — % 1.3 % — % Weighted-average grant date fair value of PRUs $ 22.83 $ 27.07 $ 28.68 ESPP Under our 2008 Employee Stock Purchase Plan, employees may annually contribute up to 10% of their gross compensation, subject to certain limitations, to purchase shares of our common stock at a discounted price. Eligible employees are offered shares through a 12-month offering period, which consists of two consecutive 6-month purchase periods, at 85% of the lower of either the fair market value on the purchase date or the fair market value at the beginning of the offering period. As of March 29, 2024, 39 million shares have been issued under this plan and 31 million shares remained available for future issuance. The following table summarizes activity related to the purchase rights issued under the ESPP: Year Ended (In millions) March 29, 2024 March 31, 2023 April 1, 2022 Shares issued under the ESPP 1 1 1 Proceeds from issuance of shares $ 12 $ 12 $ 13 The fair value of each stock purchase right under our ESPP is estimated using the Black-Scholes option pricing model. The weighted-average grant date fair value related to rights to acquire shares of common stock under our ESPP in fiscal 2024, 2023 and 2022 was $5.45 per share, $6.04 per share, and $6.77 per share, respectively. Dividend equivalent rights (DERs) Our RSUs and PRUs, except for the 4 million unvested RSUs assumed under the Avast Plans, contain DERs that entitles the recipient of an award to receive cash dividend payments when the associated award is released. The amount of DER equals to the cumulated dividends on the issued number of common stock that would have been payable since the date the associated award was granted. As of March 29, 2024 and March 31, 2023, current dividends payable related to DER was $4 million and $5 million, respectively, recorded as part of Other current liabilities in the Consolidated Balance Sheets, and long-term dividends payable related to DER was $4 million and $2 million, respectively, recorded as part of Other long-term liabilities. Stock-based award modifications No award was modified in fiscal 2024, 2023 and 2022. Stock-based compensation expense Total stock-based compensation expense and the related income tax benefit recognized for all of our equity incentive plans in our Consolidated Statements of Operations were as follows: Year Ended (In millions) March 29, 2024 March 31, 2023 April 1, 2022 Cost of revenues $ 4 $ 3 $ 2 Sales and marketing 36 34 19 Research and development 39 31 19 General and administrative 58 55 30 Restructuring and other costs 1 11 — Total stock-based compensation expense $ 138 $ 134 $ 70 Income tax benefit for stock-based compensation expense $ (16) $ (20) $ (11) As of March 29, 2024, the total unrecognized stock-based compensation expense related to our unvested stock-based awards was $186 million, which will be recognized over an estimated weighted-average amortization period of 1.8 years. Other employee benefit plans 401(k) plan We maintain a salary deferral 401(k) plan for all of our U.S. employees. This plan allows employees to contribute their pretax salary up to the maximum dollar limitation prescribed by the Internal Revenue Code. We match the first 3.5% of a participant’s eligible compensation up to $6,000 in a calendar year. Our employer matching contributions to the 401(k) plan were as follows: Year Ended (In millions) March 29, 2024 March 31, 2023 April 1, 2022 401(k) matching contributions $ 4 $ 4 $ 3 |
Net Income (Loss) Per Share
Net Income (Loss) Per Share | 12 Months Ended |
Mar. 29, 2024 | |
Earnings Per Share [Abstract] | |
Net Income (Loss) Per Share | Net Income (Loss) Per Share Basic income per share is computed by dividing net income by the weighted-average number of common shares outstanding during the period. Diluted net income per share also includes the incremental effect of dilutive potentially issuable common shares outstanding. Dilutive potentially issuable common shares include the dilutive effect of the shares underlying convertible debt and employee equity awards. Our remaining convertible debt was extinguished on August 15, 2022. The components of basic and diluted net income (loss) per share are as follows: Year Ended (In millions, except per share amounts) March 29, 2024 March 31, 2023 April 1, 2022 Net income (loss) $ 616 $ 1,349 $ 836 Net income per share - basic $ 0.97 $ 2.20 $ 1.44 Net income per share - diluted $ 0.96 $ 2.16 $ 1.41 Weighted-average shares outstanding - basic 637 614 581 Dilutive potentially issuable shares: Convertible debt — 6 7 Employee equity awards 5 4 3 Weighted-average shares outstanding - diluted 642 624 591 Anti-dilutive shares excluded from diluted net income (loss) per share calculation: Employee equity awards 1 — 1 |
Segment and Geographic Informat
Segment and Geographic Information | 12 Months Ended |
Mar. 29, 2024 | |
Segment Reporting [Abstract] | |
Segment and Geographic Information | Segment and Geographic Information We operate as one reportable segment. Our Chief Operating Decision Maker is our Chief Executive Officer, who reviews financial information presented on a consolidated basis to evaluate company performance and to allocate and prioritize resources. The following table summarizes net revenues for our major solutions: Year Ended (In millions) March 29, 2024 March 31, 2023 April 1, 2022 Consumer security revenues $ 2,417 $ 2,029 $ 1,623 Identity and information protection revenues 1,332 1,244 1,127 Total cyber safety revenues 3,749 3,273 2,750 Legacy revenues 63 65 46 Total net revenues (1) $ 3,812 $ 3,338 $ 2,796 (1) During the year ended March 29, 2024, total net revenues include an unfavorable foreign exchange impact of $25 million, consisting of $24 million from our consumer security solutions and $1 million from our identity and information protection solutions. From time to time, changes in our product hierarchy cause changes to the product categories above. When changes occur, we recast historical amounts to match the current product hierarchy. The changes have been reflected for all periods presented above. Consumer security includes revenues from our Norton 360 Security offerings, Norton, Avast, AVG, and Avira Security and VPN offerings, and other consumer security and device performance solutions through our direct, partner and small business channels. Identity and information protection includes revenues from our Norton 360 with LifeLock offerings, LifeLock identity theft protection and other identity, information protection and privacy solutions. Legacy includes revenues from products or solutions from markets that we have exited and in which we no longer operate, have been discontinued or identified to be discontinued, or remain in maintenance mode as a result of integration and product portfolio decisions. Geographic information Net revenues by geography are based on the billing addresses of our customers. The following table represents net revenues by geographic area for the periods presented: Year Ended (2) (In millions) March 29, 2024 March 31, 2023 April 1, 2022 Americas $ 2,493 $ 2,247 $ 1,936 EMEA 920 724 522 APJ 399 367 338 Total net revenues (1) $ 3,812 $ 3,338 $ 2,796 Note: The Americas include U.S., Canada, and Latin America; EMEA includes Europe, Middle East, and Africa; APJ includes Asia Pacific and Japan. (1) During the year ended March 29, 2024, total net revenues include an unfavorable foreign exchange impact of $25 million, consisting of $14 million from EMEA and $11 million from APJ. (2) From time to time, changes in allocation methodologies cause changes to the revenue by geographic area above. When changes occur, we recast historical amounts to match the current methodology, such as for fiscal 2023 and 2022 where we aligned allocation methodologies across similar product categories. Revenues from customers inside the U.S. were $2,270 million, $2,071 million, and $1,834 million during fiscal 2024, 2023 and 2022, respectively. No other individual country accounted for more than 10% of revenues. The table below represents cash and cash equivalents held in the U.S. and internationally in various foreign subsidiaries: (In millions) March 29, 2024 March 31, 2023 U.S. $ 467 $ 178 International 379 572 Total cash and cash equivalents $ 846 $ 750 The table below represents our property and equipment, net of accumulated depreciation and amortization, by geographic area, based on the physical location of the asset, at the end of each period presented: (In millions) March 29, 2024 March 31, 2023 U.S. $ 47 $ 38 Germany 12 13 Czech Republic 6 16 Other countries (1) 7 9 Total property and equipment, net $ 72 $ 76 (1) No individual country represented more than 10% of the respective totals. Significant customers and e-commerce partners In fiscal 2024, 2023 and 2022, no individual end-user customer accounted for 10% or more of our net revenues. See Note 1 for e-commerce partners that accounted for over 10% of our total accounts receivable. |
Commitments and Contingencies
Commitments and Contingencies | 12 Months Ended |
Mar. 29, 2024 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments and Contingencies | Commitments and Contingencies Purchase obligations We have purchase obligations that are associated with agreements for purchases of goods or services. Management believes that cancellation of these contracts is unlikely, and we expect to make future cash payments according to the contract terms. The following reflects estimated future payments for purchase obligations by fiscal year. The amount of purchase obligations reflects estimated future payments as of March 29, 2024. (In millions) March 29, 2024 2025 $ 324 2026 73 2027 47 2028 36 2029 28 Thereafter 2 Total purchase obligations $ 510 Deemed repatriation taxes Under the Tax Cuts and Jobs Act (H.R.1), we are required to pay a one-time transition tax on untaxed earnings of our foreign subsidiaries through July 2025. The following reflects estimated future payments for deemed repatriation taxes by fiscal year: (In millions) March 29, 2024 2025 $ 171 2026 139 Total obligations $ 310 Indemnifications In the ordinary course of business, we may provide indemnifications of varying scope and terms to customers, vendors, lessors, business partners, subsidiaries and other parties with respect to certain matters, including, but not limited to, product warranties and losses arising out of our breach of agreements or representations and warranties made by us, including claims alleging that our software infringes on the intellectual property rights of a third party. In addition, our bylaws contain indemnification obligations to our directors, officers, employees, and agents, and we have entered into indemnification agreements with our directors and certain of our officers to give such directors and officers additional contractual assurances regarding the scope of the indemnification set forth in our bylaws and to provide additional procedural protections. We maintain director and officer insurance, which may cover certain liabilities arising from our obligation to indemnify our directors and officers. It is not possible to determine the aggregate maximum potential loss under these indemnification agreements due to the limited history of prior indemnification claims and the unique facts and circumstances involved in each particular agreement. Such indemnification agreements might not be subject to maximum loss clauses. We monitor the conditions that are subject to indemnification to identify if a loss has occurred. Historically, we have not incurred material costs as a result of obligations under these agreements, and we have not accrued any material liabilities related to such indemnification obligations in our Consolidated Financial Statements. Litigation contingencies Trustees of the University of Columbia in the City of New York v. NortonLifeLock As previously disclosed, on May 2, 2022, a jury returned its verdict in a patent infringement case filed in 2013 by the Trustees of Columbia University in the City of New York (Columbia) in the U.S. District Court for the Eastern District of Virginia. Columbia originally brought suit alleging infringement of six patents owned by the university. We won a favorable claim construction order on all six patents, and the claim construction was upheld by the Federal Circuit in 2016 on all but U.S. Patent Nos. 8,601,322 and 8,074,115. We also sought inter partes review by the Patent Trial and Appeal Board of the claims of the ‘322 and ‘115 Patents and all but two claims of the ‘322 Patent and three claims of the ‘115 Patent were invalidated. The remaining claims of the ‘322 and ‘115 Patents were the only claims that remained in suit at trial. The jury found that our Norton Security products and Symantec Endpoint Protection products (the latter of which were sold by us to Broadcom as part of an Asset Purchase Agreement dated November 4, 2019) willfully infringe the ‘322 and ‘115 Patents through the use of SONAR/BASH behavioral protection technology. The jury awarded damages in the amount of $185 million. Columbia did not seek injunctive relief against us. We believe that we have ceased the use of the technology found by the jury to infringe. The jury also found that we did not fraudulently conceal its prosecution of U.S. Patent No. 8,549,643 but did find that two Columbia professors were coinventors of this patent. No damages were awarded related to this patent. On September 30, 2023, the court entered its judgment, which awarded Columbia (i) enhanced damages of 2.6 times the jury award; (ii) prejudgment interest, post-judgment interest, and supplemental damages to be calculated in accordance with the parties’ previous agreement; and (iii) attorneys’ fees subject to the parties meeting and conferring as to amount. We have complied with the court’s order and submitted a stipulation regarding the final calculations of all outstanding interest, royalties and attorneys’ fees. We have posted the required surety bond and have appealed the judgement to the Federal Circuit Court of Appeals, which remains pending. At this time, our current estimate of probable losses from this matter is approximately $583 million, which we have accrued and recorded as part of Other long-term liabilities in the Consolidated Balance Sheets . There is a reasonable possibility that a loss may be incurred in excess of our accrual for this matter; however, such loss cannot be reasonably estimated. Securities Class Action and Derivative Litigation Securities class action lawsuits, which have since been consolidated, were filed in May 2018 against us and certain of our former officers, in the U.S. District Court for the Northern District of California. The lead plaintiff’s consolidated amended complaint alleged that, during a purported class period of May 11, 2017 to August 2, 2018, defendants made false and misleading statements in violation of Sections 10(b) and 20(a), and that certain individuals violated Section 20A, of the Securities Exchange Act of 1934, as amended (the Exchange Act). On May 24, 2021, the parties reached a proposed settlement and release of all claims in the class action, for $70 million, and on June 8, 2021, the parties executed a Stipulation and Agreement of Settlement, exclusive of any claims that may be brought by shareholders who opted out of the class action. Of the $70 million, $67 million was covered under the applicable insurance policy with the remainder to be paid by us. The Court approved the settlement on February 12, 2022. On November 22, 2021, investment funds managed by Orbis Investment Management Ltd. which previously opted out of the securities class action, filed suit under the Exchange Act, the Arizona Securities Act, the Arizona Consumer Fraud Act and certain common law causes of action to recover alleged damages for losses incurred by the funds for their purchases or acquisitions of our common stock during the class period. On February 7, 2023, our Motion to Dismiss was granted in part and denied in part. The parties have now settled the matter and the action was dismissed with prejudice on April 26, 2023. The impact of settlement was not material. Purported shareholder derivative lawsuits were filed against us and certain of our former officers and current and former directors in the Delaware Court of Chancery ( In re Symantec Corp. S’holder. Deriv. Litig. ), Northern District of California ( Lee v. Clark et al., ), and the District of Delaware ( Milliken vs. Clark et al. ). These assert generally the same facts and circumstances as alleged in the securities class action and allege claims for breach of fiduciary duty and related claims. On January 4, 2023, after reaching an agreement on the terms of the proposed settlement, which provides for, among other things, a payment of $12 million to the Company by the insurers of the Company’s directors and officers, the parties to the Chancery action filed a Stipulation and Agreement of Settlement, Compromise and Release in that Court, which was approved by the Court on May 4, 2023, over the objection of the Lee and Milliken plaintiffs, and releases all claims in the Chancery, Lee , and Milliken actions, as well as any other claims based on the same operative facts. The parties in the Milliken action stipulated to a dismissal with prejudice, which was entered by that Court on May 12, 2023. The parties in the Lee action stipulated to a dismissal with prejudice, which was entered by that Court on June 12, 2023. All three shareholder derivative lawsuits are now resolved. A fourth lawsuit filed in the Delaware Superior Court, Kukard v. Symantec , brought claims derivatively on behalf of our 2008 Employee Stock Purchase Plan. The parties have reached a settlement in principle, subject to Court approval. The impact of settlement was not material. GSA During the first quarter of fiscal 2013, we were advised by the Commercial Litigation Branch of the Department of Justice’s (DOJ) Civil Division and the Civil Division of the U.S. Attorney’s Office for the District of Columbia that the government is investigating our compliance with certain provisions of our U.S. General Services Administration (GSA) Multiple Award Schedule Contract No. GS-35F-0240T effective January 24, 2007, including provisions relating to pricing, country of origin, accessibility, and the disclosure of commercial sales practices. As reported on the GSA’s publicly-available database, our total sales under the GSA Schedule contract were approximately $222 million from the period beginning January 2007 and ending September 2012. We fully cooperated with the government throughout its investigation, and in January 2014, representatives of the government indicated that their initial analysis of our actual damages exposure from direct government sales under the GSA Schedule contract was approximately $145 million; since the initial meeting, the government’s analysis of our potential damages exposure relating to direct sales increased. The government also indicated they would pursue claims for certain sales to California, Florida, and New York as well as sales to the federal government through reseller GSA Schedule contracts, which could significantly increase our potential damages exposure. In 2012, a sealed civil lawsuit was filed against us related to compliance with the GSA Schedule contract and contracts with California, Florida, and New York. On July 18, 2014, the Court-imposed seal expired, and the government intervened in the lawsuit. On September 16, 2014, the states of California and Florida intervened in the lawsuit, and the state of New York notified the Court that it would not intervene. On October 3, 2014, the DOJ filed an amended complaint, which did not state a specific damages amount. On October 17, 2014, California and Florida combined their claims with those of the DOJ and the relator on behalf of New York in an Omnibus Complaint, and a First Amended Omnibus Complaint was filed on October 8, 2015; the state claims also do not state specific damages amounts. On March 23, 2021, Plaintiffs withdrew their demand for a jury trial and we consented to proceed with a bench trial, which concluded on March 24, 2022. On January 19, 2023, the Court issued its Findings of Facts and Conclusions of Law in which it found in favor of the United States in part and awarded damages and penalties in the amount of $1.3 million. The Court also found in favor of the State of California in part and awarded penalties in the amount of $0.4 million. The resulting Judgment was filed by the Court on January 20, 2023. On February 16, 2023, Plaintiffs filed Motions to Amend Judgment to revive the damages claimed at trial. On January 16, 2024, the Court granted in part and denied in part the United States’ Motion to Amend and awarded $53 million in damages and penalties. The State of California’s Motion to Amend was denied. The January 2023 judgment amount has been paid, and at this time, our current estimate of the low end of the range of probable estimated losses from this matter is $53 million, which we have accrued and recorded as part of Other current liabilities in the Consolidated Balance Sheets. On February 13, 2024, we filed a motion to amend and correct the judgement in that the revised damages in the January 2024 decision include damages for products not included on the GSA schedule at issue in the case. The judgement in the case is not yet final, nonetheless we have posted a surety bond and continue to assess our appeal options. It is possible an appeal of the Court’s amended judgment by the plaintiffs, if brought, could lead to further claims or findings of violations of the False Claims Act and could be material to our results of operations and cash flows for any period. Resolution of False Claims Act investigations can ultimately result in the payment of somewhere between one and three times the actual damages proven by the government, plus civil penalties. There is a reasonable possibility that a loss may have been incurred in excess of our accrual for this matter; however, such loss cannot be reasonably estimated. Additionally, on May 13, 2021, we reached a settlement in principle with the State of Florida to resolve all claims it asserted in the litigation for $0.5 million, plus the relator’s statutory attorney’s fees with respect to the State of Florida’s claims. On February 28, 2022, we reached a settlement in principle with the State of New York and the relator to resolve all of the New York claims asserted in the litigation for $5 million. Jumpshot Matters At the end of 2019, Avast came under media scrutiny for provision of Avast customer data to its data analytics subsidiary Jumpshot Inc. Jumpshot was a subsidiary of Avast with its own management team and technical experts. Avast announced the decision to terminate its provision of data to, and wind down, Jumpshot on January 30, 2020. As Avast has previously disclosed, it has been in communication with certain regulators and authorities prior to completion of the acquisition of Avast, and we will continue cooperating fully in respect of all regulatory enquiries. On December 23, 2019, the United States Federal Trade Commission (FTC) issued a Civil Investigative Demand (CID) to Avast seeking documents and information related to its privacy practices, including Jumpshot's past use of consumer information that was provided to it by Avast. Avast responded cooperatively to the CID and related follow-up requests from the FTC. On October 29, 2021, staff at the FTC sent Avast a draft complaint and proposed settlement order. We have been engaged in ongoing negotiations with the FTC staff and have reached an agreement on the terms of a settlement resolving this investigation, subject to the Commission’s approval, the terms of which are not expected to have a material impact on current or ongoing operations. This includes a provision for a non-material amount of monetary relief, which has been accrued. Absent a final settlement, any litigation or other legal proceeding between us and the FTC could result in material monetary remedies and/or compliance requirements that impose significant and material cost and resource burdens on us, and may impact our ability to use data in the future. There can be no assurance that we will be successful in reaching a favorable settlement or in litigation. Any remedies or compliance requirements resulting from a litigation or other legal proceedings could adversely affect our ability to operate our business or have a materially adverse impact on our financial results. On February 27, 2020, the Czech Office for Personal Data Protection (the Czech DPA) initiated offense proceedings concerning Avast`s practices with respect to Jumpshot, the Czech DPA issued a decision in March 2022 finding that Avast had violated the GDPR and issued a fine of CZK 351 million, which we accrued. Avast appealed the decision, which was affirmed by the Czech DPA on April 10, 2024. Avast is considering its options including a further judicial action. On March 27, 2024, Stichting CUIC – Privacy Foundation for Collective Redress, a Dutch foundation (the Foundation), filed its writ of summons to initiate a collective action. The Foundation has asserted it represents the interests of Avast customers in the Netherlands whose data was provided to Jumpshot and that by doing so Avast violated the requirements of the GDPR and other provisions in Dutch and European Union privacy and consumer law entitling those customers to damages and other compensation, all of which we dispute. No specific amount of damages has been alleged to date. At this stage, we are unable to assess whether any material loss or adverse effect is reasonably possible or estimate the range of any potential loss. On April 18, 2024, we received a letter before action from counsel in the United Kingdom asserting it may bring a representative action on behalf of a class of Avast users in the United Kingdom and Wales for breach of contract and misuse of private information and seeking unspecified damages and a permanent injunction. No lawsuit has been commenced. At this stage, we are unable to assess whether any material loss or adverse effect is reasonably possible or estimate the range of any potential loss. On December 12, 2022, a putative class action, Lau v. Gen Digital Inc. and Jumpshot Inc. , was filed in the Northern District of California alleging violations of the Electronic Communications Privacy Act, California Invasion of Privacy Act, statutory larceny, unfair competition and various common law claims related to the provision of customer data to Jumpshot. Such claims, to the extent related to Jumpshot, have now been dismissed from the case. At this stage, we are unable to assess whether any material loss or adverse effect is reasonably possible as a result of this action or estimate the range of any potential loss. We dispute these claims and intend to defend them vigorously. The outcome of the regulatory proceedings, government enforcement actions and litigation is difficult to predict, and the cost to defend, settle or otherwise resolve these matters may be significant. Plaintiffs or regulatory agencies or authorities in these matters may seek recovery of large or indeterminate amounts or seek to impose sanctions, including significant monetary penalties, as well as equitable relief. The monetary and other impact of these litigations, proceedings or actions may remain unknown for substantial periods of time. Further, an unfavorable resolution of litigations, proceedings or actions could have a material adverse effect on our business, financial condition, and results of operations and cash flows. The amount of time that will be required to resolve these matters is unpredictable, and these matters may divert management’s attention from the day-to-day operations of our business. Any future investigations or additional lawsuits may also adversely affect our business, financial condition, results of operations and cash flows. Other We are involved in a number of other judicial and administrative proceedings that are incidental to our business. Although adverse decisions (or settlements) may occur in one or more of the cases, it is not possible to estimate the possible loss or losses from each of these cases. The final resolution of these lawsuits, individually or in the aggregate, is not expected to have a material adverse effect on our business, results of operations, financial condition or cash flows. |
Schedule II - Valuation and Qua
Schedule II - Valuation and Qualifying Accounts | 12 Months Ended |
Mar. 29, 2024 | |
SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract] | |
Schedule II - Valuation and Qualifying Accounts | VALUATION AND QUALIFYING ACCOUNTS All financial statement schedules have been omitted, since the required information is not applicable or is not present in material amounts, and/or changes to such amounts are immaterial to require submission of the schedule, or because the information required is included in our Consolidated Financial Statements and notes thereto included in this Form 10-K. |
Pay vs Performance Disclosure
Pay vs Performance Disclosure - USD ($) $ in Millions | 12 Months Ended | ||
Mar. 29, 2024 | Mar. 31, 2023 | Apr. 01, 2022 | |
Pay vs Performance Disclosure | |||
Net income | $ 616 | $ 1,349 | $ 836 |
Insider Trading Arrangements
Insider Trading Arrangements | 3 Months Ended |
Mar. 29, 2024 | |
Trading Arrangements, by Individual | |
Rule 10b5-1 Arrangement Adopted | false |
Non-Rule 10b5-1 Arrangement Adopted | false |
Rule 10b5-1 Arrangement Terminated | false |
Non-Rule 10b5-1 Arrangement Terminated | false |
Insider Trading Policies and Pr
Insider Trading Policies and Procedures | 12 Months Ended |
Mar. 29, 2024 | |
Insider Trading Policies and Procedures [Line Items] | |
Insider Trading Policies and Procedures Adopted | true |
Description of Business and S_2
Description of Business and Summary of Significant Accounting Policies (Policies) | 12 Months Ended |
Mar. 29, 2024 | |
Accounting Policies [Abstract] | |
Basis of presentation | The accompanying Consolidated Financial Statements of Gen Digital Inc. and our wholly-owned subsidiaries are prepared in conformity with generally accepted accounting principles in the United States (U.S. GAAP). All significant intercompany accounts and transactions have been eliminated in consolidation. |
Fiscal calendar | We have a 52/53-week fiscal year ending on the Friday closest to March 31. Fiscal 2024, 2023 and 2022 in this report refers to fiscal years ended March 29, 2024, March 31, 2023 and April 1, 2022, respectively, each of which was a 52-week year. |
Use of estimates | The preparation of Consolidated Financial Statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions that affect the amounts reported in the Consolidated Financial Statements and accompanying Notes. Such estimates include, but are not limited to, valuation of business combinations including acquired intangible assets and goodwill, loss contingencies, the recognition and measurement of current and deferred income taxes, including assessing of unrecognized tax benefits, and valuation of assets and liabilities. On an ongoing basis, management determines these estimates and assumptions based on historical experience and on various other assumptions that are believed to be reasonable. Third-party valuation specialists are also utilized for certain estimates. Actual results could differ from such estimates and assumptions due to risks and uncertainties, including uncertainty in the current economic environment as a result of macroeconomic factors such as inflation, fluctuations in foreign currency exchange rates relative to the U.S. dollars, our reporting currency, changes in interest rates, Russia’s invasion of Ukraine, and the Israel-Hamas conflict, and such differences may be material to the Consolidated Financial Statements. |
Revenue recognition and Contract liabilities | We sell products and services directly to end-users and through multiple partner distribution channels. Revenue recognition begins when we transfer control of the promised products or services to our customers in an amount that reflects the consideration we expect to be entitled to in exchange for such products or services. Our customer definition aligns with the control principles as outlined under Accounting Standards Codification (ASC) 606. Performance periods are generally one year or less, and payments are generally collected up front. Revenue is recognized net of any taxes collected from customers and subsequently remitted to governmental authorities. Our customers are primarily users of our products and solutions who sign up on our e-commerce platform and have a direct billing relationship with us. However, our customers, also include users who do not have a direct billing relationship with us but register on our e-commerce site through our e-commerce partners. When referring to e-commerce partners, we are referring to those that are our fulfillment and payment processors who perform primarily administrative functions, such as collecting payment and remitting any required sales tax to governmental authorities. Revenue from these e-commerce partners is recognized on a gross basis, excluding fees paid to e-commerce partners. We offer various channel rebates for our products. Our estimated reserves for channel volume incentive rebates are based on distributors’ and resellers’ performance compared to the terms and conditions of volume incentive rebate programs, which are typically entered into quarterly. Our reserves for rebates are estimated based on the terms and conditions of the promotional program, actual sales during the promotion, the amount of redemptions received, historical redemption trends by product and by type of promotional program and the value of the rebate. We record estimated reserves for rebates as an offset to revenue or contract liabilities. Reserves for rebates, recorded in Other current liabilities, were $4 million as of March 29, 2024 and March 31, 2023. For products that include content updates and services, rebates are recognized as a ratable offset to revenue or contract liabilities over the term of the subscription. Performance obligations At contract inception, we assess the products and services promised in the contract to identify each performance obligation and evaluate whether the performance obligations are capable of being distinct and are distinct within the context of the contract. Performance obligations that are not both capable of being distinct and are distinct within the context of the contract are combined and treated as a single performance obligation in determining the allocation and recognition of revenue. Our software solutions typically consist of a term-based subscription as well as when-and-if available software updates and upgrades. We have determined that our promises to transfer the software license subscription and the related support and maintenance are not separately identifiable because: • the licensed software and the software updates and upgrades are highly interdependent and highly interrelated, working together to deliver continuously updated protection to customers; • by identifying and addressing new threats, the software updates and upgrades significantly modify the licensed software and are integral to maintaining its utility; and • given the rapid pace with which new threats are identified, the value of the licensed software diminishes rapidly without the software updates and upgrades. We therefore consider the software license and related support obligations a single, combined performance obligation with revenue recognized over time as our solutions are delivered. Revenue from services is recognized as services are completed or ratably over the contractual period. Contract liabilities consist of deferred revenue and customer deposit liabilities and represent cash payments received or due in advance of fulfilling our performance obligations. Deferred revenue represents billings under non-cancelable contracts before the related product or service is transferred to the customer. Certain arrangements include terms that allow the customer to terminate the contract and receive a refund for a period of time. In these arrangements, we have concluded there are no enforceable rights and obligations during the period in which the option to cancel is exercisable by the customer, and therefore the consideration received or due from the customer is recorded as a customer deposit liability. |
Fair value measurements | For assets and liabilities measured at fair value, fair value is the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining fair value, we consider the principal or most advantageous market in which we would transact, and we consider assumptions that market participants would use when pricing the asset or liability. The three levels of inputs that may be used to measure fair value are: • Level 1: Quoted prices in active markets for identical assets or liabilities. • Level 2: Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities, quoted prices in less active markets or model-derived valuations. All significant inputs used in our valuations, such as discounted cash flows, are observable or can be derived principally from or corroborated with observable market data for substantially the full term of the assets or liabilities. • Level 3: Unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of assets or liabilities. We monitor and review the inputs and results of these valuation models to help ensure the fair value measurements are reasonable and consistent with market experience in similar asset classes. |
Assets measured and recorded at fair value | Cash equivalents . We consider all highly liquid investments with an original maturity of three months or less at the time of purchase to be cash equivalents. Cash equivalents are carried at amounts that approximate fair value due to the short period of time to maturity. |
Non-marketable investments | Our non-marketable investments consist of equity investments in privately-held companies without a readily determinable fair value. We primarily measure these investments at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for identical or similar investments of the same issuer. We may elect to measure certain investments at fair value, for which we utilize third-party valuation specialists at least annually in the fourth quarter of each fiscal year, or more frequently if events or changes in circumstances indicate a change in the fair value of the investment. Gains and losses on these investments, whether realized or unrealized, are recognized in Other income (expense), net in our Consolidated Statements of Operations. We assess the recoverability of our non-marketable investments by reviewing various indicators of impairment. If indicators are present, a fair value measurement is made by performing a discounted cash flow analysis of the investment. We immediately recognize the impairment to our non-marketable equity investments if the carrying value exceeds the fair value. |
Accounts receivable | Accounts receivable are recorded at the invoiced amount and are not interest bearing. We maintain an allowance for doubtful accounts or expected credit losses to reserve for expected uncollectible receivables. We review our accounts receivable by aging category to identify specific customers with known disputes or collectability issues. In addition, we maintain an allowance for all other receivables not included in the specific reserve by applying specific percentages of projected uncollectible receivables to the various aging categories. In determining these percentages, we use judgment based on our historical collection experience and current economic trends as well as reasonable and supportable forecasts of future economic conditions. |
Assets held for sale | Long-lived assets held for sale are recorded at the lower of carrying value or fair value less costs to sell. Fair value is determined based on discounted cash flows, appraised values or management’s estimates, depending upon the nature of the assets and external data available. |
Property and equipment | Property, equipment, and leasehold improvements are stated at cost, net of accumulated depreciation. Depreciation is provided on a straight-line basis over the estimated useful lives. Estimated useful lives for financial reporting purposes are as follows: buildings, 20 to 30 years; building improvements, 7 to 20 years; leasehold improvements, the lesser of the life of the improvement or the initial lease term, and computer hardware and software and office furniture and equipment, 3 to 5 years. |
Software development costs | The costs for the development of new software products and substantial enhancements to existing software products are expensed as incurred until technological feasibility has been established, at which time any additional costs would be capitalized in accordance with the accounting guidance for software. Because our current process for developing software is essentially completed concurrently with the establishment of technological feasibility, which occurs upon the completion of a working model, no costs have been capitalized for any of the periods presented. |
Internal-use software development costs | We capitalize qualifying costs incurred during the application development stage related to software developed for internal-use and amortize them over the estimated useful life of 3 years. We expense costs incurred related to the planning and post-implementation phases of development as incurred. |
Leases | We determine if an arrangement is a lease at inception. We have elected to not recognize a lease liability or right-of-use (ROU) asset for short-term leases (leases with a term of twelve months or less that do not include an option to purchase the underlying asset). Operating lease ROU assets and operating lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term at commencement date. The interest rate we use to determine the present value of future payments is our incremental borrowing rate because the rate implicit in our leases is not readily determinable. Our incremental borrowing rate is a hypothetical rate for collateralized borrowings in economic environments where the leased asset is located based on credit rating factors. Our operating lease assets also include adjustments for prepaid lease payments , lease incentives and initial direct costs . |
Business combinations | We use the acquisition method of accounting under the authoritative guidance on business combinations. We allocate the purchase price of our acquisitions to the assets acquired and liabilities assumed based on their estimated fair values. The excess of the purchase price over the fair values of these identifiable assets and liabilities is recorded as goodwill. Acquisition-related expenses are recognized separately from the business combination and are expensed as incurred. Each acquired company’s operating results are included in our Consolidated Financial Statements starting on the date of acquisition. |
Goodwill | Goodwill is recorded when consideration paid for an acquisition exceeds the fair value of net tangible and intangible assets acquired. We perform an impairment assessment of goodwill at the reporting unit level at least annually in the fourth quarter of each fiscal year, or more frequently if events or changes in circumstances indicate that the asset may be impaired. The accounting guidance gives us the option to perform a qualitative assessment to determine whether further impairment testing is necessary. The qualitative assessment considers events and circumstances that might indicate that a reporting unit’s fair value is less than its carrying amount. If it is determined, as a result of the qualitative assessment, that it is more likely than not that the fair value of a reporting unit is less than its carrying amount, a quantitative test is performed. |
Long-lived assets | In connection with our acquisitions, we generally recognize assets for customer relationships, developed technology, finite-lived trade names and indefinite-lived trade names. Finite-lived intangible assets are carried at cost less accumulated amortization. Such amortization is provided on a straight-line basis over the estimated useful lives of the respective assets, generally from 1 to 10 years. Amortization for developed technology is recognized in cost of revenue. Amortization for customer relationships and certain trade names is recognized in operating expenses. Indefinite-lived intangible assets are not subject to amortization but instead tested for impairment annually or more frequently if events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. |
Debt | Our debt includes senior unsecured notes, senior term loans and a senior secured revolving credit facility. Our senior unsecured notes are recorded at par value at issuance less a discount representing the amount by which the face value exceeds the fair value at the date of issuance and an amount which represents issuance costs. Our senior term loans are recorded at par value less debt issuance costs, which are recorded as a reduction in the carrying value of the debt. The discount and issuance costs associated with the various notes are amortized using the effective interest rate method over the term of the debt as a non-cash charge to interest expense. Borrowings under our revolving credit facility, if any, are recognized at principal balance plus accrued interest based upon stated interest rates. Debt maturities are classified as current liabilities on our Consolidated Balance Sheets if we are contractually obligated to repay them in the next twelve months or, prior to the balance sheet date, we have the authorization and intent to repay them prior to their contractual maturities and within the next twelve months. |
Treasury stock | We account for treasury stock under the cost method. Shares repurchased under our share repurchase program are retired. Upon retirement, we allocate the value of treasury stock between Additional paid-in capital and Retained earnings. |
Restructuring | Restructuring actions generally include significant actions involving employee-related severance charges, contract termination costs and asset write-offs and impairments. Employee-related severance charges are largely based upon substantive severance plans, while some charges result from mandated requirements in certain foreign jurisdictions. These charges are reflected in the period when both the actions are probable and the amounts are estimable. Contract termination costs reflect costs that will continue to be incurred under a contract for its remaining term without future economic benefit. These charges are reflected in the period when a contract is terminated. Asset write-offs and impairments, including those related to ROU lease assets, are recognized in the period that an asset is decommissioned or a facility ceases to be used. |
Income taxes | We compute the provision for income taxes using the asset and liability method, under which deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax basis of assets and liabilities and for operating losses and tax credit carryforwards in each jurisdiction in which we operate. We measure deferred tax assets and liabilities using the currently enacted tax rates that apply to taxable income in effect for the years in which those tax assets are expected to be realized or settled. We also assess the likelihood that deferred tax assets will be realized from future taxable income and based on weighting positive and negative evidence, we will assess and determine the need for a valuation allowance, if required. The determination of our valuation allowance involves assumptions, judgments and estimates, including forecasted earnings, future taxable income and the relative proportions of revenue and income before taxes in the various domestic and international jurisdictions in which we operate. To the extent we establish a valuation allowance or change the valuation allowance in a period, we reflect the change with a corresponding increase or decrease to Income tax expense (benefit) in our Consolidated Statements of Operations. We record accruals for unrecognized tax benefits when we believe that it is not more likely than not that the tax position will be sustained on examination by the taxing authorities based on the technical merits of the position. We also record accruals for unrecognized tax benefits at the largest amount that is greater than 50% likely of being realized based on the technical merits of the position. We adjust these accruals when facts and circumstances change, such as the closing of a tax audit or the refinement of an estimate. The provision for income taxes includes the effects of adjustments for unrecognized tax benefits as well as any related interest and penalties. |
Stock-based compensation | We measure and recognize stock-based compensation for all stock-based awards, including restricted stock units (RSU), performance-based restricted stock units (PRU), stock options and rights to purchase shares under our employee stock purchase plan (ESPP), based on their estimated fair value on the grant date. We recognize the costs in our Consolidated Financial Statements on a straight-line basis over the award’s requisite service period except for PRUs with graded vesting, for which we recognize the costs on a graded basis. For awards with performance conditions, the amount of compensation cost we recognize over the requisite service period is based on the actual or estimated achievement of the performance condition. We estimate the number of stock-based awards that will be forfeited due to employee turnover. The fair value of each RSU and PRU that does not contain a market condition is equal to the market value of our common stock on the date of grant. The fair value of each PRU that contains a market condition is estimated using the Monte Carlo simulation model. The fair values of RSUs and PRUs are not discounted by the dividend yield because our RSUs and PRUs include dividend-equivalent rights, except for the 4 million unvested RSUs assumed as part of our acquisition of Avast. We use the Black-Scholes model to determine the fair value of stock options and the fair value of rights to acquire shares of common stock under our ESPP . The Black-Scholes valuation model incorporates a number of variables, including our expected stock price volatility over the expected life of the awards, actual and projected employee exercise and forfeiture behaviors, risk-free interest rates and expected dividends. If we do not have sufficient historical exercise data to provide a reasonable basis upon which to estimate expected life, we estimate the expected life of the stock option awards granted based on its expected term using the simplified method available under U.S. GAAP. |
Foreign currency | For foreign subsidiaries whose functional currency is the local currency, assets and liabilities are translated to U.S. dollars at exchange rates in effect at the balance sheet date. Gains and losses resulting from translation of these foreign currency financial statements into U.S. dollars are recorded in AOCI. Remeasurement adjustments are recorded in Other income (expense), net in our Consolidated Statements of Operations. |
Concentrations of risk | A significant portion of our revenue is derived from international sales. Fluctuations of the U.S. dollar against foreign currencies, changes in local regulatory or economic conditions, or piracy could adversely affect our operating results. |
Advertising and other promotional costs | Advertising and other promotional costs are expensed as incurred, and are recorded in sales and marketing expenses. |
Contingencies | We evaluate contingent liabilities including threatened or pending litigation in accordance with the authoritative guidance on contingencies. We assess the likelihood of any adverse judgments or outcomes from potential claims or proceedings, as well as potential ranges of probable losses, when the outcomes of the claims or proceedings are probable and reasonably estimable. A determination of the amount of an accrual required, if any, for these contingencies is made after the analysis of each separate matter. Because of uncertainties related to these matters, we base our estimates on the information available at the time of our assessment. As additional information becomes available, we reassess the potential liability related to our pending claims and litigation and may revise our estimates. |
Recently issued authoritative guidance not yet adopted | ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. In November 2023, the Financial Accounting Standards Board (FASB) issued new guidance to update reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses and information used to assess segment performance. This is effective for fiscal years beginning after December 15, 2023 and interim periods within fiscal years beginning after December 15, 2024. We do not expect the adoption of this guidance will have a material impact on our Consolidated Financial Statements and disclosures. ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. In December 2023, the FASB issued new guidance to update income tax disclosure requirements, requiring disaggregated information about an entity’s effective tax rate reconciliation as well as income taxes paid. This is effective for fiscal years beginning after December 15, 2024. We are currently evaluating the impact of the adoption of this guidance on our Consolidated Financial Statements and disclosures. Although there are several other new accounting pronouncements issued or proposed by the FASB that we have adopted or will adopt, as applicable, we do not believe any of these accounting pronouncements has had, or will have, a material impact on our Consolidated Financial Statements or disclosures. |
Description of Business and S_3
Description of Business and Summary of Significant Accounting Policies (Tables) | 12 Months Ended |
Mar. 29, 2024 | |
Accounting Policies [Abstract] | |
Schedules of Concentration of Risk | E-commerce partners that accounted for over 10% of our total billed and unbilled accounts receivable, are as follows: March 29, 2024 March 31, 2023 E-commerce partner A 13 % 13 % E-commerce partner B 11 % 14 % |
Business Combinations (Tables)
Business Combinations (Tables) | 12 Months Ended |
Mar. 29, 2024 | |
Business Combination and Asset Acquisition [Abstract] | |
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed | Our final allocation of the aggregate purchase price for the acquisition as of September 12, 2022, was as follows: (In millions) September 12, 2022 Assets: Accounts receivable $ 63 Other current assets 17 Property and equipment 33 Operating lease assets 18 Intangible assets 2,383 Goodwill 7,335 Other long-term assets 11 Total assets acquired 9,860 Liabilities: Current liabilities 180 Contract liabilities 509 Operating lease liabilities 18 Long-term deferred tax liabilities 419 Other long-term obligations 46 Total liabilities assumed 1,172 Total purchase price $ 8,688 |
Schedule of Unaudited Pro Forma Information | The following table summarizes the unaudited pro forma financial information: Year Ended (In millions) March 31, 2023 April 1, 2022 Net revenues $ 3,804 $ 3,737 Net income (loss) $ 1,133 $ 242 |
Goodwill and Intangible Assets
Goodwill and Intangible Assets (Tables) | 12 Months Ended |
Mar. 29, 2024 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Schedule of Changes in the Carrying Amount of Goodwill | The changes in the carrying amount of goodwill are as follows: (In millions) Balance as of April 1, 2022 $ 2,873 Acquisition of Avast 7,265 Purchase accounting adjustments 84 Translation adjustments (5) Balance as of March 31, 2023 10,217 Purchase accounting adjustments (14) Translation adjustments 7 Balance as of March 29, 2024 $ 10,210 |
Schedule of Intangible Assets, Net, Indefinite-Lived | The following table summarizes the components of our intangible assets, net: March 29, 2024 March 31, 2023 (In millions) Gross Accumulated Net Gross Accumulated Net Customer relationships $ 1,642 $ (773) $ 869 $ 1,641 $ (549) $ 1,092 Developed technology 1,343 (388) 955 1,462 (279) 1,183 Other 90 (15) 75 91 (8) 83 Total finite-lived intangible assets 3,075 (1,176) 1,899 3,194 (836) 2,358 Indefinite-lived trade names 739 — 739 739 — 739 Total intangible assets $ 3,814 $ (1,176) $ 2,638 $ 3,933 $ (836) $ 3,097 |
Schedule of Intangible Assets, Net, Finite-Lived | The following table summarizes the components of our intangible assets, net: March 29, 2024 March 31, 2023 (In millions) Gross Accumulated Net Gross Accumulated Net Customer relationships $ 1,642 $ (773) $ 869 $ 1,641 $ (549) $ 1,092 Developed technology 1,343 (388) 955 1,462 (279) 1,183 Other 90 (15) 75 91 (8) 83 Total finite-lived intangible assets 3,075 (1,176) 1,899 3,194 (836) 2,358 Indefinite-lived trade names 739 — 739 739 — 739 Total intangible assets $ 3,814 $ (1,176) $ 2,638 $ 3,933 $ (836) $ 3,097 |
Schedule of Finite-lived Intangible Assets Amortization Expense | Amortization expense for purchased intangible assets is summarized below: Year Ended Consolidated Statements of Operations Classification (In millions) March 29, 2024 March 31, 2023 April 1, 2022 Customer relationships and other $ 233 $ 172 $ 85 Operating expenses Developed technology 229 136 39 Cost of revenues Total $ 462 $ 308 $ 124 |
Schedule of Future Intangible Asset Amortization Expense | As of March 29, 2024, future amortization expense related to intangible assets that have finite lives is as follows by fiscal year: (In millions) March 29, 2024 2025 $ 401 2026 395 2027 382 2028 379 2029 249 Thereafter 93 Total $ 1,899 |
Supplementary Information (Tabl
Supplementary Information (Tables) | 12 Months Ended |
Mar. 29, 2024 | |
Supplementary Information [Abstract] | |
Schedule of Cash and Cash Equivalents | Cash and cash equivalents: (In millions) March 29, 2024 March 31, 2023 Cash $ 408 $ 576 Cash equivalents 438 174 Total cash and cash equivalents $ 846 $ 750 |
Schedule of Accounts Receivable, Net | Accounts receivable, net: (In millions) March 29, 2024 March 31, 2023 Accounts receivable $ 165 $ 169 Allowance for doubtful accounts (2) (1) Accounts receivable, net $ 163 $ 168 |
Schedule of Other Current Assets | Other current assets: (In millions) March 29, 2024 March 31, 2023 Prepaid expenses $ 142 $ 122 Income tax receivable and prepaid income taxes 174 123 Other tax receivable 1 16 Other 17 23 Total other current assets $ 334 $ 284 |
Schedule of Property and Equipment, Net | Property and equipment, net: (In millions) March 29, 2024 March 31, 2023 Land $ 13 $ 13 Computer hardware and software 491 498 Office furniture and equipment 16 17 Buildings 28 28 Building and leasehold improvements 35 28 Construction in progress 1 1 Total property and equipment, gross 584 585 Accumulated depreciation and amortization (512) (509) Total property and equipment, net $ 72 $ 76 |
Schedule of Other Long-term Assets | Other long-term assets: (In millions) March 29, 2024 March 31, 2023 Non-marketable equity investments $ 136 $ 176 Long-term income tax receivable and prepaid income taxes 11 669 Deferred income tax assets 1,215 353 Operating lease assets 45 43 Long-term prepaid royalty 21 36 Other 66 47 Total other long-term assets $ 1,494 $ 1,324 |
Schedule of Short-term Contract Liabilities | Short-term contract liabilities: (In millions) March 29, 2024 March 31, 2023 Deferred revenue $ 1,133 $ 1,153 Customer deposit liabilities 597 555 Total short-term contract liabilities $ 1,730 $ 1,708 |
Schedule of Other Current Liabilities | Other current liabilities: (In millions) March 29, 2024 March 31, 2023 Income taxes payable $ 198 $ 172 Other taxes payable 72 76 Accrued legal fees 103 284 Accrued royalties 52 48 Accrued interest 78 27 Current operating lease liabilities 13 26 Other accrued liabilities 83 96 Total other current liabilities $ 599 $ 729 |
Schedule of Other Long-term Liabilities | Other long-term liabilities: (In millions) March 29, 2024 March 31, 2023 Long-term accrued legal fees $ 586 $ — Long-term operating lease liabilities 38 31 Other 47 43 Total other long-term liabilities $ 671 $ 74 |
Schedule of Long-term Income Taxes Payable | Long-term income taxes payable: (In millions) March 29, 2024 March 31, 2023 Unrecognized tax benefits (including interest and penalties) $ 1,346 $ 509 Deemed repatriation tax payable 139 310 Other long-term income taxes 5 1 Total long-term income taxes payable $ 1,490 $ 820 |
Schedule of Other Income, Expense Net | Other income (expense), net: Year Ended (In millions) March 29, 2024 March 31, 2023 April 1, 2022 Interest income $ 25 $ 15 $ — Foreign exchange gain (loss) (1) 3 (8) (2) Gain (loss) on early extinguishment of debt — (9) (3) Gain (loss) on equity investments (40) (7) (7) Gain (loss) on sale of properties 9 — 175 Other 9 (13) — Total other income (expense), net $ 6 $ (22) $ 163 (1) We recognize foreign currency remeasurement adjustments on unrecognized tax benefits and deferred taxes as a component of Income tax expense (benefit) in our Consolidated Statements of Operations. Foreign currency remeasurement adjustments recognized in Income tax expense (benefit) were ($27) million, ($18) million, and ($19) million for fiscal 2024, 2023 and 2022, respectively. |
Schedule of Supplemental Cash Flow Information | Supplemental cash flow information: Year Ended (In millions) March 29, 2024 March 31, 2023 April 1, 2022 Income taxes paid (received), net $ (476) $ 456 $ 356 Interest expense paid $ 607 $ 390 $ 120 Cash paid for amounts included in the measurement of operating lease liabilities $ 24 $ 26 $ 27 Non-cash operating activities: Operating lease assets obtained in exchange for operating lease liabilities $ — $ 23 $ 35 Reduction (increase) of operating lease assets as a result of lease terminations and modifications $ (20) $ 31 $ 17 Non-cash investing and financing activities: Purchases of property and equipment in current liabilities $ — $ 1 $ 1 Extinguishment of debt with borrowings from same creditors $ — $ — $ 494 Non-cash consideration for the acquisition of Avast $ — $ 2,141 $ — |
Financial Instruments and Fai_2
Financial Instruments and Fair Value Measurements (Tables) | 12 Months Ended |
Mar. 29, 2024 | |
Fair Value Disclosures [Abstract] | |
Schedule of the Carrying Value of Assets Measured at Fair Value on a Recurring Basis | The following table summarizes our financial instruments measured at fair value on a recurring basis: March 29, 2024 March 31, 2023 (In millions) Fair Value Level 1 Level 2 Fair Value Level 1 Level 2 Assets: Money market funds $ 438 $ 438 $ — $ 174 $ 174 $ — Interest rate swaps (1) 16 — 16 — — — Total $ 454 $ 438 $ 16 $ 174 $ 174 $ — (1) The fair value of our interest rate swaps is less than $1 million as of March 31, 2023. |
Leases (Tables)
Leases (Tables) | 12 Months Ended |
Mar. 29, 2024 | |
Leases [Abstract] | |
Schedule of Lease Cost and Sublease Income | The following summarizes our lease costs for fiscal 2024, 2023 and 2022: Year Ended (In millions) March 29, 2024 March 31, 2023 April 1, 2022 Operating lease costs $ 12 $ 16 $ 16 Short-term lease costs 3 2 2 Variable lease costs 6 8 6 Total lease costs $ 21 $ 26 $ 24 Other information related to our operating leases for fiscal 2024, 2023 and 2022 was as follows: Year Ended March 29, 2024 March 31, 2023 April 1, 2022 Weighted-average remaining lease term 4.6 years 2.8 years 4.7 years Weighted-average discount rate 5.35 % 4.38 % 4.04 % |
Schedule of Lessee, Operating Lease, Liability, Maturity | As of March 29, 2024, the maturities of our lease liabilities by fiscal year are as follows: (In millions) 2025 $ 15 2026 12 2027 12 2028 7 2029 6 Thereafter 5 Total lease payments 57 Less: Imputed interest (6) Present value of lease liabilities $ 51 |
Debt (Tables)
Debt (Tables) | 12 Months Ended |
Mar. 29, 2024 | |
Debt Disclosure [Abstract] | |
Schedule of Components of Debt | The following table summarizes components of our debt: (In millions, except percentages) March 29, 2024 March 31, 2023 Effective 5.0% Senior Notes due April 15, 2025 $ 1,100 $ 1,100 5.00 % Term A Facility due September 12, 2027 3,666 3,861 SOFR + % (2) 6.75% Senior Notes due September 30, 2027 900 900 6.75 % Term B Facility due September 12, 2029 2,444 3,431 SOFR + % (3) 1.29% Avira Mortgage due December 30, 2029 (1) 3 4 1.29 % 7.125% Senior Notes due September 30, 2030 600 600 7.13 % 0.95% Avira Mortgage due December 30, 2030 (1) 3 3 0.95 % Total principal amount 8,716 9,899 Less: unamortized discount and issuance costs (112) (137) Total debt 8,604 9,762 Less: current portion (175) (233) Total long-term debt $ 8,429 $ 9,529 (1) The Avira Mortgages are denominated in a foreign currency so the balances of these mortgages may fluctuate based on changes in foreign currency exchange rates. (2) Term A Facility due 2027 bears interest at a rate equal to Term SOFR plus a credit spread adjustment (CSA) plus a margin based either on the current debt rating of our non-credit-enhanced, senior unsecured long-term debt or consolidated adjusted leverage as defined in the underlying loan agreement. (3) Term B Facility due 2029 bears interest at a rate equal to Term SOFR plus CSA plus 2.00%. The interest rates for the outstanding term loans are as follows: March 29, 2024 March 31, 2023 Term A Facility due September 12, 2027 7.18 % 6.66 % Term B Facility due September 12, 2029 7.43 % 6.91 % |
Schedule of Maturities of Long-term Debt | As of March 29, 2024, the future contractual maturities of debt by fiscal year are as follows: (In millions) 2025 $ 175 2026 1,392 2027 233 2028 4,017 2029 38 Thereafter 2,861 Total future maturities of debt $ 8,716 |
Schedule of Interest Expense | The following table sets forth total interest expense recognized related to our convertible notes: Year Ended (In millions) March 31, 2023 April 1, 2022 Contractual interest expense $ 4 $ 12 Amortization of debt discount and issuance costs $ — $ 4 Payments in lieu of conversion price adjustments (1) $ 1 $ 8 (1) Payments in lieu of conversion price adjustments consist of amounts paid to holders of the Convertible Senior Notes when our quarterly dividend to our common stockholders exceeds the amounts defined in the Convertible Senior Notes agreements. |
Derivatives (Tables)
Derivatives (Tables) | 12 Months Ended |
Mar. 29, 2024 | |
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |
Schedule of Derivative Instruments | The following table summarizes our outstanding derivative instruments as of March 29, 2024 and March 31, 2023: Notional Amount Fair Value of Derivative Assets Fair Value of Derivative Liabilities (In millions) March 29, 2024 March 31, 2023 March 29, 2024 March 31, 2023 March 29, 2024 March 31, 2023 Foreign exchange contracts not designated as hedging instrument (1) $ 345 $ 291 $ — $ — $ — $ — Interest rate swap contract designed as cash flow hedge 1,000 1,000 16 1 — 2 Total $ 1,345 $ 1,291 $ 16 $ 1 $ — $ 2 (1) The fair values of the foreign exchange contracts are less than $1 million as of March 29, 2024 and March 31, 2023. |
Schedule of Effect of Cash Flow Hedges on AOCI | The following table summarizes the effect of our cash flow hedges on AOCI during the periods indicated: Year Ended (In millions) March 29, 2024 March 31, 2023 Interest rate swap contracts designated as cash flow hedge $ (32) $ — |
Schedule of Derivative Instruments, Gain (Loss) | The related gain (loss) recognized in our Consolidated Statements of Operations was as follows: Year Ended Consolidated Statements of Operations Classification (In millions) March 29, 2024 March 31, 2023 April 1, 2022 Foreign exchange contracts not designated as hedging instrument $ (7) $ (7) $ (7) Other income (expense), net Interest rate swap contracts designated as cash flow hedge 16 — — Interest expense Total $ 9 $ (7) $ (7) |
Restructuring and Other Costs (
Restructuring and Other Costs (Tables) | 12 Months Ended |
Mar. 29, 2024 | |
Restructuring and Related Activities [Abstract] | |
Schedule of Restructuring Activities | Our activities and liability balances related to our September 2022 Plan are presented in the tables below: (In millions) Liability Balance as of March 31, 2023 Net Charges Cash Payments Non-Cash Items Liability Balance as of March 29, 2024 Severance and termination benefit costs $ 7 $ 42 $ (29) $ — $ 20 Contract cancellation charges — 5 (5) — — Stock-based compensation charges — 1 — (1) — Asset write-offs — 1 — (1) — Other exit and disposal costs — 7 (7) — — Total $ 7 $ 56 $ (41) $ (2) $ 20 |
Schedule of Restructuring and Related Costs | Our restructuring and other costs are presented in the table below: Year Ended (In millions) March 29, 2024 March 31, 2023 April 1, 2022 Severance and termination benefit costs $ 42 $ 40 $ 5 Contract cancellation charges 5 2 3 Stock-based compensation charges 1 11 — Asset write-offs and impairments 1 4 5 Other exit and disposal costs 8 12 18 Total restructuring and other $ 57 $ 69 $ 31 |
Income Taxes (Tables)
Income Taxes (Tables) | 12 Months Ended |
Mar. 29, 2024 | |
Income Tax Disclosure [Abstract] | |
Schedule of Components of income tax expense (benefit) | The components of our income (loss) before income taxes are as follows: Year Ended (In millions) March 29, 2024 March 31, 2023 April 1, 2022 Domestic $ 78 $ 350 $ 791 International 381 454 251 Income (loss) before income taxes $ 459 $ 804 $ 1,042 The components of income tax expense (benefit) are as follows: Year Ended (In millions) March 29, 2024 March 31, 2023 April 1, 2022 Current: Federal $ 201 $ (479) $ 217 State 43 (28) 50 International 579 99 20 Total 823 (408) 287 Deferred: Federal (727) (111) (42) State (133) (10) (6) International (120) (16) (33) Total (980) (137) (81) Income tax expense (benefit) $ (157) $ (545) $ 206 |
Schedule of Difference Between Effective Income Tax and Federal Statutory Income Tax | The U.S. federal statutory income tax rates we have applied for fiscal 2024, 2023 and 2022 are as follows: Year Ended March 29, 2024 March 31, 2023 April 1, 2022 U.S. federal statutory income tax rate 21.0 % 21.0 % 21.0 % The difference between our effective income tax and the federal statutory income tax is as follows: Year Ended (In millions) March 29, 2024 March 31, 2023 April 1, 2022 Federal statutory tax expense (benefit) $ 96 $ 169 $ 219 State taxes, net of federal benefit — 1 33 Foreign earnings taxed at other than the federal rate (22) (11) (47) Nondeductible expenses 48 20 — Federal research and development credit (6) (5) (4) Valuation allowance increase (decrease) (4) (33) 2 Change in unrecognized tax benefits 338 163 (2) Tax interest and penalties 129 13 13 Stock-based compensation 17 9 7 US tax on foreign earnings 20 12 12 Return to provision adjustment — 1 (8) Foreign exchange loss (gain) (28) (17) (19) Capital loss (44) (910) — Legal entity restructuring (719) 42 — Other, net 18 1 — Income tax expense (benefit) $ (157) $ (545) $ 206 |
Schedule of Principal Components of Deferred Tax Assets | The principal components of deferred tax assets and liabilities are as follows: (In millions) March 29, 2024 March 31, 2023 Deferred tax assets: Tax credit carryforwards $ 27 $ 24 Net operating loss carryforwards of acquired companies 60 60 Interest 63 37 Other accruals and reserves not currently tax deductible 332 95 Goodwill 517 — Capitalized research and experimental expenditures 82 46 Loss on investments not currently tax deductible 60 68 Other 56 97 Gross deferred tax assets 1,197 427 Valuation allowance (93) (97) Deferred tax assets, net of valuation allowance 1,104 330 Deferred tax liabilities: Intangible assets (127) (328) Unremitted earnings of foreign subsidiaries (14) (15) Other (9) (20) Deferred tax liabilities (150) (363) Net deferred tax assets (liabilities) $ 954 $ (33) |
Schedule of Changes in Unrecognized Tax Benefits | The aggregate changes in the balance of gross unrecognized tax benefits were as follows: Year Ended (In millions) March 29, 2024 March 31, 2023 April 1, 2022 Balance at beginning of year $ 710 $ 527 $ 548 Settlements with tax authorities (8) (2) — Lapse of statute of limitations (14) (96) (34) Increase related to prior period tax positions 47 9 16 Decrease related to prior period tax positions (9) (15) (11) Increase related to current year tax positions 467 259 8 Increase due to acquisition — 28 — Increase (decrease) related to foreign currency exchange rates (30) — — Balance at end of year $ 1,163 $ 710 $ 527 |
Stockholders' Equity (Tables)
Stockholders' Equity (Tables) | 12 Months Ended |
Mar. 29, 2024 | |
Stockholders' Equity Note [Abstract] | |
Schedule of Stock Repurchase Program | The following table summarizes activity related to our stock repurchase program during the years ended March 29, 2024 and March 31, 2023: Year Ended (In millions, except per share amounts) March 29, 2024 March 31, 2023 Number of shares repurchased 21 40 Average price per share $ 20.87 $ 22.63 Aggregate purchase price $ 441 $ 904 |
Schedule of Accumulated Other Comprehensive Income (Loss) | Accumulated other comprehensive income (loss), net of taxes, consisted of foreign currency translation adjustments: (In millions) Foreign Currency Translation Adjustments Net Unrealized Gain (Loss) On Interest Rate Derivative Total Balance as of April 1, 2022 $ (4) $ — $ (4) Other comprehensive income (loss), net of taxes (11) — (11) Balance as of March 31, 2023 (15) — (15) Other comprehensive income (loss), net of taxes 10 16 26 Balance as of March 29, 2024 $ (5) $ 16 $ 11 |
Stock-Based Compensation and _2
Stock-Based Compensation and Benefit Plans (Tables) | 12 Months Ended |
Mar. 29, 2024 | |
Share-Based Payment Arrangement [Abstract] | |
Schedule of Restricted Stock Units Activities | RSUs (In millions, except per share and year data) Number of Weighted- Outstanding as of March 31, 2023 9 $ 22.45 Granted 5 $ 17.42 Vested (5) $ 22.30 Forfeited (1) $ 20.84 Outstanding as of March 29, 2024 8 $ 19.39 |
Schedule of PRUs Activity | PRUs (In millions, except per share and year data) Number of Weighted- Outstanding and unvested as of March 31, 2023 5 $ 27.93 Granted 2 $ 22.83 Vested (2) $ 28.24 Forfeited (1) — $ 28.49 Outstanding and unvested as of March 29, 2024 5 $ 26.02 (1) The number of shares is less than 1 million. |
Schedule Of PRUs Valuation Assumptions | The valuation and the underlying weighted-average assumptions for PRUs are summarized below: Year Ended March 29, 2024 March 31, 2023 April 1, 2022 Expected term 2.9 years 3.3 years 3.9 years Expected volatility 31.5 % 34.8 % 37.6 % Risk-free interest rate 3.5 % 3.4 % 1.0 % Expected dividend yield — % 1.3 % — % Weighted-average grant date fair value of PRUs $ 22.83 $ 27.07 $ 28.68 |
Schedule of ESPP Activities | The following table summarizes activity related to the purchase rights issued under the ESPP: Year Ended (In millions) March 29, 2024 March 31, 2023 April 1, 2022 Shares issued under the ESPP 1 1 1 Proceeds from issuance of shares $ 12 $ 12 $ 13 |
Schedule of Stock-based Compensation Expense | Total stock-based compensation expense and the related income tax benefit recognized for all of our equity incentive plans in our Consolidated Statements of Operations were as follows: Year Ended (In millions) March 29, 2024 March 31, 2023 April 1, 2022 Cost of revenues $ 4 $ 3 $ 2 Sales and marketing 36 34 19 Research and development 39 31 19 General and administrative 58 55 30 Restructuring and other costs 1 11 — Total stock-based compensation expense $ 138 $ 134 $ 70 Income tax benefit for stock-based compensation expense $ (16) $ (20) $ (11) |
Schedule of Employer 401K Contributions | Our employer matching contributions to the 401(k) plan were as follows: Year Ended (In millions) March 29, 2024 March 31, 2023 April 1, 2022 401(k) matching contributions $ 4 $ 4 $ 3 |
Net Income (Loss) Per Share (Ta
Net Income (Loss) Per Share (Tables) | 12 Months Ended |
Mar. 29, 2024 | |
Earnings Per Share [Abstract] | |
Schedule of Components of Net Income (Loss) Per Share | The components of basic and diluted net income (loss) per share are as follows: Year Ended (In millions, except per share amounts) March 29, 2024 March 31, 2023 April 1, 2022 Net income (loss) $ 616 $ 1,349 $ 836 Net income per share - basic $ 0.97 $ 2.20 $ 1.44 Net income per share - diluted $ 0.96 $ 2.16 $ 1.41 Weighted-average shares outstanding - basic 637 614 581 Dilutive potentially issuable shares: Convertible debt — 6 7 Employee equity awards 5 4 3 Weighted-average shares outstanding - diluted 642 624 591 Anti-dilutive shares excluded from diluted net income (loss) per share calculation: Employee equity awards 1 — 1 |
Segment and Geographic Inform_2
Segment and Geographic Information (Tables) | 12 Months Ended |
Mar. 29, 2024 | |
Segment Reporting [Abstract] | |
Schedule of Revenue from External Customers by Products and Services | The following table summarizes net revenues for our major solutions: Year Ended (In millions) March 29, 2024 March 31, 2023 April 1, 2022 Consumer security revenues $ 2,417 $ 2,029 $ 1,623 Identity and information protection revenues 1,332 1,244 1,127 Total cyber safety revenues 3,749 3,273 2,750 Legacy revenues 63 65 46 Total net revenues (1) $ 3,812 $ 3,338 $ 2,796 (1) During the year ended March 29, 2024, total net revenues include an unfavorable foreign exchange impact of $25 million, consisting of $24 million from our consumer security solutions and $1 million from our identity and information protection solutions. |
Schedule of Revenue from External Customers Attributed to Foreign Countries by Geographic Area | The following table represents net revenues by geographic area for the periods presented: Year Ended (2) (In millions) March 29, 2024 March 31, 2023 April 1, 2022 Americas $ 2,493 $ 2,247 $ 1,936 EMEA 920 724 522 APJ 399 367 338 Total net revenues (1) $ 3,812 $ 3,338 $ 2,796 Note: The Americas include U.S., Canada, and Latin America; EMEA includes Europe, Middle East, and Africa; APJ includes Asia Pacific and Japan. (1) During the year ended March 29, 2024, total net revenues include an unfavorable foreign exchange impact of $25 million, consisting of $14 million from EMEA and $11 million from APJ. (2) From time to time, changes in allocation methodologies cause changes to the revenue by geographic area above. When changes occur, we recast historical amounts to match the current methodology, such as for fiscal 2023 and 2022 where we aligned allocation methodologies across similar product categories. |
Schedule of Cash, Cash Equivalents and Investments | The table below represents cash and cash equivalents held in the U.S. and internationally in various foreign subsidiaries: (In millions) March 29, 2024 March 31, 2023 U.S. $ 467 $ 178 International 379 572 Total cash and cash equivalents $ 846 $ 750 |
Schedule of Disclosure on Geographic Areas, Long-Lived Assets in Individual Foreign Countries by Country | The table below represents our property and equipment, net of accumulated depreciation and amortization, by geographic area, based on the physical location of the asset, at the end of each period presented: (In millions) March 29, 2024 March 31, 2023 U.S. $ 47 $ 38 Germany 12 13 Czech Republic 6 16 Other countries (1) 7 9 Total property and equipment, net $ 72 $ 76 (1) No individual country represented more than 10% of the respective totals. |
Commitments and Contingencies (
Commitments and Contingencies (Tables) | 12 Months Ended |
Mar. 29, 2024 | |
Commitments and Contingencies Disclosure [Abstract] | |
Schedule of Unrecognized Purchase Obligations | The following reflects estimated future payments for purchase obligations by fiscal year. The amount of purchase obligations reflects estimated future payments as of March 29, 2024. (In millions) March 29, 2024 2025 $ 324 2026 73 2027 47 2028 36 2029 28 Thereafter 2 Total purchase obligations $ 510 |
Schedule of Estimated Future Payments for Deemed Repatriation Taxes by Fiscal Year | The following reflects estimated future payments for deemed repatriation taxes by fiscal year: (In millions) March 29, 2024 2025 $ 171 2026 139 Total obligations $ 310 |
Description of Business and S_4
Description of Business and Summary of Significant Accounting Policies - Additional Information (Details) shares in Millions | 12 Months Ended | |||
Mar. 29, 2024 USD ($) option | Mar. 31, 2023 USD ($) | Apr. 01, 2022 USD ($) | May 09, 2024 shares | |
Property, Plant and Equipment [Line Items] | ||||
Rebate reserves | $ 4,000,000 | $ 4,000,000 | ||
Capitalized software development costs | 0 | 0 | ||
Capitalized costs, net | $ 5,000,000 | 6,000,000 | ||
Number of option to renew | option | 1 | |||
Income tax recognized (as a percent) | 50% | |||
Advertising expense | $ 438,000,000 | $ 405,000,000 | $ 423,000,000 | |
Liability-Classified Awards | Subsequent Event | ||||
Property, Plant and Equipment [Line Items] | ||||
Outstanding and unvested (in shares) | shares | 4 | |||
Intangible assets | Minimum | ||||
Property, Plant and Equipment [Line Items] | ||||
Finite-lived intangible asset, useful life (in years) | 1 year | |||
Intangible assets | Maximum | ||||
Property, Plant and Equipment [Line Items] | ||||
Finite-lived intangible asset, useful life (in years) | 10 years | |||
Buildings | Minimum | ||||
Property, Plant and Equipment [Line Items] | ||||
Property, plant, equipment useful life (in years) | 20 years | |||
Buildings | Maximum | ||||
Property, Plant and Equipment [Line Items] | ||||
Property, plant, equipment useful life (in years) | 30 years | |||
Building Improvements | Minimum | ||||
Property, Plant and Equipment [Line Items] | ||||
Property, plant, equipment useful life (in years) | 7 years | |||
Building Improvements | Maximum | ||||
Property, Plant and Equipment [Line Items] | ||||
Property, plant, equipment useful life (in years) | 20 years | |||
Office furniture and equipment | Minimum | ||||
Property, Plant and Equipment [Line Items] | ||||
Property, plant, equipment useful life (in years) | 3 years | |||
Office furniture and equipment | Maximum | ||||
Property, Plant and Equipment [Line Items] | ||||
Property, plant, equipment useful life (in years) | 5 years | |||
Software and Software Development Costs | Minimum | ||||
Property, Plant and Equipment [Line Items] | ||||
Property, plant, equipment useful life (in years) | 3 years |
Description of Business and S_5
Description of Business and Summary of Significant Accounting Policies - Schedules of Concentration Risk (Details) - Credit Risk - Accounts Receivable | 12 Months Ended | |
Mar. 29, 2024 | Mar. 31, 2023 | |
E-commerce partner A | ||
Product Information [Line Items] | ||
Concentration risk (as a percent) | 13% | 13% |
E-commerce partner B | ||
Product Information [Line Items] | ||
Concentration risk (as a percent) | 11% | 14% |
Assets Held for Sale - Addition
Assets Held for Sale - Additional Information (Details) - USD ($) | 3 Months Ended | 12 Months Ended | ||||
Dec. 29, 2023 | Jun. 30, 2023 | Jul. 02, 2021 | Mar. 29, 2024 | Mar. 31, 2023 | Apr. 01, 2022 | |
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | ||||||
Gain on sale of properties | $ 9,000,000 | $ 0 | $ 175,000,000 | |||
Other impairments | $ 0 | |||||
Disposal Group, Held-for-sale, Not Discontinued Operations | Mountain View Buildings | ||||||
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | ||||||
Consideration from sale of properties | $ 355,000,000 | |||||
Gain on sale of properties | $ 175,000,000 | |||||
Disposal Group, Held-for-sale, Not Discontinued Operations | Dublin And Ireland Buildings | ||||||
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | ||||||
Consideration from sale of properties | $ 13,000,000 | |||||
Gain on sale of properties | $ 4,000,000 | |||||
Disposal Group, Held-for-sale, Not Discontinued Operations | Tucson And Arizona Buildings | ||||||
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | ||||||
Consideration from sale of properties | $ 12,000,000 | |||||
Gain on sale of properties | $ 5,000,000 |
Business Combinations - Additio
Business Combinations - Additional Information (Details) - USD ($) $ in Millions | 12 Months Ended | |||
Sep. 12, 2022 | Mar. 29, 2024 | Mar. 31, 2023 | Apr. 01, 2022 | |
Asset Acquisition [Line Items] | ||||
Cash payments, net of cash acquired | $ 0 | $ 6,547 | $ 39 | |
Net decrease to goodwill | 14 | $ (84) | ||
Avast plc | ||||
Asset Acquisition [Line Items] | ||||
Cash payments, net of cash acquired | $ 8,688 | |||
Net decrease to goodwill | 14 | |||
Net decrease to goodwill | $ 14 |
Business Combinations - Schedul
Business Combinations - Schedule of Preliminary Allocation of Aggregate Purchase Price (Details) - USD ($) $ in Millions | Mar. 29, 2024 | Mar. 31, 2023 | Sep. 12, 2022 | Apr. 01, 2022 |
Assets: | ||||
Goodwill | $ 10,210 | $ 10,217 | $ 2,873 | |
Avast plc | ||||
Assets: | ||||
Accounts receivable | $ 63 | |||
Other current assets | 17 | |||
Property and equipment | 33 | |||
Operating lease assets | 18 | |||
Intangible assets | 2,383 | |||
Goodwill | 7,335 | |||
Other long-term assets | 11 | |||
Total assets acquired | 9,860 | |||
Liabilities: | ||||
Current liabilities | 180 | |||
Contract liabilities | 509 | |||
Operating lease liabilities | 18 | |||
Long-term deferred tax liabilities | 419 | |||
Other long-term obligations | 46 | |||
Total liabilities assumed | 1,172 | |||
Total purchase price | $ 8,688 |
Business Combinations - Unaudit
Business Combinations - Unaudited Pro Forma Financial Information (Details) - Avast plc - USD ($) $ in Millions | 12 Months Ended | |
Mar. 31, 2023 | Apr. 01, 2022 | |
Business Acquisition [Line Items] | ||
Net revenues | $ 3,804 | $ 3,737 |
Net income (loss) | $ 1,133 | $ 242 |
Revenues - Additional Informati
Revenues - Additional Information (Details) - USD ($) $ in Millions | 12 Months Ended | |
Mar. 29, 2024 | Mar. 31, 2023 | |
Revenue from Contract with Customer [Abstract] | ||
Revenue recognized from contract liabilities balance | $ 1,671 | $ 1,213 |
Total remaining performance obligations | 1,209 | |
Customer deposit liabilities | $ 597 | $ 555 |
Revenues - Remaining Performanc
Revenues - Remaining Performance Obligations (Details) - Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-03-30 | Mar. 29, 2024 |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | |
Percent expected to be recognized as revenue | 94% |
Expected timing of satisfaction | 12 months |
Goodwill and Intangible Asset_2
Goodwill and Intangible Assets - Schedule of Changes in the Carrying Amount of Goodwill (Details) - USD ($) $ in Millions | 12 Months Ended | |
Mar. 29, 2024 | Mar. 31, 2023 | |
Goodwill [Roll Forward] | ||
Beginning balance | $ 10,217 | $ 2,873 |
Acquisition of Avast | 7,265 | |
Purchase accounting adjustments | (14) | 84 |
Translation adjustments | 7 | (5) |
Ending balance | $ 10,210 | $ 10,217 |
Goodwill and Intangible Asset_3
Goodwill and Intangible Assets - Schedule of Intangible Assets, Net (Details) - USD ($) $ in Millions | Mar. 29, 2024 | Mar. 31, 2023 |
Finite-Lived Intangible Assets [Line Items] | ||
Gross Carrying Amount | $ 3,075 | $ 3,194 |
Accumulated Amortization | (1,176) | (836) |
Net Carrying Amount | 1,899 | 2,358 |
Intangible Assets, Net (Excluding Goodwill) [Abstract] | ||
Gross Carrying Amount | 3,814 | 3,933 |
Accumulated Amortization | (1,176) | (836) |
Intangible assets, net | 2,638 | 3,097 |
Trade Names | ||
Indefinite-lived Intangible Assets [Line Items] | ||
Indefinite-lived trade names | 739 | 739 |
Customer relationships | ||
Finite-Lived Intangible Assets [Line Items] | ||
Gross Carrying Amount | 1,642 | 1,641 |
Accumulated Amortization | (773) | (549) |
Net Carrying Amount | 869 | 1,092 |
Intangible Assets, Net (Excluding Goodwill) [Abstract] | ||
Accumulated Amortization | (773) | (549) |
Developed technology | ||
Finite-Lived Intangible Assets [Line Items] | ||
Gross Carrying Amount | 1,343 | 1,462 |
Accumulated Amortization | (388) | (279) |
Net Carrying Amount | 955 | 1,183 |
Intangible Assets, Net (Excluding Goodwill) [Abstract] | ||
Accumulated Amortization | (388) | (279) |
Other | ||
Finite-Lived Intangible Assets [Line Items] | ||
Gross Carrying Amount | 90 | 91 |
Accumulated Amortization | (15) | (8) |
Net Carrying Amount | 75 | 83 |
Intangible Assets, Net (Excluding Goodwill) [Abstract] | ||
Accumulated Amortization | $ (15) | $ (8) |
Goodwill and Intangible Asset_4
Goodwill and Intangible Assets - Schedule of Amortization Expense (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Mar. 29, 2024 | Mar. 31, 2023 | Apr. 01, 2022 | |
Finite-Lived Intangible Assets [Line Items] | |||
Amortization of intangible assets | $ 233 | $ 172 | $ 85 |
Segment Reconciling Items | |||
Finite-Lived Intangible Assets [Line Items] | |||
Amortization of intangible assets | 462 | 308 | 124 |
Customer relationships | Operating expenses | |||
Finite-Lived Intangible Assets [Line Items] | |||
Amortization of intangible assets | 233 | 172 | 85 |
Developed technology | Cost of revenues | |||
Finite-Lived Intangible Assets [Line Items] | |||
Amortization of intangible assets | $ 229 | $ 136 | $ 39 |
Goodwill and Intangible Asset_5
Goodwill and Intangible Assets - Schedule of Future Intangible Asset Amortization Expense (Details) - USD ($) $ in Millions | Mar. 29, 2024 | Mar. 31, 2023 |
Goodwill and Intangible Assets Disclosure [Abstract] | ||
2025 | $ 401 | |
2026 | 395 | |
2027 | 382 | |
2028 | 379 | |
2029 | 249 | |
Thereafter | 93 | |
Net Carrying Amount | $ 1,899 | $ 2,358 |
Supplementary Information - Sch
Supplementary Information - Schedule of Cash and Cash Equivalents (Details) - USD ($) $ in Millions | Mar. 29, 2024 | Mar. 31, 2023 |
Supplementary Information [Abstract] | ||
Cash | $ 408 | $ 576 |
Cash equivalents | 438 | 174 |
Total cash and cash equivalents | $ 846 | $ 750 |
Supplementary Information - S_2
Supplementary Information - Schedule of Accounts Receivable, Net (Details) - USD ($) $ in Millions | Mar. 29, 2024 | Mar. 31, 2023 |
Supplementary Information [Abstract] | ||
Accounts receivable | $ 165 | $ 169 |
Allowance for doubtful accounts | (2) | (1) |
Accounts receivable, net | $ 163 | $ 168 |
Supplementary Information - S_3
Supplementary Information - Schedule of Other Current Assets (Details) - USD ($) $ in Millions | Mar. 29, 2024 | Mar. 31, 2023 |
Supplementary Information [Abstract] | ||
Prepaid expenses | $ 142 | $ 122 |
Income tax receivable and prepaid income taxes | 174 | 123 |
Other tax receivable | 1 | 16 |
Other | 17 | 23 |
Total other current assets | $ 334 | $ 284 |
Supplementary Information - S_4
Supplementary Information - Schedule of Property and Equipment (Details) - USD ($) $ in Millions | Mar. 29, 2024 | Mar. 31, 2023 |
Property, Plant and Equipment [Line Items] | ||
Total property and equipment, gross | $ 584 | $ 585 |
Accumulated depreciation and amortization | (512) | (509) |
Total property and equipment, net | 72 | 76 |
Land | ||
Property, Plant and Equipment [Line Items] | ||
Total property and equipment, gross | 13 | 13 |
Computer hardware and software | ||
Property, Plant and Equipment [Line Items] | ||
Total property and equipment, gross | 491 | 498 |
Office furniture and equipment | ||
Property, Plant and Equipment [Line Items] | ||
Total property and equipment, gross | 16 | 17 |
Buildings | ||
Property, Plant and Equipment [Line Items] | ||
Total property and equipment, gross | 28 | 28 |
Building and leasehold improvements | ||
Property, Plant and Equipment [Line Items] | ||
Total property and equipment, gross | 35 | 28 |
Construction in progress | ||
Property, Plant and Equipment [Line Items] | ||
Total property and equipment, gross | $ 1 | $ 1 |
Supplementary Information - Add
Supplementary Information - Additional Information (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Mar. 29, 2024 | Mar. 31, 2023 | Apr. 01, 2022 | |
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | |||
Amortization and depreciation | $ 485 | $ 329 | $ 140 |
Property, Plant and Equipment | |||
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | |||
Amortization and depreciation | $ 23 | $ 21 | $ 16 |
Supplementary Information - S_5
Supplementary Information - Schedule of Other Long-term Assets (Details) - USD ($) $ in Millions | Mar. 29, 2024 | Mar. 31, 2023 |
Supplementary Information [Abstract] | ||
Non-marketable equity investments | $ 136 | $ 176 |
Long-term income tax receivable and prepaid income taxes | 11 | 669 |
Deferred income tax assets | $ 1,215 | $ 353 |
Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration] | Total other long-term assets | Total other long-term assets |
Operating lease assets | $ 45 | $ 43 |
Long-term prepaid royalty | 21 | 36 |
Other | 66 | 47 |
Total other long-term assets | $ 1,494 | $ 1,324 |
Supplementary Information - S_6
Supplementary Information - Schedule of Short-term Contract Liabilities (Details) - USD ($) $ in Millions | Mar. 29, 2024 | Mar. 31, 2023 |
Supplementary Information [Abstract] | ||
Deferred revenue | $ 1,133 | $ 1,153 |
Customer deposit liabilities | 597 | 555 |
Contract liabilities | $ 1,730 | $ 1,708 |
Supplementary Information - S_7
Supplementary Information - Schedule of Other Current Liabilities (Details) - USD ($) $ in Millions | Mar. 29, 2024 | Mar. 31, 2023 |
Supplementary Information [Abstract] | ||
Income taxes payable | $ 198 | $ 172 |
Other taxes payable | 72 | 76 |
Accrued legal fees | 103 | 284 |
Accrued royalties | 52 | 48 |
Accrued interest | $ 78 | $ 27 |
Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] | Contract liabilities | Contract liabilities |
Current operating lease liabilities | $ 13 | $ 26 |
Other accrued liabilities | 83 | 96 |
Total other current liabilities | $ 599 | $ 729 |
Supplementary Information - S_8
Supplementary Information - Schedule of Other Long-term Liabilities (Details) - USD ($) $ in Millions | Mar. 29, 2024 | Mar. 31, 2023 |
Supplementary Information [Abstract] | ||
Long-term accrued legal fees | $ 586 | $ 0 |
Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration] | Long-term contract liabilities | Long-term contract liabilities |
Long-term operating lease liabilities | $ 38 | $ 31 |
Other | 47 | 43 |
Total other long-term liabilities | $ 671 | $ 74 |
Supplementary Information - S_9
Supplementary Information - Schedule of Long-term Income Taxes Payable (Details) - USD ($) $ in Millions | Mar. 29, 2024 | Mar. 31, 2023 |
Supplementary Information [Abstract] | ||
Unrecognized tax benefits (including interest and penalties) | $ 1,346 | $ 509 |
Deemed repatriation tax payable | 139 | 310 |
Other long-term income taxes | 5 | 1 |
Total long-term income taxes payable | $ 1,490 | $ 820 |
Supplementary Information - _10
Supplementary Information - Schedule of Other Income (Expense), Net (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Mar. 29, 2024 | Mar. 31, 2023 | Apr. 01, 2022 | |
Supplementary Information [Abstract] | |||
Interest income | $ 25 | $ 15 | $ 0 |
Foreign exchange gain (loss) | 3 | (8) | (2) |
Gain (loss) on early extinguishment of debt | 0 | (9) | (3) |
Gain (loss) on equity investments | (40) | (7) | (7) |
Gain on sale of properties | 9 | 0 | 175 |
Other | 9 | (13) | 0 |
Other income (expense), net | 6 | (22) | 163 |
Foreign currency, remeasurement adjustments | $ (27) | $ (18) | $ (19) |
Supplementary Information - _11
Supplementary Information - Schedule of Supplemental Cash Flow Information (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Mar. 29, 2024 | Mar. 31, 2023 | Apr. 01, 2022 | |
Supplementary Information [Abstract] | |||
Income taxes paid (received), net | $ (476) | $ 456 | $ 356 |
Interest expense paid | 607 | 390 | 120 |
Cash paid for amounts included in the measurement of operating lease liabilities | 24 | 26 | 27 |
Non-cash operating activities: | |||
Operating lease assets obtained in exchange for operating lease liabilities | 0 | 23 | 35 |
Reduction (increase) of operating lease assets as a result of lease terminations and modifications | (20) | 31 | 17 |
Non-cash investing and financing activities: | |||
Purchases of property and equipment in current liabilities | 0 | 1 | 1 |
Extinguishment of debt with borrowings from same creditors | 0 | 0 | 494 |
Non-cash consideration for the acquisition of Avast | $ 0 | $ 2,141 | $ 0 |
Financial Instruments and Fai_3
Financial Instruments and Fair Value Measurements - Schedule of the Carrying Value of Assets Measured at Fair Value on a Recurring Basis (Details) - USD ($) $ in Millions | Mar. 29, 2024 | Mar. 31, 2023 |
Interest rate swaps | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Fair value of interest rate swaps | $ 1 | |
Recurring | Fair Value | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Total | $ 454 | 174 |
Recurring | Fair Value | Interest rate swaps | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Debt securities, available-for-sale | 16 | 0 |
Recurring | Fair Value | Money market funds | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Money market funds | 438 | 174 |
Recurring | Reported Value Measurement | Level 1 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Total | 438 | 174 |
Recurring | Reported Value Measurement | Level 1 | Interest rate swaps | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Debt securities, available-for-sale | 0 | 0 |
Recurring | Reported Value Measurement | Level 1 | Money market funds | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Money market funds | 438 | 174 |
Recurring | Reported Value Measurement | Level 2 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Total | 16 | 0 |
Recurring | Reported Value Measurement | Level 2 | Interest rate swaps | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Debt securities, available-for-sale | 16 | 0 |
Recurring | Reported Value Measurement | Level 2 | Money market funds | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Money market funds | $ 0 | $ 0 |
Financial Instruments and Fai_4
Financial Instruments and Fair Value Measurements - Additional Information (Details) - USD ($) $ in Millions | 12 Months Ended | |
Mar. 29, 2024 | Mar. 31, 2023 | |
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Carrying value of non-marketable equity investments | $ 136 | $ 176 |
Impairment on non-marketable equity investments | 40 | |
Level 2 | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Fair value of debt | $ 2,624 | $ 2,593 |
Leases - Additional Information
Leases - Additional Information (Details) | Mar. 29, 2024 |
Minimum | Facilities | |
Property, Plant and Equipment [Line Items] | |
Operating lease, term of contract (in years) | 1 year |
Minimum | Equipment | |
Property, Plant and Equipment [Line Items] | |
Operating lease, term of contract (in years) | 1 year |
Minimum | Data Center Co-locations | |
Property, Plant and Equipment [Line Items] | |
Operating lease, term of contract (in years) | 1 year |
Maximum | Facilities | |
Property, Plant and Equipment [Line Items] | |
Operating lease, term of contract (in years) | 8 years |
Maximum | Equipment | |
Property, Plant and Equipment [Line Items] | |
Operating lease, term of contract (in years) | 4 years |
Maximum | Data Center Co-locations | |
Property, Plant and Equipment [Line Items] | |
Operating lease, term of contract (in years) | 5 years |
Leases - Lease Cost (Details)
Leases - Lease Cost (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Mar. 29, 2024 | Mar. 31, 2023 | Apr. 01, 2022 | |
Leases [Abstract] | |||
Operating lease costs | $ 12 | $ 16 | $ 16 |
Short-term lease costs | 3 | 2 | 2 |
Variable lease costs | 6 | 8 | 6 |
Total lease costs | $ 21 | $ 26 | $ 24 |
Leases - Operating Lease Inform
Leases - Operating Lease Information (Details) | Mar. 29, 2024 | Mar. 31, 2023 | Apr. 01, 2022 |
Leases [Abstract] | |||
Weighted-average remaining lease term | 4 years 7 months 6 days | 2 years 9 months 18 days | 4 years 8 months 12 days |
Weighted-average discount rate | 5.35% | 4.38% | 4.04% |
Leases - Maturity of Lease Liab
Leases - Maturity of Lease Liabilities (Details) $ in Millions | Mar. 29, 2024 USD ($) |
Leases [Abstract] | |
2025 | $ 15 |
2026 | 12 |
2027 | 12 |
2028 | 7 |
2029 | 6 |
Thereafter | 5 |
Total lease payments | 57 |
Less: Imputed interest | (6) |
Present value of lease liabilities | $ 51 |
Debt - Schedule of Components o
Debt - Schedule of Components of Debt (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Mar. 29, 2024 | Mar. 31, 2023 | Sep. 19, 2022 | |
Debt Instrument [Line Items] | |||
Total principal amount | $ 8,716 | $ 9,899 | |
Less: unamortized discount and issuance costs | (112) | (137) | |
Total debt | 8,604 | 9,762 | |
Less: current portion | (175) | (233) | |
Long-term debt | $ 8,429 | 9,529 | |
Term B Facility due September 12, 2029 | Secured Overnight Financing Rate (SOFR) Plus Credit Spread Adjustment (CSA) | |||
Debt Instrument [Line Items] | |||
Basis spread on variable rate (as a percent) | 2% | ||
Senior Notes | 5.00% Senior Notes due April 15, 2025 | |||
Debt Instrument [Line Items] | |||
Stated interest rate (as a percent) | 5% | ||
Total principal amount | $ 1,100 | 1,100 | |
Effective Interest Rate | 5% | ||
Senior Notes | 6.75% Senior Notes due September 30, 2027 | |||
Debt Instrument [Line Items] | |||
Stated interest rate (as a percent) | 6.75% | 6.75% | |
Total principal amount | $ 900 | 900 | |
Effective Interest Rate | 6.75% | ||
Senior Notes | 7.125% Senior Notes due September 30, 2030 | |||
Debt Instrument [Line Items] | |||
Stated interest rate (as a percent) | 7.125% | 7.125% | |
Total principal amount | $ 600 | 600 | |
Effective Interest Rate | 7.13% | ||
Secured Debt | Term A Facility due September 12, 2027 | |||
Debt Instrument [Line Items] | |||
Total principal amount | $ 3,666 | $ 3,861 | |
Weighted average interest rate (as a percent) | 7.18% | 6.66% | |
Secured Debt | Term B Facility due September 12, 2029 | |||
Debt Instrument [Line Items] | |||
Total principal amount | $ 2,444 | $ 3,431 | |
Weighted average interest rate (as a percent) | 7.43% | 6.91% | |
Mortgages | 1.29% Avira Mortgage due December 30, 2029 | |||
Debt Instrument [Line Items] | |||
Stated interest rate (as a percent) | 1.29% | ||
Total principal amount | $ 3 | $ 4 | |
Effective Interest Rate | 1.29% | ||
Mortgages | 0.95% Avira Mortgage due December 30, 2030 | |||
Debt Instrument [Line Items] | |||
Stated interest rate (as a percent) | 0.95% | ||
Total principal amount | $ 3 | $ 3 | |
Effective Interest Rate | 0.95% |
Debt - Schedule of Maturities o
Debt - Schedule of Maturities of Long-term Debt (Details) - USD ($) $ in Millions | Mar. 29, 2024 | Mar. 31, 2023 |
Long-term Debt, Fiscal Year Maturity [Abstract] | ||
2025 | $ 175 | |
2026 | 1,392 | |
2027 | 233 | |
2028 | 4,017 | |
2029 | 38 | |
Thereafter | 2,861 | |
Total future maturities of debt | $ 8,716 | $ 9,899 |
Debt - Additional Information (
Debt - Additional Information (Details) | 12 Months Ended | ||||||
Sep. 19, 2022 USD ($) seniorNote | Sep. 12, 2022 USD ($) | Aug. 15, 2022 USD ($) $ / shares | Mar. 29, 2024 USD ($) | Mar. 31, 2023 USD ($) | Apr. 01, 2022 USD ($) | Feb. 09, 2017 USD ($) | |
Debt Instrument [Line Items] | |||||||
Debt covenant, aggregate acquisition amount benchmark | $ 250,000,000 | ||||||
Total principal amount | $ 8,716,000,000 | $ 9,899,000,000 | |||||
Interest expense paid | 607,000,000 | 390,000,000 | $ 120,000,000 | ||||
Exchange and extinguishment of convertible notes, equity adjustment | 100,000,000 | ||||||
Senior Notes | |||||||
Debt Instrument [Line Items] | |||||||
Number of debt instruments | seniorNote | 2 | ||||||
Amended and Restated Credit Agreement | |||||||
Debt Instrument [Line Items] | |||||||
Debt covenant, consolidated leverage ratio | 5.25 | ||||||
Amended and Restated Credit Agreement | Minimum | Secured Overnight Financing Rate (SOFR) Plus Credit Spread Adjustment (CSA) | |||||||
Debt Instrument [Line Items] | |||||||
Basis spread on variable rate (as a percent) | 0.125% | ||||||
Amended and Restated Credit Agreement | Minimum | Base Rate | |||||||
Debt Instrument [Line Items] | |||||||
Basis spread on variable rate (as a percent) | 1.125% | ||||||
Amended and Restated Credit Agreement | Maximum | |||||||
Debt Instrument [Line Items] | |||||||
Debt covenant, consolidated leverage ratio | 5.75 | ||||||
Amended and Restated Credit Agreement | Maximum | Secured Overnight Financing Rate (SOFR) Plus Credit Spread Adjustment (CSA) | |||||||
Debt Instrument [Line Items] | |||||||
Basis spread on variable rate (as a percent) | 0.75% | ||||||
Amended and Restated Credit Agreement | Maximum | Base Rate | |||||||
Debt Instrument [Line Items] | |||||||
Basis spread on variable rate (as a percent) | 1.75% | ||||||
Amended and Restated Credit Agreement | Weighted Average | |||||||
Debt Instrument [Line Items] | |||||||
Debt covenant, consolidated leverage ratio | 6 | ||||||
5.0% Senior Notes due April 15, 2025 | Senior Notes | |||||||
Debt Instrument [Line Items] | |||||||
Total principal amount | $ 1,100,000,000 | ||||||
Stated interest rate (as a percent) | 5% | ||||||
6.75% Senior Notes due September 30, 2027 | Senior Notes | |||||||
Debt Instrument [Line Items] | |||||||
Total principal amount | $ 900,000,000 | 900,000,000 | |||||
Stated interest rate (as a percent) | 6.75% | 6.75% | |||||
7.125% Senior Notes due September 30, 2030 | Senior Notes | |||||||
Debt Instrument [Line Items] | |||||||
Total principal amount | $ 600,000,000 | $ 600,000,000 | |||||
Stated interest rate (as a percent) | 7.125% | 7.125% | |||||
6.75% And 7.125% Senior Notes | Senior Notes | |||||||
Debt Instrument [Line Items] | |||||||
Principal amount | $ 1,500,000,000 | ||||||
New 2.0% Convertible Senior Notes Due August 15, 2022 | Convertible Debt | |||||||
Debt Instrument [Line Items] | |||||||
Principal amount | $ 525,000,000 | ||||||
Stated interest rate (as a percent) | 2% | ||||||
Payment for debt extinguishment | $ 630,000,000 | ||||||
Dilutive earnings per share (in dollars per share) | $ / shares | $ 20.41 | ||||||
Interest expense paid | $ 5,000,000 | ||||||
Exchange and extinguishment of convertible notes, equity adjustment | $ 100,000,000 | ||||||
Revolving Credit Facility | Line of Credit | |||||||
Debt Instrument [Line Items] | |||||||
Line of credit, amount outstanding | $ 0 | ||||||
Term Loan Interim Facility A | Amended and Restated Credit Agreement | |||||||
Debt Instrument [Line Items] | |||||||
Quarterly installment payment (as a percent) | 1.25% | ||||||
Term Loan Interim Facility B | Amended and Restated Credit Agreement | |||||||
Debt Instrument [Line Items] | |||||||
Quarterly installment payment (as a percent) | 0.25% | ||||||
Avast plc | Revolving Credit Facility | Amended and Restated Credit Agreement | |||||||
Debt Instrument [Line Items] | |||||||
Principal amount | $ 1,500,000,000 | ||||||
Avast plc | Term Loan Interim Facility A | Amended and Restated Credit Agreement | |||||||
Debt Instrument [Line Items] | |||||||
Principal amount | 3,910,000,000 | ||||||
Avast plc | Term Loan Interim Facility B | Amended and Restated Credit Agreement | |||||||
Debt Instrument [Line Items] | |||||||
Principal amount | 3,690,000,000 | ||||||
Avast plc | Bridge Loan | Amended and Restated Credit Agreement | |||||||
Debt Instrument [Line Items] | |||||||
Principal amount | $ 750,000,000 |
Debt - Schedule of Interest Exp
Debt - Schedule of Interest Expense and Debt Discount and Issuance Costs (Details) - Convertible Debt - USD ($) $ in Millions | 12 Months Ended | |
Mar. 31, 2023 | Apr. 01, 2022 | |
Debt Instrument [Line Items] | ||
Contractual interest expense | $ 4 | $ 12 |
Amortization of debt discount and issuance costs | 0 | 4 |
Payments in lieu of conversion price adjustments | $ 1 | $ 8 |
Derivatives - Additional Inform
Derivatives - Additional Information (Details) | Mar. 29, 2024 USD ($) |
Derivative [Line Items] | |
Interest rate hedges | $ 12,000,000 |
Interest rate swaps | 3.762% Fixed Rate | |
Derivative [Line Items] | |
Notional Amount | $ 500,000,000 |
Fixed rate (as a percent) | 3.762% |
Interest rate swaps | 3.55% Fixed Rate | |
Derivative [Line Items] | |
Notional Amount | $ 500,000,000 |
Fixed rate (as a percent) | 3.55% |
Term A Facility due September 12, 2027 | |
Derivative [Line Items] | |
Maximum borrowing capacity | $ 1,000,000,000 |
Derivatives - Schedule of Deriv
Derivatives - Schedule of Derivative Instruments (Details) - Cash Flow Hedging - USD ($) $ in Millions | Mar. 29, 2024 | Mar. 31, 2023 |
Derivatives, Fair Value [Line Items] | ||
Notional Amount | $ 1,345 | $ 1,291 |
Fair Value of Derivative Assets | 16 | 1 |
Fair Value of Derivative Liabilities | 0 | 2 |
Foreign Exchange Forward | ||
Derivatives, Fair Value [Line Items] | ||
Fair values of foreign exchange contracts | 1 | 1 |
Foreign Exchange Forward | Not Designated as Hedging Instrument | ||
Derivatives, Fair Value [Line Items] | ||
Notional Amount | 345 | 291 |
Fair Value of Derivative Assets | 0 | 0 |
Fair Value of Derivative Liabilities | 0 | 0 |
Interest rate swaps | Designated as Hedging Instrument | ||
Derivatives, Fair Value [Line Items] | ||
Notional Amount | 1,000 | 1,000 |
Fair Value of Derivative Assets | 16 | 1 |
Fair Value of Derivative Liabilities | $ 0 | $ 2 |
Derivatives - Schedule of Effec
Derivatives - Schedule of Effect of Cash Flow Hedges on AOCI (Details) - USD ($) $ in Millions | 12 Months Ended | |
Mar. 29, 2024 | Mar. 31, 2023 | |
Interest rate swaps | ||
Derivatives, Fair Value [Line Items] | ||
Interest rate swap contracts designated as cash flow hedge | $ (32) | $ 0 |
Derivatives - Schedule of Der_2
Derivatives - Schedule of Derivative Instruments, Gain (Loss) (Details) - USD ($) $ in Millions | 3 Months Ended | 12 Months Ended | |
Mar. 29, 2024 | Mar. 31, 2023 | Apr. 01, 2022 | |
Derivatives, Fair Value [Line Items] | |||
Derivative, gain (loss) on derivative, net | $ 9 | $ (7) | $ (7) |
Not Designated as Hedging Instrument | Foreign Exchange Forward | |||
Derivatives, Fair Value [Line Items] | |||
Derivative, gain (loss) on derivative, net | (7) | (7) | (7) |
Designated as Hedging Instrument | Interest rate swaps | |||
Derivatives, Fair Value [Line Items] | |||
Derivative, gain (loss) on derivative, net | $ 16 | $ 0 | $ 0 |
Restructuring and Other Costs -
Restructuring and Other Costs - Additional Information (Details) - USD ($) $ in Millions | Mar. 29, 2024 | Dec. 31, 2020 |
September 2022 Plan | ||
Restructuring Cost and Reserve [Line Items] | ||
Expected cost of restructuring | $ 150 | |
Cumulative restructuring cost incurred to date | $ 125 | |
December 2020 Plan | ||
Restructuring Cost and Reserve [Line Items] | ||
Cumulative restructuring cost incurred to date | $ 24 |
Restructuring and Other Costs_2
Restructuring and Other Costs - Schedule of Restructuring Summary (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Mar. 29, 2024 | Mar. 31, 2023 | Apr. 01, 2022 | |
Restructuring Reserve [Roll Forward] | |||
Net Charges | $ 57 | $ 69 | $ 31 |
Severance and termination benefit costs | |||
Restructuring Reserve [Roll Forward] | |||
Net Charges | 42 | 40 | 5 |
Contract cancellation charges | |||
Restructuring Reserve [Roll Forward] | |||
Net Charges | 5 | 2 | 3 |
Stock-based compensation charges | |||
Restructuring Reserve [Roll Forward] | |||
Net Charges | 1 | 11 | 0 |
Other exit and disposal costs | |||
Restructuring Reserve [Roll Forward] | |||
Net Charges | 8 | 12 | $ 18 |
September 2022 Plan | |||
Restructuring Reserve [Roll Forward] | |||
Beginning balance | 7 | ||
Net Charges | 56 | ||
Cash Payments | (41) | ||
Non-Cash Items | (2) | ||
Ending balance | 20 | 7 | |
September 2022 Plan | Severance and termination benefit costs | |||
Restructuring Reserve [Roll Forward] | |||
Beginning balance | 7 | ||
Net Charges | 42 | ||
Cash Payments | (29) | ||
Non-Cash Items | 0 | ||
Ending balance | 20 | 7 | |
September 2022 Plan | Contract cancellation charges | |||
Restructuring Reserve [Roll Forward] | |||
Beginning balance | 0 | ||
Net Charges | 5 | ||
Cash Payments | (5) | ||
Non-Cash Items | 0 | ||
Ending balance | 0 | 0 | |
September 2022 Plan | Stock-based compensation charges | |||
Restructuring Reserve [Roll Forward] | |||
Beginning balance | 0 | ||
Net Charges | 1 | ||
Cash Payments | 0 | ||
Non-Cash Items | (1) | ||
Ending balance | 0 | 0 | |
September 2022 Plan | Asset write-offs | |||
Restructuring Reserve [Roll Forward] | |||
Beginning balance | 0 | ||
Net Charges | 1 | ||
Cash Payments | 0 | ||
Non-Cash Items | (1) | ||
Ending balance | 0 | 0 | |
September 2022 Plan | Other exit and disposal costs | |||
Restructuring Reserve [Roll Forward] | |||
Beginning balance | 0 | ||
Net Charges | 7 | ||
Cash Payments | (7) | ||
Non-Cash Items | 0 | ||
Ending balance | $ 0 | $ 0 |
Restructuring and Other Costs_3
Restructuring and Other Costs - Schedule of Restructuring and Other Costs (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Mar. 29, 2024 | Mar. 31, 2023 | Apr. 01, 2022 | |
Restructuring Cost and Reserve [Line Items] | |||
Restructuring and other costs | $ 57 | $ 69 | $ 31 |
Severance and termination benefit costs | |||
Restructuring Cost and Reserve [Line Items] | |||
Restructuring and other costs | 42 | 40 | 5 |
Contract cancellation charges | |||
Restructuring Cost and Reserve [Line Items] | |||
Restructuring and other costs | 5 | 2 | 3 |
Stock-based compensation charges | |||
Restructuring Cost and Reserve [Line Items] | |||
Restructuring and other costs | 1 | 11 | 0 |
Asset write-offs and impairments | |||
Restructuring Cost and Reserve [Line Items] | |||
Restructuring and other costs | 1 | 4 | 5 |
Other exit and disposal costs | |||
Restructuring Cost and Reserve [Line Items] | |||
Restructuring and other costs | $ 8 | $ 12 | $ 18 |
Income Taxes - Components of Ou
Income Taxes - Components of Our Income (loss) Before Income Taxes (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Mar. 29, 2024 | Mar. 31, 2023 | Apr. 01, 2022 | |
Income Tax Disclosure [Abstract] | |||
Domestic | $ 78 | $ 350 | $ 791 |
International | 381 | 454 | 251 |
Income (loss) before income taxes | $ 459 | $ 804 | $ 1,042 |
Income Taxes - Components of In
Income Taxes - Components of Income Tax Expense (Benefit) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Mar. 29, 2024 | Mar. 31, 2023 | Apr. 01, 2022 | |
Current: | |||
Federal | $ 201 | $ (479) | $ 217 |
State | 43 | (28) | 50 |
International | 579 | 99 | 20 |
Total | 823 | (408) | 287 |
Deferred: | |||
Federal | (727) | (111) | (42) |
State | (133) | (10) | (6) |
International | (120) | (16) | (33) |
Total | (980) | (137) | (81) |
Income tax expense (benefit) | $ (157) | $ (545) | $ 206 |
Income Taxes - Effective Income
Income Taxes - Effective Income Tax Rate, Federal Statutory Income Tax Rate (Details) | 12 Months Ended | ||
Mar. 29, 2024 | Mar. 31, 2023 | Apr. 01, 2022 | |
Income Tax Disclosure [Abstract] | |||
U.S. federal statutory income tax rate | 21% | 21% | 21% |
Income Taxes - Schedule of Diff
Income Taxes - Schedule of Difference Between Effective Income Tax and Federal Statutory Income Tax (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Mar. 29, 2024 | Mar. 31, 2023 | Apr. 01, 2022 | |
Income Tax Disclosure [Abstract] | |||
Federal statutory tax expense (benefit) | $ 96 | $ 169 | $ 219 |
State taxes, net of federal benefit | 0 | 1 | 33 |
Foreign earnings taxed at other than the federal rate | (22) | (11) | (47) |
Nondeductible expenses | 48 | 20 | 0 |
Federal research and development credit | (6) | (5) | (4) |
Valuation allowance increase (decrease) | (4) | (33) | 2 |
Change in unrecognized tax benefits | 338 | 163 | (2) |
Tax interest and penalties | 129 | 13 | 13 |
Stock-based compensation | 17 | 9 | 7 |
US tax on foreign earnings | 20 | 12 | 12 |
Return to provision adjustment | 0 | 1 | (8) |
Foreign exchange loss (gain) | (28) | (17) | (19) |
Capital loss | (44) | (910) | 0 |
Legal entity restructuring | (719) | 42 | 0 |
Other, net | 18 | 1 | 0 |
Income tax expense (benefit) | $ (157) | $ (545) | $ 206 |
Income Taxes - Principal Compon
Income Taxes - Principal Components of Deferred Tax Assets and Liabilities (Details) - USD ($) $ in Millions | Mar. 29, 2024 | Mar. 31, 2023 |
Deferred tax assets: | ||
Tax credit carryforwards | $ 27 | $ 24 |
Net operating loss carryforwards of acquired companies | 60 | 60 |
Interest | 63 | 37 |
Other accruals and reserves not currently tax deductible | 332 | 95 |
Goodwill | 517 | 0 |
Capitalized research and experimental expenditures | 82 | 46 |
Loss on investments not currently tax deductible | 60 | 68 |
Other | 56 | 97 |
Gross deferred tax assets | 1,197 | 427 |
Valuation allowance | (93) | (97) |
Deferred tax assets, net of valuation allowance | 1,104 | 330 |
Deferred tax liabilities: | ||
Intangible assets | (127) | (328) |
Unremitted earnings of foreign subsidiaries | (14) | (15) |
Other | (9) | (20) |
Deferred tax liabilities | (150) | (363) |
Net deferred tax assets (liabilities) | $ 954 | |
Net deferred tax assets (liabilities) | $ (33) |
Income Taxes - Additional Infor
Income Taxes - Additional Information (Details) - USD ($) $ in Millions | 3 Months Ended | 12 Months Ended | |
Sep. 29, 2023 | Mar. 29, 2024 | Mar. 31, 2023 | |
Income Taxes [Line Items] | |||
Valuation allowance | $ 93 | $ 97 | |
Operating loss carryforwards, subject to expiration | 28 | ||
Operating loss carryforwards, not subject to expiration | 164 | ||
Tax refund | 954 | ||
Change in gross unrecognized tax benefit | $ 285 | 453 | |
Unrecognized tax benefits which would affect the effective income tax rate | 1,007 | ||
Accrued penalties and interest | 225 | ||
Interest included in the provision for income taxes | 43 | ||
Deferred tax liability | 14 | $ 15 | |
U.S. Federal | |||
Income Taxes [Line Items] | |||
Tax refund | 899 | ||
Domestic | U.S. Federal | |||
Income Taxes [Line Items] | |||
Operating loss carryforwards | 192 | ||
State | |||
Income Taxes [Line Items] | |||
Operating loss carryforwards | 133 | ||
Tax refund | 2 | ||
Foreign | |||
Income Taxes [Line Items] | |||
Operating loss carryforwards | $ 14 |
Income Taxes - Schedule Of Chan
Income Taxes - Schedule Of Changes In Unrecognized Tax Benefits (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Mar. 29, 2024 | Mar. 31, 2023 | Apr. 01, 2022 | |
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward] | |||
Balance at beginning of year | $ 710 | $ 527 | $ 548 |
Settlements with tax authorities | (8) | (2) | 0 |
Lapse of statute of limitations | (14) | (96) | (34) |
Increase related to prior period tax positions | 47 | 9 | 16 |
Decrease related to prior period tax positions | (9) | (15) | (11) |
Increase related to current year tax positions | 467 | 259 | 8 |
Increase due to acquisition | 0 | 28 | 0 |
Decrease related to foreign currency exchange rates | (30) | ||
Increase related to foreign currency exchange rates | 0 | 0 | |
Balance at end of year | $ 1,163 | $ 710 | $ 527 |
Stockholders' Equity - Addition
Stockholders' Equity - Additional Information (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions | 12 Months Ended | ||||
May 09, 2024 | Mar. 29, 2024 | Mar. 31, 2023 | Apr. 01, 2022 | May 14, 2024 | |
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||||
Cash dividends declared per common share (in dollars per share) | $ 0.50 | $ 0.50 | $ 0.50 | ||
Subsequent Event | |||||
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||||
Cash dividends declared per common share (in dollars per share) | $ 0.125 | ||||
Share Repurchase Program | |||||
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||||
Remaining authorized repurchase amount | $ 429 | ||||
New Share Repurchase Program | Subsequent Event | |||||
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||||
Stock repurchase, authorized amount | $ 3,000 | ||||
Liability-Classified Awards | Subsequent Event | |||||
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||||
Outstanding and unvested (in shares) | 4 |
Stockholders' Equity - Schedule
Stockholders' Equity - Schedule of Stock Repurchase Program (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions | 12 Months Ended | |
Mar. 29, 2024 | Mar. 31, 2023 | |
Stockholders' Equity Note [Abstract] | ||
Number of shares repurchased (in shares) | 21 | 40 |
Average price per share (in dollars per share) | $ 20.87 | $ 22.63 |
Aggregate purchase price | $ 441 | $ 904 |
Stockholders' Equity - Schedu_2
Stockholders' Equity - Schedule of Accumulated Other Comprehensive Income (Loss) (Details) - USD ($) $ in Millions | 12 Months Ended | |
Mar. 29, 2024 | Mar. 31, 2023 | |
AOCI Attributable to Parent, Net of Tax [Roll Forward] | ||
Beginning balance | $ 2,200 | $ (93) |
Ending balance | 2,197 | 2,200 |
Accumulated Other Comprehensive Income (Loss) | ||
AOCI Attributable to Parent, Net of Tax [Roll Forward] | ||
Beginning balance | (15) | (4) |
Other comprehensive income (loss), net of taxes | 26 | (11) |
Ending balance | 11 | (15) |
Foreign Currency Translation Adjustments | ||
AOCI Attributable to Parent, Net of Tax [Roll Forward] | ||
Beginning balance | (15) | (4) |
Other comprehensive income (loss), net of taxes | 10 | (11) |
Ending balance | (5) | (15) |
Net Unrealized Gain (Loss) On Interest Rate Derivative | ||
AOCI Attributable to Parent, Net of Tax [Roll Forward] | ||
Beginning balance | 0 | 0 |
Other comprehensive income (loss), net of taxes | 16 | 0 |
Ending balance | $ 16 | $ 0 |
Stock-Based Compensation and _3
Stock-Based Compensation and Benefit Plans - Additional Information (Details) $ / shares in Units, $ in Millions | 12 Months Ended | ||
Mar. 29, 2024 USD ($) plan purchasePeriod $ / shares shares | Mar. 31, 2023 USD ($) $ / shares shares | Apr. 01, 2022 USD ($) $ / shares shares | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Number of equity incentive plans | plan | 2 | ||
Current dividends payable | $ | $ 4 | $ 5 | |
Long-term dividend payable | $ | $ 4 | $ 2 | |
Award (in shares) | 0 | 0 | 0 |
Liability-Classified Awards | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Unrecognized compensation costs | $ | $ 186 | ||
Weighted-average remaining (in years) | 1 year 9 months 18 days | ||
Restricted Stock Units (RSUs) | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Outstanding and unvested (in shares) | 8,000,000 | 9,000,000 | |
Award vesting period (in years) | 3 years | ||
Weighted-average grant date fair value (in dollars per share) | $ / shares | $ 17.42 | $ 22.38 | $ 22.53 |
Total fair value of stock released | $ | $ 85 | $ 74 | $ 57 |
Weighted average grant date fair value (in dollars per share) | $ / shares | $ 19.39 | $ 22.45 | |
PRUs | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Outstanding and unvested (in shares) | 5,000,000 | 5,000,000 | |
Award vesting period (in years) | 3 years | ||
Weighted-average grant date fair value (in dollars per share) | $ / shares | $ 22.83 | $ 27.07 | $ 28.68 |
Total fair value of stock released | $ | $ 20 | $ 5 | $ 0 |
Award performance conditions measurement period (in years) | 2 years | ||
Weighted average grant date fair value (in dollars per share) | $ / shares | $ 26.02 | $ 27.93 | |
Employee Stock Purchase Plan | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Remaining shares available for future issuance (in shares) | 31,000,000 | ||
Maximum employee subscription rate (up to) (as a percent) | 10% | ||
Award offering period (in months) | 12 months | ||
Purchase periods, number | purchasePeriod | 2 | ||
Purchase period (in months) | 6 months | ||
Purchase price of common stock (as a percent) | 85% | ||
Stock issued under employee stock purchase plan (in shares) | 39,000,000 | ||
Weighted average grant date fair value (in dollars per share) | $ / shares | $ 5.45 | $ 6.04 | $ 6.77 |
Minimum | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Performance award range (as a percent) | 0% | ||
Minimum | PRUs | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Award market conditions measurement period (in years) | 3 years | ||
Maximum | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Performance award range (as a percent) | 200% | ||
Maximum | PRUs | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Award vesting period (in years) | 5 years | ||
2013 Equity Incentive Plan | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Shares approved and reserved for issuance (in shares) | 82,000,000 | ||
Remaining shares available for future issuance (in shares) | 3,000,000 | ||
2013 Equity Incentive Plan | Stock Options | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Expiration period (in years) | 10 years |
Stock-Based Compensation and _4
Stock-Based Compensation and Benefit Plans - Schedule of RSUs and PSUs Activity (Details) - $ / shares shares in Millions | 12 Months Ended | ||
Mar. 29, 2024 | Mar. 31, 2023 | Apr. 01, 2022 | |
Restricted Stock Units (RSUs) | |||
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] | |||
Number of shares, unvested at beginning of year (in shares) | 9 | ||
Number of shares, granted (in shares) | 5 | ||
Number of shares, vested (in shares) | (5) | ||
Number of shares, forfeited (in shares) | (1) | ||
Number of shares, unvested at end of year (in shares) | 8 | 9 | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] | |||
Weighted-average exercise price, outstanding and unvested at beginning of year (in dollars per share) | $ 22.45 | ||
Weighted-average exercise price, granted (in dollars per share) | 17.42 | $ 22.38 | $ 22.53 |
Weighted-average exercise price, vested (in dollars per share) | 22.30 | ||
Weighted-average exercise price, forfeited (in dollars per share) | 20.84 | ||
Weighted-average exercise price, outstanding and unvested at end of year (in dollars per share) | $ 19.39 | $ 22.45 | |
PRUs | |||
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] | |||
Number of shares, unvested at beginning of year (in shares) | 5 | ||
Number of shares, granted (in shares) | 2 | ||
Number of shares, vested (in shares) | (2) | ||
Number of shares, forfeited (in shares) | 0 | ||
Number of shares, unvested at end of year (in shares) | 5 | 5 | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] | |||
Weighted-average exercise price, outstanding and unvested at beginning of year (in dollars per share) | $ 27.93 | ||
Weighted-average exercise price, granted (in dollars per share) | 22.83 | $ 27.07 | $ 28.68 |
Weighted-average exercise price, vested (in dollars per share) | 28.24 | ||
Weighted-average exercise price, forfeited (in dollars per share) | 28.49 | ||
Weighted-average exercise price, outstanding and unvested at end of year (in dollars per share) | $ 26.02 | $ 27.93 |
Stock-Based Compensation and _5
Stock-Based Compensation and Benefit Plans - Valuation Assumptions (Details) - PRUs - $ / shares | 12 Months Ended | ||
Mar. 29, 2024 | Mar. 31, 2023 | Apr. 01, 2022 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Expected term | 2 years 10 months 24 days | 3 years 3 months 18 days | 3 years 10 months 24 days |
Expected volatility | 31.50% | 34.80% | 37.60% |
Risk-free interest rate | 3.50% | 3.40% | 1% |
Expected dividend yield | 0% | 1.30% | 0% |
Weighted-average grant date fair value of PRUs (in dollars per share) | $ 22.83 | $ 27.07 | $ 28.68 |
Stock-Based Compensation and _6
Stock-Based Compensation and Benefit Plans - Employee Stock Purchase Plan Activity (Details) - 2008 Employee Stock Purchase Plan - USD ($) shares in Millions, $ in Millions | 12 Months Ended | ||
Mar. 29, 2024 | Mar. 31, 2023 | Apr. 01, 2022 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Stock issued under ESPP (in shares) | 1 | 1 | 1 |
Proceeds from issuance of shares | $ 12 | $ 12 | $ 13 |
Stock-Based Compensation and _7
Stock-Based Compensation and Benefit Plans - Schedule of Stock-based Compensation Expense (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Mar. 29, 2024 | Mar. 31, 2023 | Apr. 01, 2022 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Total stock-based compensation expense | $ 138 | $ 134 | $ 70 |
Income tax benefit for stock-based compensation expense | (16) | (20) | (11) |
Cost of revenues | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Total stock-based compensation expense | 4 | 3 | 2 |
Sales and marketing | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Total stock-based compensation expense | 36 | 34 | 19 |
Research and development | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Total stock-based compensation expense | 39 | 31 | 19 |
General and administrative | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Total stock-based compensation expense | 58 | 55 | 30 |
Restructuring and other costs | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Total stock-based compensation expense | $ 1 | $ 11 | $ 0 |
Stock-Based Compensation and _8
Stock-Based Compensation and Benefit Plans - Employer 401K Matching Contributions (Details) - USD ($) | 12 Months Ended | ||
Mar. 29, 2024 | Mar. 31, 2023 | Apr. 01, 2022 | |
Share-Based Payment Arrangement [Abstract] | |||
Contributions per employee, percent | 3.50% | ||
Contributions per employee, amount | $ 6,000 | ||
401(k) matching contributions | $ 4,000,000 | $ 4,000,000 | $ 3,000,000 |
Net Income (Loss) Per Share - S
Net Income (Loss) Per Share - Schedule of Components of Net Income Per Share (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions | 12 Months Ended | ||
Mar. 29, 2024 | Mar. 31, 2023 | Apr. 01, 2022 | |
Earnings Per Share [Abstract] | |||
Net income (loss) | $ 616 | $ 1,349 | $ 836 |
Net income per share - basic (in dollars per share) | $ 0.97 | $ 2.20 | $ 1.44 |
Net income per share - diluted (in dollars per share) | $ 0.96 | $ 2.16 | $ 1.41 |
Weighted-average shares outstanding — basic (in shares) | 637 | 614 | 581 |
Dilutive potentially issuable shares: | |||
Dilutive potentially issuable shares - convertible debt (in shares) | 0 | 6 | 7 |
Dilutive potentially issuable shares - employee equity awards (in shares) | 5 | 4 | 3 |
Weighted-average shares outstanding - diluted (in shares) | 642 | 624 | 591 |
Employee equity awards | |||
Anti-dilutive shares excluded from diluted net income (loss) per share calculation: | |||
Anti-dilutive shares excluded from diluted net income per share calculation (in shares) | 1 | 0 | 1 |
Segment and Geographic Inform_3
Segment and Geographic Information - Additional Information (Details) $ in Millions | 12 Months Ended | ||
Mar. 29, 2024 USD ($) segment | Mar. 31, 2023 USD ($) | Apr. 01, 2022 USD ($) | |
Segment Reporting Information [Line Items] | |||
Number of reportable segment | segment | 1 | ||
Revenues | $ 3,812 | $ 3,338 | $ 2,796 |
U.S. | |||
Segment Reporting Information [Line Items] | |||
Revenues | $ 2,270 | $ 2,071 | $ 1,834 |
Segment and Geographic Inform_4
Segment and Geographic Information - Schedule of Product Revenue Information (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Mar. 29, 2024 | Mar. 31, 2023 | Apr. 01, 2022 | |
Segment Reporting Information [Line Items] | |||
Net revenues | $ 3,812 | $ 3,338 | $ 2,796 |
Unfavorable foreign exchange impact on revenue | (25) | ||
Consumer security revenues | |||
Segment Reporting Information [Line Items] | |||
Net revenues | 2,417 | 2,029 | 1,623 |
Unfavorable foreign exchange impact on revenue | (24) | ||
Identity and information protection revenues | |||
Segment Reporting Information [Line Items] | |||
Net revenues | 1,332 | 1,244 | 1,127 |
Unfavorable foreign exchange impact on revenue | (1) | ||
Total cyber safety revenues | |||
Segment Reporting Information [Line Items] | |||
Net revenues | 3,749 | 3,273 | 2,750 |
Legacy revenues | |||
Segment Reporting Information [Line Items] | |||
Net revenues | $ 63 | $ 65 | $ 46 |
Segment and Geographic Inform_5
Segment and Geographic Information - Schedule of Revenue by Geographical Location (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Mar. 29, 2024 | Mar. 31, 2023 | Apr. 01, 2022 | |
Revenue from External Customer [Line Items] | |||
Net revenues | $ 3,812 | $ 3,338 | $ 2,796 |
Unfavorable foreign exchange impact on revenue | (25) | ||
Americas | |||
Revenue from External Customer [Line Items] | |||
Net revenues | 2,493 | 2,247 | 1,936 |
EMEA | |||
Revenue from External Customer [Line Items] | |||
Net revenues | 920 | 724 | 522 |
Unfavorable foreign exchange impact on revenue | (14) | ||
APJ | |||
Revenue from External Customer [Line Items] | |||
Net revenues | 399 | $ 367 | $ 338 |
Unfavorable foreign exchange impact on revenue | $ (11) |
Segment and Geographic Inform_6
Segment and Geographic Information - Schedule of Assets by Geographic Location (Details) - USD ($) $ in Millions | Mar. 29, 2024 | Mar. 31, 2023 |
Revenue from External Customer [Line Items] | ||
Total cash and cash equivalents | $ 846 | $ 750 |
Total property and equipment, net | 72 | 76 |
U.S. | ||
Revenue from External Customer [Line Items] | ||
Total cash and cash equivalents | 467 | 178 |
Total property and equipment, net | 47 | 38 |
International | ||
Revenue from External Customer [Line Items] | ||
Total cash and cash equivalents | 379 | 572 |
Germany | ||
Revenue from External Customer [Line Items] | ||
Total property and equipment, net | 12 | 13 |
Czech Republic | ||
Revenue from External Customer [Line Items] | ||
Total property and equipment, net | 6 | 16 |
Other countries | ||
Revenue from External Customer [Line Items] | ||
Total property and equipment, net | $ 7 | $ 9 |
Commitments and Contingencies -
Commitments and Contingencies - Schedule of Unrecognized Purchase Obligations (Details) $ in Millions | Mar. 29, 2024 USD ($) |
Commitments and Contingencies Disclosure [Abstract] | |
2025 | $ 324 |
2026 | 73 |
2027 | 47 |
2028 | 36 |
2029 | 28 |
Thereafter | 2 |
Total purchase obligations | $ 510 |
Commitments and Contingencies_2
Commitments and Contingencies - Schedule of Deemed Repatriation Taxes (Details) $ in Millions | Mar. 29, 2024 USD ($) |
Commitments and Contingencies Disclosure [Abstract] | |
2025 | $ 171 |
2026 | 139 |
Total obligations | $ 310 |
Commitments and Contingencies_3
Commitments and Contingencies - Additional Information (Details) Kč in Millions | 1 Months Ended | 12 Months Ended | 69 Months Ended | |||||||||||||
Jan. 16, 2024 USD ($) | Sep. 30, 2023 multiplier | Jan. 19, 2023 USD ($) | Jan. 04, 2023 USD ($) | May 02, 2022 USD ($) coinventor patent numberOfClaim | Feb. 28, 2022 USD ($) | Jun. 08, 2021 USD ($) | May 24, 2021 USD ($) | May 13, 2021 USD ($) | Jan. 31, 2014 USD ($) | Mar. 29, 2024 USD ($) lawsuit | Mar. 31, 2023 USD ($) | Apr. 01, 2022 USD ($) | Sep. 30, 2012 USD ($) | Jan. 31, 2023 USD ($) | Feb. 27, 2020 CZK (Kč) | |
Loss Contingencies [Line Items] | ||||||||||||||||
Loss contingency, number of patent, claim | 6 | 3 | ||||||||||||||
Litigation settlement payment | $ 12,000,000 | $ 70,000,000 | $ 70,000,000 | |||||||||||||
Number of coinventors | coinventor | 2 | |||||||||||||||
Estimated loss (low end) | Kč | Kč 351 | |||||||||||||||
Loss contingency, insurance recoveries | $ 67,000,000 | |||||||||||||||
Net revenues | $ 3,812,000,000 | $ 3,338,000,000 | $ 2,796,000,000 | |||||||||||||
U.S. | ||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||
Loss contingency, damages awarded, value | $ 53,000,000 | $ 1,300,000 | ||||||||||||||
Net revenues | $ 2,270,000,000 | $ 2,071,000,000 | $ 1,834,000,000 | |||||||||||||
California | ||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||
Loss contingency, damages awarded, value | $ 400,000 | |||||||||||||||
322 Patents Remained in Suit | ||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||
Loss contingency, pending claims, number | numberOfClaim | 2 | |||||||||||||||
115 Patents Remained in Suit | ||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||
Loss contingency, pending claims, number | numberOfClaim | 3 | |||||||||||||||
Trustees of the University of Columbia in the City of New York v. NortonLifeLock | ||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||
Litigation settlement payment | $ 185,000,000 | |||||||||||||||
Loss contingency, damages awarded, value | 0 | |||||||||||||||
Multiplier | multiplier | 2.6 | |||||||||||||||
Estimated loss (low end) | $ 583,000,000 | $ 53,000,000 | ||||||||||||||
GSA Schedule Contract | ||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||
Litigation settlement payment | $ 5,000,000 | $ 500,000 | ||||||||||||||
Net revenues | $ 222,000,000 | |||||||||||||||
Estimated damage | $ 145,000,000 | |||||||||||||||
GSA Schedule Contract | Minimum | ||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||
Estimated litigation payment as times of actual damages proven | 1 | |||||||||||||||
GSA Schedule Contract | Maximum | ||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||
Estimated litigation payment as times of actual damages proven | 3 |